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Abstract 
 
Over 94% of human genes are alternatively spliced. Alternative splicing regulation is 
necessary for some developmental pathways. Many proteins including RNA binding 
proteins such as STAR family, hnRNPs, SR and SR-like proteins are involved in 
alternative splicing regulation. Some members of these proteins also have important 
roles in gene expression, transcription, signal transduction, RNA metabolism, cell cycle 
regulation and cancer. Although these proteins are known to be involved in alternative 
splicing control of specific targets, mechanisms of many of their actions and protein 
interaction partners are unknown. The aim of present study was the identification and 
characterization of protein interaction partners of some of these proteins including: 
STAR family (T-STAR, Sam68), hnRNP proteins (hnRNP G, hnRNP G-T) and SR-like 
proteins (Tra2β). The cDNAs of T-STAR, wild type Sam68 and P439R mutant Sam68 
were cloned into a FLAG epitope encoding vector. The next step was generation of 
stable cell lines expressing these FLAG tagged proteins. To induce protein expression, 
stable cell lines were treated with tetracycline. The wild type Sam68-FLAG tagged 
protein was nuclear, while the P439R mutant Sam68-FLAG had cytoplasmic localization. 
Using immunoprecipitation and mass spectroscopy, both FLAG tagged proteins and co-
purified proteins were purified and identified. RHA (RNA helicase A) was detected as 
an interacting partner for T-STAR, wild type and P439R mutant Sam68. Also, CCAR1 
(cell division cycle and apoptosis regulator 1) was detected as a further partner for wild 
type and mutant Sam68. In addition, stable cell lines expressing FLAG tagged hnRNP G, 
hnRNP G-T and Tra2β were generated. These proteins and their candidate protein 
partners were pulled down and detected using immunoprecipitation and mass 
spectroscopy. Some of these detected proteins such as hnRNP C, hnRNP CL1 and RNA 
binding motif protein, X-Linked-Like 1 were common interacting candidates for both 
hnRNP G and hnRNP G-T. In addition to confirmation the roles of hnRNP G and hnRNP 
G-T in reduction of cell growth, the over-expression of hnRNP G-T led to remarkable 
cell morphological changes and alternative splicing of some target genes. In conclusion, 
in this project new interacting protein partners for T-STAR, Sam68, hnRNP G, hnRNP G-
T were detected which their roles need to be tested within the cell.
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1 Introduction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
1.1 Human genes produce multiple mRNAs 
 
From a molecular view, a gene is defined as a nucleic acid sequence which give rises to 
functional products such as proteins and RNAs (Lodish, 2004; Gerstein et al., 2007). In 
eukaryotic cells there are different machineries for controlling gene expression. At first 
it seemed that selection and activation of gene promoters are most important factors 
for regulation of gene expression. This view was changed by understanding more 
about post-transcriptional mechanisms (Siomi and Dreyfuss, 1997). Although in 
prokaryotes transcription and translation take place at the same location, in 
eukaryotes transcription happens in the nucleus and translation occurs in the 
cytoplasm. As a result this leads to more post-transcriptional processing of pre-mRNAs 
(Glisovic et al., 2008).  
For a long time there was a belief that the number of genes established the complexity 
of an organism. This idea was changed after discovering the fact that there is not very 
much difference in the number of genes between human and less complex creatures. 
Therefore, there must be other processes inside the cell which lead to human 
complexity. By post-transcriptional regulation diverse cell types can adjust patterns of 
their gene expression in different situations. Especially in some developmental 
processes such as pattern configuration and differentiation, post-transcriptional 
regulation has a very important role (Siomi and Dreyfuss, 1997).  Also creation of 
different types of proteins from one single gene can be achieved by post-
transcriptional regulation of gene expression. Ways for generating RNA sequence 
diversity include: RNA editing (Smith and Sowden, 1996), alternative polyadenylation 
site selection (Proudfoot, 1996), and alternative splicing of pre-mRNAs (Chabot, 1996) 
(figure1). 
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Figure 1: Some ways to produce RNA sequence diversity. Alternative splicing, RNA 
editing and alternative polyA site selection are some of the important ways to 
produce RNA sequence diversity. Alternative splicing can lead to different 
combination of exons from one pre-mRNA and to generate diverse mRNAs.  Base RNA 
editing changes such as C→U and also alternative polyA site selection can lead to  the 
production of RNA sequence diversity. The picture is modified from (Siomi and 
Dreyfuss, 1997). 
 
 
1.2 Alternative splicing 
 
Pre-mRNAs are produced by RNA Polymerase II. They also have a historical name, 
heterogeneous nuclear RNAs (hnRNAs), which describes the heterogeneity and 
localization of pre-mRNA (Dreyfuss et al., 2002). Production of mature mRNA requires 
some processes such as capping, polyadenylation and splicing (Beyer and Osheim, 
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1988; Bauren et al., 1998). The splicing process was discovered for the first time in 
1977 (Berget et al., 1977; Chow et al., 1977; Gelinas and Roberts, 1977). It has been 
shown by sequencing that in human only 1.2% of DNA bases are in exons (Lander et al., 
2001; Venter et al., 2001). Mature RNA which is exported to the cytoplasm only 
contains exons (Elliott and Grellscheid, 2006). Therefore, mature transcripts in 
eukaryotes are much shorter than genes. For example, the average gene length in 
human is about 27000bp while mature transcript length is about 1300bp (Lander et al., 
2001; Venter et al., 2001). This means that usually introns are much longer in 
comparison with exons (Elliott and Grellscheid, 2006).  
Splicing takes place in the nucleus using a complex called the spliceosome. This 
spliceosome complex is made of small nuclear RNAs and proteins (Gerstein et al., 
2007). There are more than one hundred proteins and five small nuclear ribonuclear 
proteins (snRNPs) in this complex (U1,U2,U4/U6 and U5) (Wahl et al., 2009). 
Spliceosome complexes are assembled on transcripts (Gornemann et al., 2005; Lacadie 
and Rosbash, 2005; Azubel et al., 2006). Splicing occurs in two steps. Firstly, the branch 
point adenosine attacks the 5' splice site. This reaction leads to making a lariat 
intermediate. Secondly, the free 5' exon attacks the 3' splice site and exons will be 
attached to each other. Afterwards, the lariat will be discarded (figure 2). Spliceosome 
composition and assembly are still under analysis (Azubel et al., 2004; Gornemann et 
al., 2005; Lacadie and Rosbash, 2005; Chen and Moore, 2014; Matera and Wang, 2014). 
Conversely to older models with the idea that splicing occurs after completion of 
transcription, current data show splicing and transcription can take place at the same 
time (Bentley, 2005). 
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Figure 2: Splicing mechanism. This picture shows how an intron is removed and 
exons attach to each other. The picture is modified from (Newman, 2001). The 
branch point adenosine attacks the 5' splice site. This reaction creates a lariat 
intermediate. The free 5' exon attacks the 3' splice site and exons will be attached to 
each other.  
 
An important property of alternative splicing is that it is a good process to produce 
different combination of exons from one pre-mRNA and to generate diverse mRNAs 
(Matlin et al., 2005) (figure 3). Therefore, alternative splicing can lead to an extension 
of the coding capacity in the genome and the production of many different kinds of 
proteins (Stamm, 2002). Additionally, alternative splicing can alter the reading frame 
of transcripts (Johnson et al., 2003). By alternative splicing, one genetic locus can be 
used for coding of diverse pre-mRNAs (Gerstein et al., 2007).  
 
Chapter 1: Introduction 
 
5 
 
There are some sequences inside the pre-mRNA such as ‘exonic splicing enhancers’ 
(ESEs) and ‘intronic splicing enhancers’ (ISEs) which enhance splicing. On the other 
hand, silencing signals such as ‘exonic splicing silencers’ (ESSs) and ‘intronic splicing 
silencers’ (ISSs) repress the splicing process. In addition, secondary structures within 
the pre-mRNA have roles in splicing by hiding or displaying splicing signals and also 
placing specific sequences close to each other (Warf and Berglund, 2010). In this way 
splicing efficiency will be increased (Warf and Berglund, 2010). It is thought that 
correct splicing of target RNA depends on different expression levels of RNA splicing 
regulators (Fu, 2004; Matlin et al., 2005). 
 
Specific patterns of tissue gene expression can also be achieved by alternative splicing 
(Pan et al., 2004). It has been shown that alternative splicing can influence about 90% 
of human genes (Wang et al., 2008). Selection of splice sites is regulated by factors 
such as splicing proteins which bind to RNA, the structure of pre-mRNA, and the 
presence of some specific sequences in pre-mRNAs. Testing of alternative splicing has 
been established by constructing minigenes which contain some exons and splicing 
signals as well as flanking introns (Stoss et al., 1999). A number of signalling pathways 
which act in response to extra cellular stimuli can also regulate alternative splicing 
(Lynch, 2007). 
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Figure 3: Alternative splicing can make different proteins from one gene. The picture 
is modified from (Guttmacher and Collins, 2002). 
 
Especially during development, alternative splicing has a key role. Although our 
knowledge about this process is not complete yet, it seems that expression of cell or 
tissue-specific splicing factors and also extrinsic signals have important effects on this 
process (Maniatis and Tasic, 2002; Stamm, 2002; Gooding et al., 2003). It has been 
shown that in some tissues there are high levels of alternative splicing (Liu and Elliott, 
2010). For example, the highest levels of alternative splicing have been identified in 
brain, testis and liver respectively (Yeo et al., 2004). While high levels of evolutionarily 
conserved splicing have been seen when comparing between brains of humans and 
mice, in the testes there is more non-conserved splicing. Based on evolutionarily 
conservation, it is thought that conserved splicing between human and mouse in the 
brain has an important role (Kan et al., 2005; Yeo et al., 2005).  
 
One of the most important sites of continuing development in the adult is in the testis. 
In this tissue male germ cells undergo essential developmental pathways. By 
differentiation of spermatogonia in prophase of Meiosis I, primary spermatocytes are 
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produced. First and second meiotic divisions of each spermatogonium lead to the 
production of two secondary spermatocytes and four spermatids respectively. 
Spermiogenic differentiation is a process which makes mature sperm from spermatids. 
In this process, some important events take place such as nuclear condensation and 
cytoplasmic ejection. Histone replacement (sequentially by transitional proteins and 
protamins) leads to chromatin packaging during spermiogenesis (Amann and Howards, 
1980).  
 
There are particular programmes of gene expression in the testes. These programmes 
lead to producing mature spermatozoa from spermatogonia. One of these 
programmes is alternative splicing of pre-mRNAs (Venables, 2002). In a human testis 
108 sperm are produced per day, and during the spermatogenesis process division and 
differentiation of an enormous number of germ cells occurs (Gilbert, 2000). It seems 
that the high level of alternative splicing in the testes is due to the requirement of 
increased transcript isoforms (Liu et al., 2009). In the testis the high level of alternative 
splicing requires distinct expression patterns of splicing regulators in spermatogenesis 
(Kan et al., 2005; Schmid et al., 2013). 
 
1.3 Regulators of alternative splicing 
 
There are different kinds of alternative splicing mechanisms including: alternative 5’ 
splice sites, alternative 3’ splice sites, retained introns, exon skipping and mutually 
exclusive exons. Alternative mRNA isoforms can also be made using alternative 
promoters and alternative polyadenylation (Keren et al., 2010). Important cis- 
elements include ESS (Exonic Splicing Silencer), ESE (Exonic Splicing Enhancer), ISS 
(Intronic Splicing Silencer) and ISE (Intronic Splicing Enhancer). Trans-acting proteins 
are involved in regulation of alternative splicing (Heyd and Lynch, 2011). The 
spliceosome plus approximately one hundred regulatory factors are involved in 
selection of splicing sites in the pre-mRNA (Tsuda et al., 2011). Some alternative 
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splicing regulators which are tissue-specific have been recognized such as Nova-1, 
ESRP1 and ESRP2 (Grabowski, 2000; Warzecha et al., 2009).  
 
Among the factors regulating alternative splicing, serine/arginine-rich (SR) proteins, 
Signal Transduction and Activation of RNA (STAR) family and heterogeneous 
ribonucleoproteins (hnRNPs) have been identified as important alternative splicing 
regulators (Bourgeois et al., 2004; Martinez-Contreras et al., 2007; Long and Caceres, 
2009). In the next sections more information regarding these groups of RNA binding 
proteins has been discussed. 
 
1.4 RNA binding proteins 
 
RNA binding proteins have important roles in processing, transportation, localization, 
translation and stabilization of mRNAs. 2% of genes in Caenorhabditis elegans and 
Drosophila melanogaster encode RNA binding proteins. There are three types of 
modification for RNA binding proteins: phoshorylation, arginine  methylation and 
SUMO (small ubiquitin-like modifier) (Glisovic et al., 2008). In the SUMOylation process 
SUMO proteins are added to the target proteins. There are three isoforms of SUMO 
proteins (Matunis et al., 1996; Chen et al., 1998; Kamitani et al., 1998). SUMOylation 
can compete with ubiquitination and acetylation as lysine residues are the targets for 
these post-translational modifications as well. SUMOylation can block or create 
interaction surfaces (Kerscher, 2007). Studies show lack of RNA binding proteins can 
lead to genomic instability, defects in cell cycle regulation and cancer (Lukong et al., 
2008). RNA binding proteins may have some roles in cell attachments and cancer 
metastasis as well (de Hoog et al., 2004; Lukong et al., 2008). 
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1.4.1 Some important groups of RNA binding proteins 
 
Important kinds of RNA binding proteins include STAR (signal transduction and 
activation of RNA), hnRNPs (heterogeneous nuclear ribonucleoproteins) and SR 
(Serine/arginine-rich) families (Sergeant et al., 2007; Long and Caceres, 2009; Ehrmann 
and Elliott, 2010; Busch and Hertel, 2012). These groups of RNA binding proteins have 
fundamental roles in alternative splicing (Lukong and Richard, 2003) (figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.2 Roles of RNA binding proteins in alternative splicing  
 
Each RNA binding protein has specific RNA target sequences (Black, 2003; Matlin et al., 
2005). It has been confirmed that binding of some RNA-binding proteins to splicing 
enhancers and repressors within pre-mRNAs can control the splicing pathway (Black, 
 
Figure 4: Some important groups of RNA binding proteins. The STAR 
(Signal Transduction and Activation of RNA) family (including T-STAR, 
Sam68 and SLM-1), SR (serine/arginine-rich protein) and SR-like 
proteins such as Tra2β and hnRNP (heterogeneous nuclear 
ribonucleoproteins) are some of important groups of RNA binding 
proteins. These proteins interact with each other. 
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2003; Matlin et al., 2005). Modulations of nuclear RNA binding protein concentration 
in different cell types and tissues can control pre-mRNA splicing (Elliott et al., 1997; 
Ehrmann et al., 2008). For example, SR proteins usually promote and hnRNP proteins 
usually repress exon inclusion (Dreumont et al., 2010). It has been shown that 
considerable changes in the expression of RNA binding proteins occur during male 
germ cell development (Elliott and Grellscheid, 2006). RNA binding protein activity can 
be controlled by some post-transcriptional modifications. For example, RNA binding 
protein activity is influenced by acetylation or phosphorylation of their specific sites 
(Zhang et al., 2003; Lu et al., 2005; Najib et al., 2005). 
 
1.4.3 Structure of RNA binding proteins 
 
RNA binding proteins contain one or multiple RNA binding domains such as KH (hnRNP 
K homology) domain, cold-shock domain, RNA Recognition Motif (RRM), Sm domain, 
RGG (Arg-Gly-Gly) box, DEAD/DEAH box, dsRBD (double stranded RNA binding domain) 
and zinc finger (Glisovic et al., 2008). Generally, these domains are important for 
interactions between RNA binding proteins and their target RNA and also with other 
proteins. When misregulation of these interactions happens, different kinds of disease 
including cancer can occur (Huranova et al., 2009). KH domain and RRMs bind single 
stranded RNA (Lunde et al., 2007). 
The RRM (RNA recognition motif) has an important role in mediating the binding of 
proteins to specific RNA sequences (Nagai et al., 1995; Perez-Canadillas and Varani, 
2001; Clery et al., 2008). RNP1 and RNP2 are two conserved sequences within the RRM 
motif (Kielkopf et al., 2004). The RRM motif contains 4 β sheets (β1-β4) and 2 α helixes 
(α1 and α2) (Birney et al., 1993). RNP1 is located in β3 and RNP2 is present on β1 (Han 
et al.). The structure and function of the RRM is more characterized than the KH 
domain and the double stranded RNA binding domain (dsRBD) (Chen and Varani, 2005). 
The KH domain has an important role in RNA binding activity of many RNA binding 
proteins. This domain was first characterized in a heterogeneous ribonucleoprotein 
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named hnRNP K (Siomi et al., 1993; Najib et al., 2005). There are three α helixes and β 
sheets in the structure of KH domain (Grishin, 2001). 
 
1.5 STAR Family 
 
The STAR family is a family of RNA binding proteins which link RNA processing to 
signalling transduction (Vernet and Artzt, 1997; Lukong and Richard, 2003). It has been 
shown that there are homologues for STAR proteins in different species such as GLD-1, 
HOW and QKI in C.elegans, D. Melanogaster and various mammals respectively 
(Baehrecke, 1997; Lo and Frasch, 1997; Zaffran et al., 1997; Larocque and Richard, 
2005; Hansen and Schedl, 2006; Kimble and Crittenden, 2007). T-STAR (testis signal 
transduction and activation of RNA), Sam68 (Src-associated in mitosis 68 kDa) and 
SLM1 (Sam68-like mammalian protein 1) are members of the STAR family (Sergeant et 
al., 2007). The genes encoding these three proteins are called KHDRBS3, KHDRBS1 and 
KHDRBS2 respectively. These genes evolved from a common ancestral gene around 
500 million years ago (Ehrmann et al., 2013). A STAR domain (including KH RNA binding 
domain, QUA1 and QUA2 domains) is present within the structure of these proteins. 
This STAR domain has important roles in protein interactions and also RNA processing.  
 
In addition to the STAR domain there are other domains in the structure of STAR family 
members. For example, the tyrosine-rich C-terminal domain (containing candidate SH2 
binding domains) and proline rich sequences (SH3 binding sites) are possibly involved 
in cell signalling pathways (Lukong and Richard, 2003; Ehrmann and Elliott, 2010; Sette, 
2010; Sette et al., 2010). Phosphorylation of tyrosine residues can enable these STAR 
family members as a dock for signalling proteins which contain SH2 domains (Sanchez-
Jimenez et al., 2011). 
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1.6 SLM-1 
SLM-1 (Sam68-like mammalian protein 1) is a STAR family protein. In mouse SLM1 is 
located on chromosome 1 (Ehrmann and Elliott, 2010). This protein is also called 
KHDRBS2 (Di Fruscio et al., 1999). In addition to interaction with itself, SLM1 has 
interactions with Sam68, T-STAR and hnRNP G (Stoss et al., 2004). SLM-1 is only 
expressed in the brain and, in smaller amounts, in the testis (Stoss et al., 2004). In 
addition to a KH domain, the SLM-1 structure contains proline and tyrosine rich 
residues within its structure (Di Fruscio et al., 1999). 
 
1.7 T-STAR 
 
T-STAR protein has similarities with Sam68. There are other names such as SLM-2 and 
KHDRBS3 for this protein. The T-STAR gene is located on chromosome 8 and 15 in 
human and mouse respectively (Venables et al., 2004; Ehrmann and Elliott, 2010). The 
STAR family has important roles in splicing, localization and translation of mRNAs (Li et 
al., 2000; Matter et al., 2002; Wu et al., 2002; Mootz et al., 2004; Schumacher et al., 
2005; Edenfeld et al., 2006; Paronetto et al., 2007). T-STAR has important roles in 
signal transduction and RNA binding (Elliott, 2004). On the other hand, it seems that T-
STAR may have some roles in cell division. It has been shown that ectopic expression of 
T-STAR in fibroblasts from chicken embryo increases the time of cell division (Lee and 
Burr, 1999). In addition, it has been shown that in immortalized cells, T-STAR is down 
regulated (Kool et al., 2001). 
Similar to other members of the STAR family, T-STAR has a KH domain (Lukong and 
Richard, 2003). In addition, the KH domain is flanked by two other conserved domains 
called QUA1 and QUA2 (Volk et al., 2008) (figure 5). These three domains (QUA1, 
QUA2 and KH) make up the STAR domain (Maxi-KH region in figure 5). The KH domain 
of Sam68 and T-STAR are used for binding of these two proteins to RNA (Elliott, 2004). 
A difference with Sam68 is that T-STAR does not have an N-terminal domain which is 
present in Sam68. Amongst the similarities, there is an arginine and glycine rich region 
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(RG rich region) in both T-STAR and Sam68 proteins (Elliott, 2004). In T-STAR, within 
the arginine and glycine rich region there is one SH3-binding site (Ehrmann and Elliott, 
2010). The C-terminal region of both T-STAR and Sam68 proteins contain conserved 
tyrosine residues (Elliott, 2004). These tyrosine residues can be phosphorylated by 
protein kinases and then act like a dock for signalling proteins which contain SH2 
domains. There are proline rich sites in T-STAR and Sam68 which act like docking sites 
for proteins with SH3 domains (Ehrmann and Elliott, 2010). 
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Figure 5: T-STAR structure. There is a STAR domain (Maxi-KH region) which contains QUA1, KH 
and QUA2 domains. Also T-STAR contains RG-rich and Tyrosine-rich regions in its structure. The 
picture is modified from (Elliott, 2004). 
 
Unlike Sam68 which has ubiquitous expression, T-STAR is expressed only in the 
developing brain, adult testis and kidney (Venables et al., 1999; Venables et al., 2004). 
T-STAR protein is amplified in the medulloblastoma (Lu et al., 2009). It has been 
proven that T-STAR interacts with hnRNP G and nuclear proteins which have effects on 
splicing activity such as SAFB (Hartmann et al., 1999; Stoss et al., 2001). It seems that 
both T-STAR and Sam68 interacts with hnRNP G-T and RBMY (Elliott et al., 1997; Elliott 
et al., 2000b; Venables et al., 2000). Interestingly, Sam68 and T-STAR have interactions 
with each other (Venables et al., 2000) and hnRNP G (Stoss et al., 2001). Interestingly, 
hnRNP G inhibits T-STAR splicing activity after co-expression (Stoss et al., 2001). 
 
1.8 Sam68 
 
Another member of the STAR family is Sam68 (Src-associated in mitosis 68 kDa) (Stoss 
et al., 2001; Paronetto et al., 2007; Chawla et al., 2009). The KHDRBS1 gene is located 
on chromosome 1 (Lukong and Richard, 2003) and 4 (Ehrmann and Elliott, 2010) in 
human and mouse respectively. KHDRBS1 has 9 exons in human and mouse (Lukong 
and Richard, 2003). There are conserved sequences within KHDRBS1 which are also 
present in other members of the STAR family (Najib et al., 2005). KHDRBS1 has been 
cloned from different species. The sequences of important domains are highly 
conserved among these different species (Taylor and Shalloway, 1994; Richard et al., 
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1995; Di Fruscio et al., 1998; Fung et al., 1998). Sam68 protein has different roles 
including contribution to the growth and invasion of cancer cells (Busa et al., 2007; 
Richard et al., 2008) plus regulation of apoptosis and progression of cell cycle (Taylor et 
al., 2004; Paronetto et al., 2007). Sam68 protein also has some roles in signal 
transduction , alternative splicing and viral RNAs transportation as well (Lukong and 
Richard, 2003). 
 
1.8.1 Structure of Sam68 
 
There are 443 amino acids in the Sam68 protein. The sequences of these amino acids 
are highly conserved among different species (Lukong and Richard, 2003). The KH 
domain is one of the important domains in Sam68 (Fumagalli et al., 1994). The KH 
domain plus the flanking regions (QUA1 and QUA2) make up the STAR domain (also 
called the Maxi KH region) (figure 6) (Elliott, 2004). Also, there are proline-rich motifs 
in Sam68 protein which facilitate binding of Sam68 to other proteins that contain an 
SH3 domain (figure 7) (Reddy, 2000). In addition, in Sam68 protein there are 
SH3-binding sites (figure 7) (Ehrmann and Elliott, 2010). There are 24 amino acids in 
the C-terminus of Sam68 called the NLS (nuclear localization signal) which have a role 
in the localization of this protein (Ishidate et al., 1997) (figure 6). 
 
 
 
Figure 6: Sam68 domains. As well as the maxi-KH region (STAR domain), there are RG-rich and 
Tyrosine rich regions in the structure of Sam68 proteins. Six SH3 and two SH2 domains 
respectively are present in this protein. This picture is modified from  (Elliott, 2004). 
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Figure 7: Sam68 amino acid sequence and domains. Different domains are shown in different 
colours. Dark green: extended N-terminal domain of Sam68; green: proline rich sequences 
(SH3 binding sites); red: N-terminus; bold and underlined: Qua1 domain; bold, blue and 
underlined: KH Domain; blue font color with under line: Qua2 domain; yellow: RG-rich domain; 
purple: tyrosine-rich C-terminal domain; gray: Tyrosine residues (candidate SH2 binding sites). 
Picture is modified from (Ehrmann and Elliott, 2010). 
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1.8.2 Sam68 localization 
 
Sam68 protein has a mostly nuclear localization, but initially was identified in the 
cytoplasm during mitosis (Rajan et al., 2008a). It has been shown that while 
methylated Sam68 is localized in the nucleus, hypomethylation of this protein leads 
Sam68 to be localized in the cytoplasm (Babic et al., 2004). In cancer cells, Sam68 
protein has a general nucleoplasmic distribution and is also concentrated in nuclear 
SNB (SLM/Sam68 Nuclear Bodies) structures (Chen et al., 1999b). 
Although SNBs function has not been determined yet, it seems that these structures 
contain nucleic acids, some splicing regulators, signalling components (Rajan et al., 
2009) and hnRNP A1 interacting protein (HAP) which has roles in nuclear structure and 
transcription (Denegri et al., 2001). Sam68 seems to be exclusively nuclear in most 
somatic cells. Sam68 protein has been observed in the cytoplasm of secondary 
spermatocytes. In addition, Sam68 has some interactions with signalling molecules 
which are cytoplasmic (Lukong and Richard, 2003; Paronetto et al., 2006; Paronetto et 
al., 2009). It has been shown that after mutation of the Sam68 NLS (P439R, changing 
proline to arginine), the resulting protein will be localized in the cytoplasm (Reddy, 
2000). 
 
1.8.3 Sam68 modifications  
 
There are different types of posttranslational modifications known for Sam68 such as: 
acetylation (Babic et al., 2004), methylation (Cote et al., 2003), tyrosine 
phosphorylation (Fumagalli et al., 1994; Taylor and Shalloway, 1994) and 
serine/threonine phosphorylation (Matter et al., 2002; Paronetto et al., 2006).  
Methylation of arginine residues prevents interactions of Sam68 with proteins which 
have SH3 domains (Najib et al., 2005). Phosphorylation of Sam68 regulates some roles 
of Sam68 protein such as RNA binding ability and splicing activity (Haegebarth et al., 
2004; Lukong et al., 2005). There is a positive correlation between acetylation of  
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Sam68 lysine residues and  RNA binding activity of this protein (Babic et al., 2004). 
There are some proline rich domains in Sam68 that interact with proteins which 
contain SH3 domains. Furthermore, there is a tyrosine rich C-terminal domain in 
Sam68. This domain is a substrate for tyrosine kinase enzymes. Therefore, tyrosine 
phosphorylation of Sam68 can lead to the interaction of this protein with proteins 
which contain SH2 domains (Najib et al., 2005). The tyrosine-rich site can be 
phosphorylated by tyrosine kinases. Phosphorylation of Sam68 is important for its 
roles in signal transduction within the cell (Vernet and Artzt, 1997). 
 
1.8.4 Sam68 interactions 
 
There are some interactions between Sam68 and other RNA binding proteins 
(Venables et al., 1999; Elliott et al., 2000a). Sam68 protein is able to have protein-
protein and protein-RNA interactions through some of its consensus motifs (Lukong 
and Richard, 2003). Sam68 RNA binding activity has been shown to be negatively 
regulated by binding of Sam68 with SH3 domain containing proteins (Chen et al., 1997; 
Fusaki et al., 1997; Derry et al., 2000). 
Diverse proteins which have important roles in cell signalling and RNA processing                                      
interact with Sam68. It has been reported that nuclear transcriptional regulators and 
hnRNP A1 which has a splicing repressive role, interact with Sam68 (Hong et al., 2002; 
Paronetto et al., 2007; Rajan et al., 2008b) . It has been shown that Sam68 and hnRNP 
L have both a spatial and physical association within SNBs, but they do not help or 
antagonize each other’s activity. Conversely, hnRNP G which is generally nucleoplasmic 
rather than SNB in location, can inhibit some of Sam68 splicing activity (Rajan et al., 
2009). Although some proteins which interact with Sam68 have been identified, it is 
likely that there are other interacting proteins still to be identified (Rajan et al., 2009). 
Identification of these undetected interacting protein partners can lead to better 
understanding of Sam68 roles within the cells. 
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1.8.5 Roles of Sam68 in development, cell division and cancer 
 
Sam68 plays a key role in regulation of pre-mRNA splicing during neural development 
and neurogenesis (Chawla et al., 2009). Over expression of Sam68 with a deletion of its 
KH domain leads to inhibition of DNA synthesis. This variant is particularly expressed at 
growth arrest (Barlat et al., 1997). It has been shown that in NIH3T3 cells, after ectopic 
expression of Sam68 with KH deletion domain, cyclin D1/CCND1 expression is down 
regulated and cells will be stopped in the transit from G1 to S phase (Barlat et al., 
1997) These results suggest a role for Sam68 in the G1/S transition stage of the cell 
cycle (Reddy, 2000). STAR family members including Sam68 have important roles in 
cell cycle regulation. While expression of ΔKH Sam68 leads to cell growth arrest, 
expression of the full length of this protein in cell lines with limited level of expression 
of Sam68 can promote S phase (Barlat et al., 1997). At first it was thought that Sam68 
has a tumour suppressor role, but recently it has been found that this protein plays a 
pro-oncogenic function (Lukong and Richard, 2007). Some RNA binding proteins have 
altered expression in cancer. SRSF1 (Karni et al., 2007) and Tra2β (Best et al., 2013) are 
up-regulated in different kinds of cancers, and Fox2 shows down regulation in ovarian 
cancer (Venables et al., 2009). It has been reported that in prostate and breast 
tumours Sam68 is over expressed (Elliott and Rajan; Busa et al., 2007; Rajan et al., 
2008b; Elliott and Rajan, 2010). Sam68 protein is up-regulated in thyroid and liver 
cancers as well (Busa and Sette, 2010). 
Sam68 knockout mice, in addition to bone metabolism problems, have defects in 
locomotion and mesenchymal cell differentiation which imply developmental roles of 
this protein (Richard et al., 2005; Lukong et al., 2008; Richard et al., 2008). Unlike T-
STAR which is not essential for male infertility (Ehrmann et al., 2013), Sam68 has 
important roles in male germ cell development. It has been shown that male Sam68 
knockout mice are infertile (Ehrmann and Elliott, 2010; Sette et al., 2010). In addition, 
being a splicing regulator is another role for Sam68 which is important in neural 
development (Chawla et al., 2009).  
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1.8.6 Roles of Sam68 in gene expression, cell signalling and RNA processing  
 
Sam68 has an essential role in linking transcriptional and post-transcriptional 
regulation of gene expression to signalling pathways (Rajan et al., 2008a). Sam68 
participates in signal transduction pathways controlled by tyrosine kinases. Sam68 
protein acts like a dock for recruiting other signalling molecules, acting like an adaptor 
in signalling pathways (Najib et al., 2005). Cytoplasmic Sam68 acts to link proteins to 
each other by using SH2 (phosphotyrosine) and SH3 (polyproline) binding domains. By 
acting as an adaptor, Sam68  has important roles in signal transduction (Elliott, 2004). 
For example, after interaction of insulin with its receptor, the insulin receptor plus 
Sam68 will be tyrosine phosphorylated. These proteins are then able to interact and 
activate the PI3K (phosphatidylinositol-3-kinase) p85 subunit. SH2 domains of p85 
subunit interact with phosphorylated Sam68.  Signalling complexes will be then 
formed by PI3K pathway. Also, phosphorylated Sam68 has association with p120GAP 
to link the phosphatidylinositol-3-kinase pathway to other signalling pathways. In 
summary, insulin stimulation leads to interaction of Sam68 as a dock with PI3K, 
initiating an intracellular signalling cascade to control glucose levels (Kahn, 1994; 
Sanchez-Margalet and Najib, 2001; Niswender and Schwartz, 2003).  
One of the most important roles of Sam68 is in regulation of RNA processing. SELEX 
experiments (systematic evolution of ligands by exponential enrichment) have shown 
Sam68 protein binds specifically to UAAA or UUUA as high–affinity binding sequences 
(Lin et al., 1997). Also, Sam68 has some roles in nuclear export and cytoplasmic 
processing of viral mRNAs (Reddy et al., 1999; Cote et al., 2003). Sam68 also is involved 
in alternative splicing. A role of Sam68 protein has been shown in activating inclusion 
of exon V5 in CD44 mRNA (Matter et al., 2002).  
Different isoforms of CD44 can be produced by inclusion or exclusion of variant exons. 
Alternative splicing of CD44 is important in cancer and development (Cooper and 
Dougherty, 1995; Sherman et al., 1996; Sherman et al., 1998). The Ras signalling 
pathway is involved in regulation of exon V5 inclusion. Sam68 which is a target in this 
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signalling pathway can bind to exonic splicing enhancers within the V5 exon. Sam68 
phosphorylation can lead to inclusion of exon V5 in CD44 mRNA (Matter et al., 2002). 
In addition, Sam68 protein is necessary for alternative splicing of mRNAs in neuronal 
cell lines (Chawla et al., 2009). 
 
1.9 HnRNPs 
 
Another group of RNA binding proteins are called HnRNPs (heterogeneous nuclear 
ribonucleoproteins). These proteins have key roles in the regulation of transcript 
packaging, alternative splicing and translation (Han et al., 2010). Also, members of this 
family are involved in RNA metabolism (Weighardt et al., 1996). HnRNP G has been 
reported as a spliceosome component (Rappsilber et al., 2002; Heinrich et al., 2009). 
Initially, hnRNPs  A, B and C with their associated RNAs were separated and identified 
using sucrose density gradients (Beyer et al., 1977). 
 
The number of identified hnRNPs were increased using UV cross-linking experiments 
(van Eekelen et al., 1981). Using immunopurification accompanied  with  two-
dimensional gel electrophoresis led to a complete list of these kinds of RNA binding 
proteins (Pinol-Roma et al., 1988) comprising hnRNPs A–U (figure 8). More information 
about the sequences and structure of hnRNPs was achieved by using monoclonal 
antibodies. Furthermore, using immunostaining has proved that contrary to SR 
proteins and snRNPs (Small nuclear ribonucleoproteins) which have a speckled 
distribution in the nucleus, hnRNPs have diffuse pattern. HnRNPs have ubiquitous 
expression in different tissues (Kamma et al., 1995).  
 
1.9.1 Structure of hnRNPs 
 
In structure, hnRNP proteins contain at least one RNA binding motif and other domains 
involved in their localisations and protein interactions (Dreyfuss et al., 2002). There are 
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a number of distinct RNA binding motifs in hnRNP proteins including the KH domain, 
RGG box and RRM (figure 8). In addition, there are some domains to mediate protein-
protein interactions (Dreyfuss et al., 2002). Each of these motifs, including the RRM, is 
not present in all hnRNPs (figure 8) (Han et al., 2010). In hnRNP G there is an N-
terminal RRM (figure 9) (Soulard et al., 1993). There is a motif in human RBMY called 
SRGY which is enriched in serine, arginine, glycine and tyrosine amino acids (figure 9). 
This sequence in Human RBMY motif is longer in comparison with mouse (Elliott et al., 
1996; Mahadevaiah et al., 1998; Venables et al., 1999). There is also an RRM in RBMY 
(figure 9). The identity of this motif between human and mouse is around 74% 
(Mahadevaiah et al., 1998). Between human and mouse RRM there are 22 amino acid 
differences (Skrisovska et al., 2007). Most of the active copies of RBMY have been 
mapped to the AZFb region (Elliott et al., 1997; Elliott, 2000). Some genes involved in 
spermatogenesis which are located on long arm of Y chromosome. AZFb is one of the 
regions on Y chromosome which is important for spermatogenesis and microdeletion 
of this region can lead to male infertility (Lahn and Page, 1997; McElreavey and Krausz, 
1999). In this AZFb region six functional RBMY copies have been found (Skaletsky et al., 
2003). 
 
 
 
Figure 8: HnRNP structures. Most of these proteins contain an RRM (RNA recognition motif). 
Also KH and Gly-Rich domains are some of the common domains in the structure of hnRNPs.  
(Han et al., 2010). 
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Figure 9: Structures of RBMY, hnRNP G and hnRNP G-T proteins. All of these three proteins 
contain an RRM. However only RBMY contains an SRGY box. (Elliott, 2004). 
 
1.9.2 Role of hnRNPs in alternative splicing, mRNA transportation and localization  
 
The hnRNP proteins have important roles in splicing (Min et al., 1995; Chen et al., 
1999a; Chou et al., 1999; Tange et al., 2001), and transport of RNA from the nucleus to 
the cytoplasm (Liu and Mertz, 1995; Lee et al., 1996; Izaurralde et al., 1997; Gallouzi 
and Steitz, 2001), translation, and localization of mRNA (Dreyfuss et al., 2002). It has 
been shown that some hnRNP proteins shuttle between the nucleus and the cytoplasm 
(Alzhanova-Ericsson et al., 1996; Caceres et al., 1998). While RBMX has roles in 
selection of splicing sites in somatic cells, it seems that RBMY and hnRNP G-T have the 
same roles in germ cells (Elliott, 2004). For example, human RBMY is present in 
locations where gene expression is active. Also, the RBMY protein can interact with 
and affect SR protein activity or by preventing their access to their target mRNA, has 
some roles in splicing and can influence on this process (Dreumont et al., 2010). 
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1.9.3 Some interactions of hnRNP family members 
 
The binding of hnRNP proteins (to target RNA) has some effects on interactions and 
the fate of transcripts (Dreyfuss et al., 2002). The RBMY and hnRNP G-T proteins have 
interactions with other RNA binding proteins such as SR and SR-related families and 
STAR family (Elliott et al., 2000a; Elliott et al., 2000b; Venables et al., 2000; Venables et 
al., 2005). For example, RBMY has direct interaction with Sam68 and T-STAR 
(Skrisovska et al., 2007). Also, Tra2β (an RNA binding protein, SR-like protein) and 
hnRNP G directly interact with each other (Venables et al., 2000). The hnRNP G protein 
action is synergistically or antagonistically with Tra2β. This action depends on the 
mRNA substrate (Hofmann and Wirth, 2002; Nasim et al., 2003). For example while 
hnRNP G and Tra2β have cooperation in splicing of SMN2 transcript (Elliott, 2004), 
they usually show opposite effects on splicing of dystrophin transcripts and slow 
skeletal α-tropomyosin (Nasim et al., 2003). 
 
Human RBMY interactions with some SR or SR-like proteins and its localization at the 
periphery of nuclear speckles have been recognized (Dreumont et al., 2010). It has 
been shown that hRBMY interactions with SRSF3 or Tra2β can influence splicing 
decisions (Elliott et al., 2000a; Venables et al., 2000).  
 
 
1.9.4  HnRNP G (RBMX), hnRNP G-T (RBMXL2) and RBMY 
 
The hnRNP G (encoded by RBMX), hnRNP G-T (encoded by RBMXL2) and RBMY 
proteins play important roles in nuclear RNA processing (Elliott, 2004). RBMX is the X- 
homologue of RBMY (RNA-binding motif gene on Y chromosome). Both RBMX and 
RBMY were originally a pair of autosomal genes (Delbridge et al., 1997; Mazeyrat et al., 
1999) and encode proteins which have similar structures. The hnRNP G protein has an 
N-terminal RRM and domains rich in glycine, arginine and serine (Elliott, 2004). The 
RBMX gene has ubiquitous expression except during X chromosome inactivation in 
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meiosis. It is thought that the RBMX acts as a housekeeping gene (Elliott and 
Grellscheid, 2006). The expression level of RBMX gene is different based on a tissue 
specific manner (Nasim et al., 2003). 
 
The hnRNP G protein has a nuclear localisation, and shows a speckled pattern in the 
nucleus.  Using the electron microscope hnRNP G was found to be localised within the 
ICGCs (interchromatin granule clusters) (Soulard et al., 1991). The ICGCs seem to be 
storage sites which contain different proteins including splicing factors (Lewis and 
Tollervey, 2000; Spector, 2001; Sutherland et al., 2001). HnRNP G was implicated as a 
splicing factor using purification and proteomic analysis of spliceosome (Rappsilber et 
al., 2002). The hnRNP G protein also interacts with other proteins involved in splicing 
such as Tra2β (Venables et al., 2000). 
 
Another member of the hnRNP family is hnRNP G-T protein. HnRNP G-T is encoded by 
an autosomal retrogene, called RBMXL2, which is located on human chromosome 
11p15. The hnRNP G-T protein is expressed only in the testis. It has been shown that 
the RBMXL2 gene was derived from transcript retrotransposition of the RBMX gene 
(Elliott et al., 2000b). In human, there are 9 other retrogene copies of RBMX as well as 
RBMXL2. These include RBMXL1 and RBMXL9 which are located on chromosome 1 and 
9 respectively (Lingenfelter et al., 2001). It has been proven by RT-PCR that, while 
RBMXL1 expression is common in all tissues including the testis, RBMXL9 is only 
expressed in the brain and testis. The presence of different retrogenes of RBMX gene 
may imply their roles in replacement of the RBMX gene function during meiosis 
(Ehrmann et al., 2008). 
 
Although the proteins encoded by the RBMX retrogene copies are very similar to 
hnRNP G, the hnRNP G-T protein is only 73% identical to the hnRNP G protein. This 
means that hnRNP G-T evolved earlier or has been under less selective constraint. The 
hnRNP G-T protein is more similar to the hnRNP G protein in comparison to the protein 
encoded by RBMY. The RBMY protein is around 50% identical to the hnRNP G protein 
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(Elliott, 2004). In addition to interacting with Sam68, T-STAR, both hnRNP G-T and 
RBMY proteins interact with other RNA binding proteins including: SR proteins (SRSF3) 
and SR-like proteins (Tra2β) (Elliott et al., 2000a; Elliott et al., 2000b; Venables et al., 
2000; Venables et al., 2005). 
 
 
1.9.5 Roles of hnRNP G, hnRNP G-T and RBMY  
 
The hnRNP G protein cooperates with other RNA binding proteins to perform 
important functions in splicing regulation of some target genes including the SMN2 
gene which can be considered as a target for treatment (gene therapy) of the SMA 
(proximal spinal muscular atrophy) disease (Elliott, 2004). It also regulates splicing of 
Tau gene. Splicing misregulation and abnormal ratios of Tau protein isoforms can lead 
to frontotemporal dementia with Parkinsonism (FTDP-17) (Wang et al., 2011). In frogs 
and zebrafish, the hnRNP G proteins play important roles in neural development 
pathway (Tsend-Ayush et al., 2005; Dichmann et al., 2008). 
 
In mammals, during male meiosis a process called Meiotic Sex Chromosome 
Inactivation happens in which sex chromosomes become inactivated.  During this time, 
autosomal retrogenes of X-linked genes play an important role (Turner et al., 2005; 
Wang et al., 2005; Turner et al., 2006). It has been shown that human hnRNP G-T 
protein is highly expressed in the nuclei of pachytene spermatoctes and round 
spermatids (Elliott et al., 2000b). This suggests the hnRNP G-T protein is replacing the 
RBMX function when RBMX is inactivated during and after XY body formation. While 
hnRNP G plays a role in regulation of splice site selection in somatic cells, the same role 
can be considered for hnRNP G-T and RBMY proteins in germ cells (Elliott, 2004). 
 
Specific expression of hnRNP G-T only in male germ cells suggests the role of this gene 
as a candidate gene in male infertility (Elliott, 2004). In mice, haploinsufficiency of 
hnRNP G-T protein prevents normal spermatogenesis suggesting a fundamental role in 
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meiotic and post-meiotic germ cell development (Ehrmann et al., 2008). By analogy, 
the HNRNP G-T gene might have an important role in human infertility. It has been 
shown that in men with impaired fertility there are some variations in the sequence of 
this gene (Westerveld et al., 2004). In addition, in some patients with incomplete 
spermatogenesis, hnRNP G-T is not expressed (Maymon et al., 2002; Westerveld et al., 
2004). 
 
Expression of human RBMY (hRBMY) is particularly found in nuclei of male germ cells 
during spermatogenesis. It has been shown that deletion of the RBMY copies leads to 
arrest of meiotic division I in spermatogenesis (Elliott et al., 1997). In mouse, reduction 
in numbers of RBMY gene copies leads to sperm abnormalities (Mahadevaiah et al., 
1998). Therefore, conservation of RBMY in all mammals implies an important role in 
development of male germ cells (Delbridge et al., 1997). Unlike in human, mice with 
deficiency of RBMY expression have abnormal sperm development but they are still 
fertile (Mahadevaiah et al., 1998).  
 
 
1.10 SR proteins and Tra2β 
 
SR proteins are splicing regulators (Manley and Tacke, 1996; Valcarcel and Green, 
1996). SR proteins contain one domain rich in serine and arginine dipeptides and 
normally one or two RNA binding domains (Fu, 1995; Matlin et al., 2005; Long and 
Caceres, 2009) (figure 10). Unlike hnRNP proteins which most of the time bind to 
splicing silencers to inhibit splicing, SR proteins usually activate splicing by binding to 
the splicing enhancer sequences (Matlin et al., 2005). It has been shown that in the 
splicing process, SR proteins are antagonistic partners of hnRNP A1 (Graveley, 2000; 
Long and Caceres, 2009). After binding of SR proteins to RNA, binding of other 
components of the spliceosome are facilitated. It has been shown that SR proteins 
bind to exonic splicing enhancers (Zheng, 2004). Serine and arginine rich domains have 
important role in protein-protein interactions (Bourgeois et al., 2004). 
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In flies there is a prototypical alternative splicing regulator called Tra2 which has 
important role in sexual differentiation and spermatogenesis. There is a homologue 
gene of Tra2 in human called TRA2B (encoding Tra2β protein) (Black, 2003). There are 
two protein isoforms for Tra2β called Tra2β-1 and Tra2β-3 (Stoilov et al., 2004). While 
most SR proteins contain 1-2 RRM domains and only one RS domain, Tra2β (SR-like 
protein) contains two RS domains in addition to one RRM. Tra2β contains RS-rich 
region which acts like a splicing activator and binds to purine-rich (GAA) repeats within 
the exons (Tacke et al., 1998). Tra2β binds to several RNA sequences (Tsuda et al., 
2011). 
 
SR proteins such as ASF/SF2, SRSF3, SRp30 and the SR-like protein Tra2β act as 
important splicing factors (Venables et al., 2000) and have ubiquitous expression 
(Elliott, 2004). Their presence influences on the selection of splice sites (Matlin et al., 
2005).  
 
 
 
 
 
Figure 10: Structure of SR and SR-like proteins (Elliott, 2004). In addition to an RRM motif, RS 
domains (which contain arginine and serine residues) are present at the N-terminal and C-
terminal of Tra2β (Sciabica and Hertel, 2006). 
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1.10.1 Phosphorylation of SR proteins by splice factor kinases (SRPKs and CLK1 
families) 
 
The SR proteins can be phosphorylated by splice factor kinases such as SRPK (SR 
protein kinase) and CLK (Cdc2-like kinase) families. While SRPK1 and SRPK2 belong to 
SRPK family, CLK1, CLK2, CLK3 and CLK4 are members of CLK family (Stojdl and Bell, 
1999). The modification of protein sequences and the extent of phosphorylation 
carried out by members of SRPK and CLK families can be different (Colwill et al., 1996a; 
Ngo et al., 2005; Velazquez-Dones et al., 2005; Bullock et al., 2009). 
 
Serines in the RS domain of Serine/arginine-rich proteins are the target for these 
phosphorylations. RS domains phosphorylation affects the function of serine/arginine-
rich proteins in the spliceosome (Wu and Maniatis, 1993; Kohtz et al., 1994). 
Phosphorylation of RS domains also plays important roles in alternative splicing 
regulation of pre-mRNA (Zhu and Krainer, 2000; Massiello and Chalfant, 2006), cellular 
distribution of SR proteins (Gui et al., 1994; Duncan et al., 1995; Colwill et al., 1996b), 
Interaction of the nuclear import receptor with SR proteins and also transportation of 
serine/arginine-rich proteins (Caceres et al., 1997; Kataoka et al., 1999; Lai et al., 2000). 
The nuclear import and nuclear distribution of SR proteins can be regulated by SRPKs 
and CLK families respectively (Ghosh and Adams, 2011). 
 
 
 
1.10.2 Similarities between SR proteins and hnRNPs 
 
There are many similarities between SR proteins and hnRNPs (Han et al., 2010). For 
example, there are multiple RNA binding domains such as RRM and auxiliary domains 
in both of these proteins (figure 11). Furthermore, both groups of proteins can act like 
shuttles to export mRNAs to the cytoplasm (Gorlach et al., 1993; Good, 1995; Caceres 
et al., 1998; Borgeson and Samson, 2005). Both groups of SR and hnRNP proteins also 
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have important roles in the regulation of post-transcriptional events (Singh and 
Valcarcel, 2005; Samson, 2008). It has been shown that there is an overlap in 
localization of hnRNP G with SR proteins (Venables et al., 2000).  
 
 
 
Figure 11: Structural similarities between hnRNPs and SR proteins. RRM and Gly-rich domains 
are present in the structure of most members of hnRNPs and SR proteins.  (Han et al., 2010) 
 
1.10.3 Some roles of Tra2β 
 
Tra2β acts as a splicing activator (Elliott, 2004). The exon inclusion percentage of target 
mRNA will be higher when the concentration of this protein is increased (Grellscheid et 
al., 2011; Elliott et al., 2012).  The TRA2A and TRA2B genes are two homologues genes 
of Tra2 (Tacke et al., 1998). Tra2α and Tra2β proteins have more than 60% amino acid 
identity (Elliott et al., 2012). It has been shown that if there is Tra2B deletion during 
embryogenesis, Tra2α is not able to compensate the vital roles of Tra2β and Tra2B −/− 
mouse dies during gestation (Mende et al., 2010).  
 
It seems that the lack of Tra2β protein and its role in alternative splicing regulation is 
involved in the death of Tra2B −/− mice embryos (Elliott et al., 2012). Tra2β plays a 
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critical role in embryonic brain development as well (Grellscheid et al., 2011). Also, 
Tra2β protein plays a role as a splicing activator of SMN1 and SMN2 mRNAs. Deletion 
of SMN1 leads to SMA. SMN2 exon 7 is mostly excluded from the mRNA which leads to 
production of unstable protein. Over-expression of Tra2β activates inclusion of this 
exon which makes functional SMN2 protein. Afterwards, SMN2 protein can 
compensate roles of SMN1 protein. Rescue of SMN2 splicing could be considered as a 
potential   gene therapy in the future (Hofmann et al., 2000; Elliott, 2004). 
 
1.10.4 Expression and interactions of SR proteins and Tra2β 
 
Tra2β and SR proteins are expressed ubiquitously (Elliott et al., 2000a; Venables, 2002). 
Although TRA2B mRNAs can be found ubiquitously in the cells, the highest expression 
of this protein is in the testis and developing brain (Beil et al., 1997; Nayler et al., 1998; 
Venables et al., 2000; Chen et al., 2003). The TRA2B transcript is amplified in different 
kinds of human cancer including: stomach, uterus, ovary and lung cancers (Best et al., 
2013). Also, Tra2β is up-regulated in ovarian, cervical, breast and colon cancers 
(Fischer et al., 2004; Watermann et al., 2006; Gabriel et al., 2009; Kajita et al., 2013). 
By knocking down TRA2B, the percentage of cell apoptosis is increased in colon cancer 
(Kajita et al., 2013). 
 
The phosphorylation of serine residues in the RS domain has an important role in 
controlling protein interactions of SR proteins with other proteins and RNAs (Xiao and 
Manley, 1997; Yeakley et al., 1999). The phosphorylation of Tra2β strengthens protein 
interaction, which shows the importance of the RS domain.  The RNA binding activity 
of Tra2β has been shown to be reduced by its hyperphosphorylation (Venables et al., 
2000). 
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1.11 Aims of project 
 
The main aim in this project was to analyse the role of RNA binding proteins T-STAR, 
Sam68, hnRNP G, hnRNP G-T and Tra2β and to identify their interacting protein 
partners. Investigation of these proteins will help us to understand their roles and 
importance within the cells, and specifically in different kinds of diseases such as 
cancer: 
 
1.11.1 First aim: 
The first aim was to create stable cell lines expressing epitope tagged T-STAR, Sam68, 
hnRNP G, hnRNP G-T and Tra2β proteins. This was achieved by cloning the open 
reading frame (ORFs) encoding these RNA binding proteins (T-STAR, Sam68, hnRNP G, 
hnRNP G-T and Tra2β) into the pcDNA5 vector. Then transfection of these open 
reading frames to HEK293 knock in cell lines was carried out to enable integration into 
the genome. The next step was selection of stable cell lines by using blastocidin and 
hygromicin antibiotics. After setting up the stable cell lines, tetracycline antibiotic was 
used to increase the protein expression of genes of interest (T-STAR, Sam68, hnRNP G, 
hnRNP G-T and TRA2B). As the cell lysate was used for immunoprecipitation (IP) of 
tagged proteins there was a possibility that some proteins which do not interact with 
each other normally in vivo could have the opportunity to interact within the cell 
lysate (Mili and Steitz, 2004). Specifically there was a possibility that by over-
expression of the FLAG-tagged proteins within the cells false interactions could be 
detected due to the high level of protein expression. In other words, this approach 
could lead to interaction of some proteins with other proteins which were not original 
protein partners.  To solve this problem after detection of the interaction between 
proteins, the validity of interactions were also tested at the endogenous level of 
protein expression. 
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1.11.2 Second aim: 
The second aim of the project was to use these stable cell lines to investigate the cell 
biology and interaction partners of these proteins. This included making stable cell 
lines expressing the wild type and P439R Sam68 proteins to compare the localisation 
of these proteins and their protein interacting networks. After identification of the 
interacting proteins, the next step was to investigate the possible roles of new 
interacting protein candidates within the cells such as their roles in alternative splicing 
regulation of selected target genes. 
 
1.11.3 Third aim: 
The final aim of the project was to use these stable cell lines to investigate RNA 
processing pathways. In particular, some morphological changes occurred after 
induction of cells expressing hnRNP G-T protein. Therefore, one of the aims of project 
was focused on the roles of hnRNP G-T protein in: A) Morphological changes B) 
Regulation of cell proliferation  
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Chapter 2 
 
2 Identification of protein partners of T-STAR, wild type and P439R 
Sam68 
 
2.1 Introduction 
 
The STAR family proteins have known important roles, including RNA processing, signal 
transduction (Vernet and Artzt, 1997; Lukong and Richard, 2003), splicing, localization 
and translation of mRNAs (Li et al., 2000; Matter et al., 2002; Wu et al., 2002; Mootz et 
al., 2004; Schumacher et al., 2005; Edenfeld et al., 2006; Paronetto et al., 2007). 
However we need to find out more information about their interaction networks and 
pathways to fully understand these proteins’ roles. 
 
In this Chapter, the main focus will be on the T-STAR and Sam68 proteins and the 
proteomic approach carried out to identify their protein partners.  
 
Sam68 protein has a mostly nuclear localization. Initially Sam68 was identified in the 
cytoplasm during mitosis (Rajan et al., 2008a). There are 24 amino acids in the  C-
terminus of Sam68 called an NLS (nuclear localization signal) which is essential for the 
localization of this protein (Ishidate et al., 1997). By making mutation of Sam68 (P439R 
Sam68, changing proline to arginine), the resulting protein will be localized in the 
cytoplasm (Reddy, 2000). Therefore, one of the aims of project was to see whether or 
not changing the localization of a mostly nuclear Sam68 to a cytoplasmic one would 
change the Sam68 interacting protein partners’ network. Figure 12 is a schematic 
design showing the difference between the wild type and P439R Sam68 proteins. 
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Figure 12 : Difference between wild type and P439R mutant Sam68. The only 
difference between the wild type and P439R mutant Sam68 proteins was a 
point mutation in the codon encoding amino-acid 439 (changing proline to 
arginine). This amino acid substitution is highlighted by pink. CCA encodes 
proline whereas CGA encodes arginine. After making this mutation of Sam68 
(P439R, changing proline to arginine), the resulting protein localized in the  
cytoplasm of HeLa cells  rather than the nucleus (Reddy, 2000). 
 
To achieve this aim of project the open reading frames of the T-STAR, wild type and 
P439R mutant Sam68 proteins were cloned into the pcDNA5 vector. Secondly, the 
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stable cell lines expressing these FLAG tagged RNA binding proteins were made. The 
next step was purification of the FLAG tagged T-STAR, wild type and P439R mutant 
Sam68 proteins plus their partners using immunoprecipitation. Finally, 
immunoprecipitated proteins were identified by mass spectrometry. RHA (RNA 
helicase A) was detected as the new common interacting protein partner of T-STAR, 
wild type and P439R Sam68. Furthermore, CCAR1 (Cell division cycle and apoptosis 
regulator protein 1) was detected as the new candidate interacting protein partner of 
the wild type and P439R Sam68 proteins.  Interestingly it was found out that both wild 
type (nuclear) and P439R (cytoplasmic) Sam68 have the same interacting protein 
partners. 
 
Also described in this Chapter are some investigations into the identified endogenous 
interacting protein partners of T-STAR, wild type and P439R mutant Sam68 to confirm 
their interactions. 
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2.2  Methods and Materials 
 
2.2.1 Standard molecular biology 
 
2.2.1(a) PCR 
 
T-STAR, wild type and P439R Sam68 were PCR amplified with the combination of 
reagents described in table 1 and 2 respectively. Phusion DNA polymerase, dNTPs and 
primers were from Finnzymes, Promega and Integrated DNA Technology (IDT) 
companies respectively. Table 3 shows the primers used in this project.  
 
Reagent Quantity for a 50l reaction 
dH2O 31.5µl 
5X GC Buffer (contains KCl, Tris-HCl and MgCl2) 10µl 
10M dNTPs (Deoxyribonucleotide triphosphates) 1µl 
10M Forward primer 2.5l 
10M Reverse primer 2.5l 
Template DNA (~100ng) 2µl 
Phusion DNA Polymerase 0.5l 
 
Table 1: PCR recipe for amplification of T-STAR. Here the reagents used in a typical 
50l reaction are shown. 
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Reagent Quantity for a 50l reaction 
dH2O 16.5µl 
Template DNA (~100ng) 2µl 
ImmoMIX 25µl 
10M Forward primer 3l 
10M Reverse primer 3l 
Phusion DNA Polymerase 0.5l 
 
Table 2:  PCR recipe for making wild type and P439R Sam68. Here the reagents used in a 
typical 50l reaction are shown. 
 
 
Primer name Sequence (5’-3’) Restrictio
n Enzyme 
T-STARBGLIIF AAAAAAAAAAGATCTATGGAGGAGAAGTACCTGCC BglII 
T-STARXHOIB AAAAAAAAACTCGAGTCAGTATCTGCCATATGGCTGGT XhoI 
MSam68 F-BamHI AAAAAAAAAGGATCC ATGCAGCGCCGGGACGATCCT BamHI 
Wt MSam68 R-SalI AAAAAAAAAGGATCCTTAATAACGTCCATATGGATGCTCTCTGTATG SalI 
Mutant MSam68R-SalI AAAAAAAAAGTCGACTTAATAACGTCCATATCGATGCTCTCTGTATG  SalI 
pCDNArev ACAATGCGATGCAATTTCCTC  
Table 3: Primers used for PCR amplification of T-STAR, wild type and P439R Sam68. 
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A DNA Engine DYAD thermal cycler (MJ Research) was used for PCR amplifications. The 
amplification protocol used for amplifying T-STAR, wild type and P439R Sam68 are 
shown in table 4 and table 5 respectively. 
 
1 Heat Activation 98 °C 30 seconds   
2 Denaturation 98 °C 10 seconds   
3 Annealing 60 °C 20 seconds   
4 Extension 72 °C 1 minute Cycling to step 2 30 
5 Final Extension 72 °C 4minutes   
6 Cooling 15°C ∞   
1 Heat Activation 95 °C 10 minutes   
2 Denaturation 95°C 30 seconds   
3 Annealing 57.2°C 30 seconds   
4 Extension 72 °C 1 minute Cycling to step 2 25 
5 Final Extension 72 °C 10 minutes   
6 Cooling 10°C ∞   
Table 5: PCR Programme for PCR amplification of wild type and P439R Sam68. 
 
 
 
2.2.1(b) Restriction digests 
 
PCR products and the pcDNA5 vector were incubated for three hours with appropriate 
restriction enzymes separately for the first and second digestions. The restriction 
enzymes BamHI and XhoI were used for digestion of plasmid DNA (pcDNA5). The 
combinations of enzymes (BglII, XhoI) and (BamHI, SalI) were used for digestion of T-
STAR and Sam68 (wild type and 439R) PCR products respectively.  BSA (Bovine Serum 
Table 4: PCR Programme for T-STAR. 
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Albumin) was used for enzymes to work efficiently. The digestion mixes used for PCR 
products and plasmids are shown in table 6:  
 
 
PCR product  Plasmid (pcDNA5 vector) 
 First     
digestion 
Second 
digestion 
  First         
digestion 
Second        
digestion 
dH2O 9.5 µl 3µl  dH2O 32 µl 8 µl 
Purified DNA 20 µl 25µl  Purified DNA 5 µl 20 µl 
BSA (10X) 4 µl 4µl  BSA (10X) 5 µl 4µl 
Buffer 4 µl 4µl  Buffer 5 µl 4µl 
Enzyme 2.5 µl 4µl  Enzyme 3 µl 4µl 
Total 40 µl 40 µl  Total 50µl 40 µl 
 
Table 6: Recipes of restriction digest mixes used for PCR products (left) and plasmid 
digestions (right). PCR products and pcDNA5 vector were incubated with appropriate 
restriction enzyme separately for between 2-3 hours. 
 
 
 
2.2.1(c) Ligations and Re-cleavage 
 
After digestion, the purified digested vector and the DNA insert were ligated to each 
other in a 10-20 μl reaction volume containing DNA ligase (table 7). T4 DNA ligase and 
its buffer were purchased from New England biolabs. The ligation mixtures were 
incubated overnight at 16°C.  
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Purified digested vector 1-15μl 
Purified digested insert 1-15μl 
T4 DNA ligase buffer 2 μl 
T4 DNA ligase enzyme 2 μl 
Total 20 μl 
Table 7: Recipe of ligation mixtures. 
 
 
Heat inactivation of incubation ligation mixtures was carried out at 65°C for 10 minutes. 
To confirm the ligation mixtures contained the desired clones, the PCRs with reverse 
primer of the vector and forward primer of the DNA insert were carried out. To enrich 
for the desired clones, re-cleaving of ligated vectors using an appropriate enzyme in a 
20 μl reaction volume was carried out. The re-cleavage was selected to cut the ligated 
vectors which do not contain the insert in their multi cloning sites. Figure 13 shows a 
schematic design of cloning of T-STAR, wild type and P439R Sam68 into pcDNA5. 
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Figure 13 : Schematic picture of digestion and ligation strategy to clone inserts into the 
pcDNA5 vector. 
 (A) Schematic picture of the digestion and ligation strategy to clone the T-STAR ORF into the 
pcDNA5 vector. T-STAR PCR product (insert) was digested by the restriction enzymes BglII and 
XhoI. The pcDNA5 vector was digested by the restriction enzymes BamHI and XhoI.  After the 
ligation procedure, re-cleavage with BamHI enzyme was carried out to remove the ligated 
vectors which did not contain an insert. Ligation to BglII destroys the BamHI site in the pcDNA5 
vector. B) Schematic picture of digestion and ligation strategy to clone wild type and P439R 
Sam68 into the pcDNA5 vector. The Sam68 PCR product (insert) was digested by the restriction 
enzymes BamHI and SalI (B) The pcDNA5 vector was digested by the restriction enzymes 
BamHI and XhoI (C) After the ligation procedure, re-cleavage with NotI enzyme was carried out 
to remove re-ligated pcDNA5 vectors which did not contain an insert. 
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2.2.1(d)  Purification of DNA after PCR or restriction digests 
 
The QIAquick PCR purification kit (Qiagen) was used to purify PCR products or 
restriction digested DNA from enzymes, buffers and dNTPs. Purification was done 
based on the manufacturer’s instructions. 
 
2.2.1(e) Dialysis 
 
Residual salt from ligation/re-cleavage mixtures were removed using dialysis discs 
(Millipore). Samples were placed on filters. These filters were floated in plates which 
contain dH2O. The dialysis was carried out at room temperature for 1 hour. 
 
2.2.1(f) Transformation into E. coli 
 
Transformation of the plasmids was carried out by electroporation into an E.coli strain 
called DH5α. 2μl of dialysed, ligation mixtures were mixed with 20 μl of the electro-
competent cells and transferred into an electroporation cuvette. The competent cells, 
dialysed re-cleaved ligation mixtures and electroporation cuvette were kept 
completely cooled. The electroporation voltage was at 1.5kV. The electroporated cells 
were incubated in 1 ml LB broth for 1 hour at 37°C enable recovery. The LB agar plates 
which contain 50μg/ml ampicillin were used for plating out competent cells. Plates 
were incubated at 37°C overnight. (The recipes for LB broth and LB Agar mixtures are 
shown in table 8). 
 
 
 
 
 
 
 
Chapter 2: A proteomic approach to identify protein partners of T-STAR, wild type and P439R 
Sam68 
 
44 
 
 
 
LB broth mixture(500mL)  LB agar mixture 
dH2O 
Tryptone 
Yeast Extract 
Sodium Chloride 
300ml 
5gr 
2.5gr 
5gr 
 dH2O 300ml 
 Tryptone 5gr 
 Yeast Extract 2.5gr 
 Sodium Chloride 5gr 
dH2O up to                               500ml   dH2O up to 500ml 
    Agar 7.5gr 
 
Table 8: LB broth (left) and LB agar (right) recipe. 
 
 
2.2.1(g) Purification of plasmid DNA 
 
Single colonies were selected from the plates and inoculated into tubes which 
contained 5 ml LB broth plus 50μg/ml ampicillin. The tubes were incubated in a shaker 
for an overnight step at 37°C. The next step was centrifugation of cultures at 8000rpm 
for 3 minutes. A QIAprep Miniprep Kit (Qiagen) was used to extract plasmid DNAs from 
pellets. The purification of plasmids was then carried out according to the 
manufacturer’s instructions. 
 
 
2.2.1(h) Agarose gel electrophoresis 
 
Preparation of 1% agarose gels was carried out by melting 0.80g agar in 80ml TAE 
buffer (1X Tris-acetate-EDTA) and 8μl of 1000X ethidium bromide. DNA samples were 
mixed with the appropriate amount of 10X loading dye, and electrophoresed at 100 
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volts in 1X TAE buffer (50X TAE buffer: 242g Tris base, 57.1ml acetic acid, 100ml of 
500mM EDTA pH 8) for 1 hour. Syngene (Gene Genius Bioimaging System) was used to 
visualize DNA with UV light. 1Kb plus DNA ladder (Invitrogen) was used to estimate 
sizes. 
 
2.2.1(i) Sequencing 
 
Sequencing was carried out by the Geneservice Company using plasmids 
concentrations at 100ng/μl. The primers pCDNArev (ACAATGCGATGCAATTTCCTC), BGH 
(TAGAAGGCACAGTCGAGG) and CMV (CGCAAATGGGCGGTAGGCGTG3) were used for 
sequencing. 
 
 
2.2.2 Cell culture 
 
2.2.2(a) Establishment of stable cell lines 
 
Flp-In HEK293 cells were given to our group by Dr Nicholas Watkins and Dr Andrew 
Knox (Institute for Cell and Molecular Biosciences, Newcastle University). In the 
genome of these cells there is an FRT site and a blasticidin resistance gene which has 
been stably integrated. In addition, the Tet repressor is expressed in these cells. 
Expression of the genes of interest cloned into the FRT site is controlled by the 
tetracycline promoter. Therefore, a high level of gene expression will be achieved by 
adding tetracycline to the cell culture medium. To ensure the presence of the FRT site 
in the Flp-In HEK293 cells, blasticidin was added every third feed. After 24 hours of 
seeding cells in 10% FBS DMEM (Dulbecco’s MEM) with glutamax-1 medium (high 
glucose (4.5g/l) with L-Glutamine), when they were 60% confluent, the constructs 
containing the open reading frames of the T-STAR, wild type and P439R Sam68 
proteins cloned in the pcDNA5 vector were co-transfected with a plasmid pOG44 
(encoding Flp recombinase) at a ratio of 9:1. The empty pcDNA5 vector was co-
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transfected with the plasmid pOG44 as the negative control. Selection of transfected 
cells was carried out 48 hours later using 1μg/ml hygromycin B (Sigma-Aldrich). The 
stable transfected cells had a hygromycin resistance gene, therefore, they survived 
after adding the hygromycin to the media. The dead cells were removed from the plate. 
The live cells were then washed with 1ml of 1xPBS, followed by adding 2 ml of fresh 
medium and 2 μl of hygromycin B. After a few weeks of selection by hygromycin B, 
colonies were re-plated. When the cells were confluent enough, expression of the 
genes of interest were induced by adding 1μg/ml tetracycline (Sigma-Aldrich) to the 
cell culture medium.   
 
 
2.2.2(b) HEK293 and HeLa cells 
 
HEK293 and HeLa cells (provided in Professor Elliott’s lab, IGM, Newcastle University) 
were seeded (at a density of 1×105 /ml) in 10% FBS DMEM (Dulbecco’s MEM) with 
glutamax-1 medium and were incubated at 37°C in 5% CO2. 
 
 
2.2.2(c) Harvesting cells 
 
After removing growth medium (Invitrogen) cells were washed with 1X PBS 
(Invitrogen). Trypsin-EDTA (Invitrogen) was added to detach the cells from the plate. 
Next, the growth medium was added, followed by mixing and centrifugation of the 
cells at 8000rpm for 2 minutes. Cell pellets were washed with 1X PBS, centrifuged at 
8000rpm for 2 minutes followed by removal of  the supernatant in order to make the 
cell pellets ready for Western blotting or co-immunoprecipitation. For SDS-PAGE, after 
harvesting the cells, 2X SDS sample loading dye (4% SDS, 100mM Tris-HCl pH6.8, 20% 
glycerol, 200mM DTT, Bromophenol Blue) was added to the cell pellets before 
sonication. 
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2.2.3 Protein based methods 
 
2.2.3(a) SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Before loading, the sonicated samples were incubated at 96°C for 5 minutes and 
centrifuged at 8000rpm for 2 minutes. For Western blotting, 4% stacking gels and 10% 
running gels were made for loading the protein samples. Electrophoresis was carried 
out at 150V for approximately 50 minutes. For Simply Blue staining (Invitrogen), 4% 
stacking and 12% resolving gels (Invitrogen) were used and the protein samples were 
electrophoresed at 15V for more than 2 hours. De-staining of Simply Blue stained gels 
was carried out by using dH2O. A Page Ruler prestained protein ladder (10kDa-170kDa), 
Page Ruler plus prestained protein ladder (10kDa-250kDa) (Fermentas) and prestained 
protein marker broad range (7kDa-175kDa) (New England Biolabs) were used to 
estimate the protein sizes.  
 
 
2.2.3(b) Western blot (Protein immunoblot analysis) 
 
Transferring of gels to the nitrocellulose (NC) membranes (Amersham Biosciences) was 
carried out for 30 minutes at 15V using transfer buffer (0.04% SDS, 58mM Tris, 39mM 
Glycine, 20% MeOH). Nitrocellulose membranes were then washed with 1xTBS-T 
buffer (6.5g/l Tris-HCl, 8.75g/l NaCl, 2ml/l Tween) and incubated for 1 hour in the 
blocking solution (milk powder in 1xTBS-T). Incubations with the primary antibody 
(table 9) were carried out for 1 hour. Before adding the secondary antibody, the 
nitrocellulose membrane was washed three times with 1xTBS-T. After 1 hour 
incubation with the secondary antibody (table 10), the nitrocellulose membrane was 
washed three times with 1xTBS-T (each time for 5 minutes). All steps were carried out 
at room temperature. Lastly, the nitrocellulose membranes were incubated with 1ml 
of both ECLI (0.44% Coumaric acid, 1% Luminol, and 100mM Tris pH 8.5) and ECLII 
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(0.02% hydrogen peroxide in100mM Tris pH 8.5) solutions for 1 minute and then 
exposed to film (Kodak). 
 
 
Primary Antibody Source Monoclonal 
/Polyclonal 
Species Dilution for  
Western Blot 
Dilution  for  
immunofluorescence 
Anti β Actin Sigma Polyclonal Rabbit 1:1000 - 
Monoclonal anti Flag Sigma Monoclonal Mouse 1:1000 1:200 
Rabbit Anti DHX9 (RHA) ProteinTech 
Group 
Polyclonal Rabbit 1:2000 1:200 
Rabbit anti CCAR1 Sigma Polyclonal Rabbit 1:500 1:200 
Anti hnRNP L(4D11) Sigma Monoclonal Mouse - 1:200 
Table  9: Primary antibodies used for Western blot and immunofluorescence. 
 
 
Secondary Antibody Source Monoclonal 
/Polyclonal 
Species Dilution for 
 Western Blot 
Dilution  for  
immunofluorescence 
Anti-mouse-HRP Amersham Polyclonal Sheep 1:1000 - 
Anti-rabbit-HRP Jackson lab Polyclonal Goat 1:1000 - 
Anti-sheep-HRP DAKO A/S Polyclonal Rabbit 1:1000 - 
Anti-rabbit-
488(Green) 
Molecular 
Probes 
Polyclonal Donkey - 1:400 
Anti-mouse-594(Red) Molecular 
Probes 
Polyclonal Donkey - 1:400 
Anti-mouse-HRP Amersham Polyclonal Sheep 1:1000 - 
Table 10: Secondary antibodies used for Western blot and immunofluorescence. 
 
 
2.2.3(c) Immunoprecipitation using α-FLAG affinity resin 
 
The transfected Flp-In HEK293 cells were harvested 72 hours after induction with 
tetracycline (as explained above). 1.5 ml of IP +Benzonase (100mM KCl, 50mM Tris pH 
7.4, 5mM NaF, 5mM MgCl2, 0.1% NP-40, 2µl Benzonase , 1X Roche Complete Protease 
Inhibitor Cocktail) was added to the cell pellets followed by a 20 minute incubation on 
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ice. The FLAG resin (Sigma) was washed 3 times with TBS pH 7.4 and the samples were 
centrifuged for 10 minutes at 4°C. 30 μl of the supernatant was kept as Input and the 
rest of the supernatant was incubated with the FLAG resin for an overnight step at 4°C. 
The samples were centrifuged at 1000rpm for 30 seconds and 30 μl of the supernatant 
was kept and labelled SupIP. Next, the FLAG resin was washed six to seven times with 
IP wash buffer (100mM KCL, 50mM Tris pH 7.4, 0.1% NP-40). To check the efficiency of 
co-immunoprecipitation, 2X SDS sample loading dye was added to samples for loading 
on SDS-PAGE and checked by Western blotting. 
 
 
2.2.3(d) Mass spectrometry 
 
Electrophoresis of protein-FLAG immunoprecipitation (IP) samples on SDS-PAGE gels 
(NuPAGE 4-12% Bis-Tris Gel, Invitrogen) was followed by staining gels with Simply Blue 
for 1 hour and de-staining by using dH2O. The protein bands were cut and sent for 
analysis by Dr Gary Black and Dr Andrew Porter (Department of Biomedical Sciences, 
School of Life Sciences at Northumbria University). 
 
 
2.2.3(e) Immunofluorescence 
 
When HeLa cells were 50-70% confluent, coverslips were washed with 1XPBS, followed 
by fixation of the cells with 4% (w/v) PFA (Paraformaldehyde) for 20 minutes at room 
temperature. The cells were permeabilised by incubation in 1% Triton X-100 for 15 
minutes, and blocked in 10% horse serum/0.1% Triton X-100 for 1 hour. Incubation of 
the cells in primary and fluorescent conjugated secondary antibodies (tables 9 and 10) 
diluted in blocking solution was carried out for 1 hour for each of the antibodies. After 
incubation with the antibodies, cells were washed with 1XPBS each time for 5 minutes. 
The coverslips were mounted using VectaShield Mounting Medium with 4’, 6-
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diamidino-2-phenylindole (DAPI) (Vector Laboratories). The fluorescent images were 
obtained on an Axiovision microscope.  
 
2.3 Results 
2.3.1 Cloning of T-STAR into pcDNA5 (generation of T-STAR construct) 
 
Primers T-STARBGLIIF and T-STARXHOIB were used to PCR amplify the open reading 
frame of T-STAR, using T-STAR cloned into the GFP3 as a template. The PCR 
amplification resulted in a ~ 1Kb product (figure 14). The pcDNA5 vector and PCR 
product (insert) were digested by the restriction enzymes (BamHI, XhoI) and (BglII, 
XhoI) respectively and then ligated together. After the ligation procedure, a re-
cleavage with BamHI enzyme was carried out to remove the ligated vectors which did 
not contain an insert. The ligation mixes were transformed into E.coli DH5α, which 
were plated out on media suplimented with ampicillin. 20 colonies were screened by 
PCR in which insert forward primer (T-STARBGLIIF) and vector reverse primer (BGH 
reverse primer) were used. Colonies were selected on the LB medium plus 50μg/ml 
ampicillin. After overnight incubation at 37°C on a shaker, plasmid purification was 
carried out. To confirm the correct presence of inserts in the pcDNA5 vector, 100ng/µl 
of constructs were sequenced. The results confirmed the presence of the insert 
containing the open reading frame of T-STAR within the constructs. The sequencing 
results are shown in the Appendix A. 
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Figure 14: Amplification of the open reading frame (ORF) of T-STAR for cloning. The PCR 
amplification resulted in a 1041bp product being identified on an ethidium bromide stained 
agarose gel.  A 1kb plus DNA ladder was run in parallel on the gel. 
 
2.3.2 Cloning of wild type and P439R mutant Sam68 into pcDNA5  
 
The only difference between wild type and P439R mutant Sam68 was a point mutation 
in the codon encoding P439 (changing proline to arginine). To clone the ORFs for these 
proteins into the pcDNA5, MSam68 F-BamHI was used as the forward primer for both 
wild type and P439R mutant Sam68. As the reverse primers, Wt MSam68 R-SalI and 
Mutant MSam68R-SalI were used for wild type and P439R Sam68 respectively. These 
primers were used to PCR amplify the open reading frames of wild type and P439R 
mutant Sam68 using Sam68 cloned into a pACT2 AD construct as a template. The PCR 
amplification resulted in 1.3Kb products (figure 15). 
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Figure 15: PCR amplification of the wild type and P439R mutant Sam68 for cloning into 
pcDNA5. (A) Schematic picture of the PCR amplification of the open reading frame of wild type 
and mutant Sam68. MSam68 F-BamHI was used as the forward primer for both wild type and 
P439R mutant Sam68. As the reverse primers, Wt MSam68 R-SalI and Mutant MSam68R-SalI 
were used for wild type and P439R mutant Sam68 respectively. (B) PCR amplifications resulted 
in 1332bp products in ethidium bromide stained agaros gel. 1) Wild type Sam68 and 2) P439R 
mutant Sam68. As it has been shown the size of Sam68 PCR product is 1332bp. 1kb plus DNA 
ladder also has been shown in this picture. 
 
 
The pcDNA5 vector and Sam68 PCR product (insert) were digested by the restriction 
enzymes (BamHI, XhoI) and (BamHI, SalI) respectively. NotI was used for the re-
cleavage process to remove the ligated vectors which did not contain an insert. 
Sequencing results confirmed the presence of inserts containing the open reading 
frames of wild type and P439R Sam68 within the constructs (see Appendix A). 
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2.3.3 Establishment of stable cell lines expressing T-STAR, wild type and P439R 
mutant Sam68 FLAG-tagged proteins 
 
Stable cell lines expressing epitope tagged proteins were made by transfecting the T-
STAR, wild type and P439R mutant Sam68 open reading frames cloned in the pcDNA5 
into the Flp-In HEK293 knock in cell line. In the genome of these knock in cells there is 
an FRT site and a blasticidin resistance gene which has been stably integrated. In 
addition, the tet repressor is expressed in these cells. Expression of the gene of 
interest cloned into the FRT site was controlled by the tetracycline promoter. 
Therefore, a high level of gene expression would be achieved by adding tetracycline to 
the cell culture medium. To ensure the presence of the FRT site in the Flp-In HEK293 
cells, blasticidin was added every third feed. 
 
After 24 hours of seeding cells in 10% FBS DMEM with glutamax-1 medium , when they 
were 60% confluent, the open reading frame of T-STAR, wild type and P439R mutant 
Sam68 proteins cloned in the pcDNA5 vector were co-transfected with a plasmid 
pOG44 (encoding Flp recombinase). Also, empty pcDNA5 vector was co-transfected 
with a plasmid pOG44 as the negative control. Selection of transfected cells was 
carried out 48 hours later using hygromycin B. The stable transfected cells had a 
hygromycin resistance gene, therefore, they would survive after adding hygromycin to 
the media. In the case of cell death, untransfected cells were removed from the plate. 
Live cells then were washed with PBS and this step was followed by adding fresh 
medium and hygromycin B. After few weeks of selection by hygromycin B, colonies 
were re-plated.  
 
When the cells were confluent enough, the genes of interest were induced by adding 
tetracycline to the cell culture medium. Using Western blotting, the  presence of FLAG 
tagged proteins (T-STAR, wild type and P439R mutant Sam68) expression was tested 
after induction in comparison with negative control (FLAG tagged pcDNA5) (figure 16). 
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Any FLAG tagged protein at 0, but substantial induction at 24, 48 and 72 hours was 
detected. 
 
The molecular weight of the endogenous T-STAR and Sam68 proteins are 55kDa and 
68 kDa respectively. Because there are 16  and  six  amino acids in 2x FLAG (D  Y  K  D  D  
D  D  K  D  Y K  D  D  D  D  K ) and His tags (H  H  H  H  H  H) respectively, the weight of 
recombinant proteins were higher than the weight of the endogenous proteins. 
 
Blots were probed with monoclonal anti-FLAG and anti-mouse conjugated to HRP as 
the primary and secondary antibodies respectively. Then, blots were re-probed with α-
β actin and α-rabbit IgG conjugated to HRP as the primary and secondary antibodies 
respectively to test that the sample had been loaded equally. As it has been shown in 
figure 16 equal actin loading was present in each lane. 
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Figure 16:  Induced expression of FLAG tagged proteins (T-STAR, wild type and P439R 
mutant Sam68) in the stable cell lines as monitored by Western blotting. The presence 
of FLAG tagged proteins (T-STAR, wild type and mutant Sam68) was confirmed after 24, 
48 and 72 hours induction in comparison with the negative control (pcDNA5). The weight 
of endogenous T-STAR and Sam68 proteins are 55kDa and 68 kDa respectively. Because 
there are FLAG tags and His tags in these recombinant proteins, their weights were higher 
than the endogenous proteins. T-STAR, wild type and P439R Sam68 were around 60kDa 
and 80kDa respectively. A) Negative control (pcDNA5), B) T-STAR, C) wild type Sam68, D) 
P439R Sam68. Monoclonal anti-FLAG and anti-mouse conjugated to HRP were used as the 
primary and secondary antibodies respectively to detect the presence of FLAG tagged 
proteins. Blots were re-probed with α-β actin and α-rabbit IgG conjugated to HRP as the 
primary and secondary antibodies respectively to confirm that the samples had been 
loaded equally. Equal levels of actin loading control were present in each lane. 
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2.3.4 Localisation of FLAG tagged Sam68 proteins in the stable cell lines 
 
After detecting the expression and correct size of FLAG-tagged proteins using Western 
blot, immunofluorescence experiments were carried out to see if these proteins 
correctly localise in the cell. Sam68 protein has a mostly nuclear localization, even 
though initially it was identified in the cytoplasm during mitosis (Rajan et al., 2008a). It 
has been shown that by mutating NLS in Sam68 (P439R, changing proline to arginine), 
the resulting Sam68 protein is localized in the cytoplasm of HeLa cells (Reddy, 2000). 
The plan was to test if the P439R mutant Sam68 protein would have a similar 
cytoplasmic localisation in the Flp-In HEK293 cells after induction in a stable cell line 
expressing FLAG tagged P439R mutant Sam68. Consistent with this, FLAG-tagged 
P439R mutant Sam68 was only localized in the cytoplasm and not present within the 
nucleus (figure 17). 
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Figure 17: Localization of FLAG tagged wild type and P439R mutant Sam68 proteins after 
induction in stable Flp-In HEK293 cell lines.  A) Negative control (pcDNA5), B) Localization of 
Wild type Sam68 after induction by tetracycline and C) Localization of P439R mutant Sam68 
after induction by tetracycline. Wild type Sam68 is completely nuclear while P439R mutant 
Sam68 is only localized within the cytoplasm. Monoclonal anti FLAG and α-mouse IgG (594) 
were used as the primary and secondary antibodies respectively. The pcDNA5 is stably 
transfected with a control empty vector. These cells did not contain any FLAG epitope 
containing induced gene and were used as the negative control samples. DAPI was used to 
stain the nucleus and the red colour is showing the localization of induced proteins. The scale 
bars are equal to 10µm. Monoclonal anti FLAG and α-mouse IgG (594) were used as the 
primary and secondary antibodies respectively. 
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2.3.5 Purification of FLAG tagged proteins using immunoprecipitation  
 
After I confirmed the localization of wild type and P439R Sam68 proteins within the 
cell, the next step in the project was to investigate more about protein partners of T-
STAR, wild type and mutant Sam68. Therefore, 72 hours after tetracycline induction of 
the stable Flp-In HEK293 cells, the cells were harvested, followed by the 
immunoprecipitation of the FLAG-tagged proteins (T-STAR, wild and P439R mutant 
Sam68) using α-FLAG affinity resin. The immunoprecipitated (IP) samples were first 
analysed by Western blotting to confirm the presence of FLAG-tagged proteins within 
the input and IP samples. Monoclonal anti FLAG antibody was used as the primary 
antibody to probe the Western blots and analyse whether the immunoprecipitation 
was successful. The IP lanes of FLAG tagged proteins in comparison with the control 
sample (pcDNA5) showed that the immunoprecipitations were successful in retrieving 
the tagged proteins (figure 18). 
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Figure 18: Successful Immunoprecipitation (IP) of the FLAG tagged proteins from stable cell 
lines. Western blotting carried out to determine IP efficiency. Monoclonal anti FLAG antibody 
and HRP-conjugated anti-mouse were used as the primary and secondary antibodies. Lanes 1, 
2 and 3 show the Input, IP and Sup samples respectively. The IP lanes of FLAG tagged proteins 
in comparison with the control sample (pcDNA5) showed that the immunoprecipitations were 
successful. The Size markers are in kDa. Input: soluble supernatant before 
immunoprecipitation, IP: immunoprecipitated samples Sup: soluble supernatant after 
immunoprecipitation. All samples were performed in triplicate. 
 
2.3.6 Identification of candidate interacting protein partners of T-STAR using mass 
spectrometry 
 
After the process of Western blotting showed the efficient recovery of the FLAG-
tagged proteins, the next stage was to try and identify any co-immunoprecipitated 
proteins. In order to identify the candidate interacting protein partners for T-STAR, 
protein-FLAG immunoprecipitation (IP) samples were loaded on SDS-PAGE gels and 
electrophoresed, followed by staining of gels with Simply Blue stain for 1 hour. Gels 
were de-stained by using dH2O overnight. The protein bands were theb cut and sent 
for mass spectrometry.  The gel in figure 19 shows more proteins in the T-STAR lane 
compared with the control sample lane (empty pcDNA5). T-STAR specific protein bands 
were cut out of the gel and sent for identification by mass spectrometry. Based on the 
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sequencing results (table 11), identities of three candidate T-STAR interacting proteins 
were predicted.  
 
In addition to proving the presence of T-STAR, two other proteins, hnRNP G and RNA 
helicase A (RHA) were detected as the potential T-STAR partners (figure 19). The 
expected presence of T-STAR and hnRNP G were consistent with the 
immunoprecipitation having worked, since they were known T-STAR interacting 
protein partners (Ehrmann and Elliott, 2010). In addition, RHA was detected as a novel 
candidate interacting partner for T-STAR. Figure 20 shows the sequences of these 
proteins.  Matched peptides identified by mass spectrometry are shown in red. Extra 
information including Swiss-Prot entry name, Accession number, Gene name, 
Recommended Name and Nominal mass (Mr) of these proteins are shown in table 11. 
 
 
 
Figure 19: Simply Blue staining for detection of candidate interacting protein partners of T-
STAR. After loading IP samples on 4-12% gradient gels and gel elctrophoresis, Simply Blue safe 
stain was used for staining the gels. Stained gels were washed with dH2O. The protein bands 
which are highlighted by asterisks were cut and sent for sequencing by mass spectrometry. 
There are more protein bands in the T-STAR lane in comparison with the control sample 
(pcDNA5) suggesting the existence of T-STAR interacting proteins. Based on mass 
spectrometry, T-STAR, hnRNP G and RHA were detected. The presence of T-STAR and hnRNP G 
showed that the immunoprecipitation had worked. In addition, RHA was detected as a novel 
candidate interacting partner for T-STAR. 
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Figure 20: Mass spectrometry results for T-STAR interacting proteins. Showing the sequences 
of identified proteins. Matched peptide sequences are shown in red. The percentage of the 
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protein that was covered by the peptide sequences detected by Mass Spec. were 13%, 5% and 
2% for T-STAR, hnRNP G and RNA helicase A (RHA) respectively. 
 
 
 
 
 Swiss-Prot entry name Accession number Gene name Recommended  Name Nominal 
mass(Mr) 
1 KHDR3_HUMAN O75525 KHDRBS3/ T-
STAR 
 
KH domain-containing, RNA-
binding, signal transduction-
associated protein 3 
38833 
2 HNRPG_HUMAN P38159 RBMX 
 
Heterogeneous nuclear 
ribonucleoprotein G 
47419 
3 DHX9_HUMAN Q08211 DHX9 ATP-dependent RNA helicase A 143405 
Table 11: Candidate protein partners of T-STAR identified by FLAG immunoprecipitation. 
Based on mass spectrometry results, the three proteins T-STAR, hnRNP G and RHA were 
detected by immunoprecipitation and mass spectrometry.  Information about these proteins 
such as Swiss-Prot entry name, Accession number, Gene name, Recommended Name and 
Nominal mass (Mr) are from two websites:  http://www.genecards.org/ and 
http://www.uniprot.org/. 
 
 
2.3.7 Identification of the interacting partners of wild type and P439R mutant 
Sam68 using mass spectrometry 
 
A similar analysis was carried out for Sam68. After loading IP samples on 4-12% 
gradient gels and gel electrophoresis, Simply Blue safe stain was used for staining the 
gels. The stained gels were washed with dH2O. As shown in figure 21 there were more 
protein bands in the wild type and P439R mutant Sam68 lanes in comparison with the 
control sample (pcDNA5). Candidate Sam68 interacting proteins bands were cut from 
the gel and sent for identification. Based on mass spectrometry results, in addition to 
proving the presence of Sam68, a new candidate protein called CCAR1 (cell cycle and 
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apoptosis regulatory protein 1) was detected for wild type Sam68. On the other hand, 
for P439R mutant Sam68, in addition to detecting the presence of Sam68, two new 
candidate interacting protein partners called RHA (RNA helicase A) and CCAR1 were 
detected. Matched peptides identified by mass spectrometry are shown in red in 
figures 22 and 23. Extra information including Swiss-Prot entry name, Accession 
number, Gene name, Recommended name and Nominal mass (Mr) of these proteins 
are shown in tables 12 and 13. 
 
 
 
 
Figure 21:  Simply Blue staining for detection of wild type and P439R mutant Sam68 
interacting protein partners. After loading the IP samples on 4-12% gradient gels and gel 
electrophoresis, Simply Blue safe stain was used for staining the gels. Stained gels were 
washed with dH2O. Protein bands which are highlighted by asterisks were cut out of the gel 
and sent for sequencing. There were more protein bands in the wild type and P439R mutant 
Sam68 lanes in comparison with the control sample (pcDNA5). 
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Figure 22: Mass spectrometry results for wild type Sam68 interacting proteins. This picture 
shows the sequences of identified proteins. Matched peptide sequences identified by mass 
spectrometry are shown in red. Sam68 and CCAR1 were detected as the interacting protein 
partners. The peptide coverages recovered by Mass Spec. were 7% for both wild type Sam68 
and CCAR1 proteins. 
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 Swiss-Prot entry name Accession number Gene name Recommended  Name Nominal 
mass(Mr) 
1 KHDR1_HUMAN Q07666 KHDRBS1/Sam68 
 
KH domain-containing, RNA-
binding, signal transduction-
associated protein 1 
48456 
2 CCAR1_HUMAN Q8IX12 CCAR1 
 
Cell division cycle and 
apoptosis regulator protein 1 
133338 
 
Table 12: Candidate protein partners of wild type Sam68 identified by FLAG 
immunoprecipitation.  Based on mass spectrometry results, the presence of Sam68 in the 
immunoprecipitate shows the IP has worked. In addition to proving the presence of Sam68, a 
new candidate interacting protein called CCAR1 (cell cycle and apoptosis regulatory protein 1) 
was detected for wild type Sam68. Information about these proteins such as  Swiss-Prot entry 
name, Accession  number, Gene name, Recommended Name and Nominal mass (Mr) are from 
two websites:  http://www.genecards.org/ and  http://www.uniprot.org/ 
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Figure 23 : Mass spectrometry results for P439R mutant Sam68 interacting proteins. This 
picture shows the sequences of identified proteins as interacting with the P439R mutant 
Sam68 protein. Matched peptide sequences are shown in red. Sam68, RHA and CCAR1 were 
detected as the interacting protein partners. The peptide coverages for identified proteins by 
Mass Spec.  were 9%, 26% and 29% for P439R Sam68, CCAR1 and RHA respectively. 
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 Swiss-Prot entry name Accession 
number 
Gene name Recommended  Name Nominal 
mass(Mr) 
1 KHDR1_HUMAN Q07666 KHDRBS1/Sam68 
 
KH domain-containing, RNA-
binding, signal transduction-
associated protein 1 
48456 
2 CCAR1_HUMAN Q8IX12 CCAR1 
 
Cell division cycle and 
apoptosis regulator protein 1 
133338 
3 DHX9_HUMAN Q08211 DHX9/RHA ATP-dependent RNA helicase A 115243 
 
Table 13: Protein partners of P439R mutant Sam68 identified by FLAG 
immunoprecipitation.  Based on mass spectrometry results, the presence of Sam68 in the 
precipitated proteins shows the IP has worked. In addition to proving the presence of 
Sam68, two new candidate proteins called CCAR1 (cell cycle and apoptosis regulatory 
protein 1) and RHA (RNA helicase A) were detected for P439R Sam68. Information about 
these proteins such as  Swiss-Prot entry name, Accession  number, Gene name, 
Recommended Name and Nominal mass (Mr) are from two websites:  
http://www.genecards.org/ and  http://www.uniprot.org/ 
 
 
2.3.8 Confirmation of the presence of RNA Helicase A (RHA) in T-STAR, wild type 
and P439R mutant Sam68 IP samples  
 
After sending cut bands from the SDS-PAGE gel for mass spectrometry, I next carried 
out experiments to test the presence of RHA in each of the IP samples. Therefore, 
Western blots of all samples were probed with rabbit anti DHX9 (RHA) antibody. The 
presence of this protein (RHA) in all IP samples including T-STAR, wild type Sam68 and 
even P439R mutant Sam68 was detected (figure 24) but not in the IPs from stable cell 
lines made with empty pcDNA5. The immunoprecipitated RHA migrated at exactly the 
predicted molecular weight for RHA (140kDa). Rabbit anti DHX9 (RHA) and anti-rabbit 
conjugated to HRP were used as primary and secondary antibodies respectively. 
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Although based on mass spectrometry sequencing results RHA was detected as a new 
candidate interacting protein partner of T-STAR and the P439R mutant Sam68, using 
Western blotting and the RHA antibody, the presence of this protein in wild type 
Sam68 IP samples was detected as well. 
 
 
Figure 24: Western blot which confirms the presence of RHA in T-STAR, wild type and 
P439Rmutant Sam68 cell lysate IP samples. This experiment shows the presence of RHA 
protein in T-STAR, P439R mutant and even wild type Sam68 cell lysate IP samples. Although 
based on mass spectrometry sequencing results RHA was detected as a new candidate 
interacting protein partner of only T-STAR and P439R mutant Sam68, but interestingly, by 
using Western blot and RHA antibody, presence of this protein in wild type Sam68 IP samples 
was detected as well. Rabbit Anti-DHX9 (RHA) and anti-rabbit IgG (HRP) were used as primary 
and secondary antibodies respectively. (1): negative control (pcDNA5), (2): positive control 
(HEK293 cell lysate), (3): T-STAR IP sample, (4): wild type Sam68 IP sample, (5): P439R mutant 
Sam68 IP sample. The size marker is in kDa. 
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2.3.9 Confirmation of the presence of the CCAR1 protein in wild type and P439R 
mutant Sam68 IP samples  
 
After cutting bands from the SDS PAGE gel and sending them for mass spectrometry, 
the next step was confirmation of the presence of CCAR1 protein in the IP samples. 
Therefore, to test the presence of CCAR1 protein in the wild type and P439R mutant 
Sam68 IP samples, these samples were probed with anti CCAR1 antibody after 
Western blotting. The presence of this protein in all IP samples including wild type and 
P439R mutant was detected (figure 25). Rabbit anti CCAR1 and anti-rabbit-HRP were 
used as primary and secondary antibodies respectively. No CCAR1 was detected in the 
negative control (pcDNA5, empty vector). Immunoprecipitated CCAR1 migrated at 
exactly the predicted molecular weight of 140kDa. 
 
 
 
Figure 25: Confirming the presence of CCAR1 protein in wild type and mutant Sam68 cell 
lysate IP samples. To test the presence of CCAR1 in wild type and P439R mutant Sam68 IP 
samples, these samples were probed with anti CCAR1 antibody. This picture shows the 
presence of CCAR1 in both wild type and P439R mutant Sam68 cell lysate IP samples. Rabbit 
anti CCAR1 and anti-rabbit IgG (HRP) were used as primary and secondary antibodies 
respectively. (1): negative control (pcDNA5), (2 and 3): positive controls (HEK293 cell lysate 
and HeLa cell lysate), (4): wild type Sam68 IP sample, (5): P439R mutant Sam68 IP sample. The 
size marker is in kDa. 
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2.4 Summary and discussion 
 
The aim of this Chapter was to establish stable cell lines expressing FLAG tagged 
proteins (T-STAR, wild type and P439R mutant Sam68), and to use them to investigate 
their interacting proteins partners. To achieve this, the open reading frames of these 
RNA binding proteins were cloned in to the pcDNA5 vector. This vector encodes a FLAG 
epitope. These constructs were then transfected into the Flp-In HEK293 cells for 
integration into the genome. After making stable cell lines and inducing gene 
expression by using tetracycline antibiotic it was possible to express the protein of 
interest. 
 
I firstly used these stable cell lines for cell biological investigation into the localization 
of wild type and P439R mutant Sam68 after induction in the Flp-In HEK293 cells. Wild 
type Sam68 is nuclear and P439R mutant Sam68 protein is completely cytoplasmic. 
These results were similar to the previous study carried out by Reddy et al in HeLa cells 
(Reddy, 2000). The point mutation (P439R, changing proline to arginine) in the 
tyrosine-rich C-terminal domain of Sam68 changes the localization of Sam68 protein, 
making Sam68 a completely cytoplasmic protein. 
 
Based on these findings, the next step was to see whether or not changing the 
localization of nuclear Sam68 to the cytoplasm would change the Sam68 interacting 
protein partner network in Flp-In HEK293 cells. Therefore, the next steps were to 
purify FLAG tagged proteins (T-STAR, wild type and P439R mutant Sam68) and their 
partners using immunoprecipitation and to identify the immunoprecipitated proteins 
using mass spectrometry. 
 
Based on mass spectrometry sequencing results, in addition to proving the presence of 
Sam68, CCAR1 protein was detected in the wild type Sam68 IP lane. Also, two potential 
proteins, CCAR1 and RHA were detected in the P439R mutant Sam68 IP lane. As it has 
been previously shown that Sam68 and RHA can interact with each other (Reddy et al., 
Chapter 2: A proteomic approach to identify protein partners of T-STAR, wild type and P439R 
Sam68 
 
71 
 
2000) this confirmed the IP approach was identifying bona fide targets. But this was 
the first time that CCAR1 was detected as a potential interacting partner for Sam68. 
 
Based on mass spectrometry results, RHA was detected only as a partner of the P439R 
mutant Sam68 IP. Interestingly, by using Western blot and DHX9 (RHA) antibody, RHA 
protein was found to be a partner of wild type Sam68 as well. To prove the presence of 
CCAR1 in wild type and mutant Sam68 IP samples, these samples were probed with 
anti CCAR1 antibody and the presence of this protein in all IP samples including wild 
type and P439R mutant Sam68 was detected. Hence, in terms of interacting protein 
partners of both wild type and P439R Sam68, there was no difference detected 
between wild type and mutant versions of Sam68. 
 
In addition to proving the presence of T-STAR in the immunoprecipitates two other 
proteins (hnRNP G and RNA helicase A (RHA)) were detected as T-STAR partners by 
mass spectrometry. The expected presence of T-STAR showed that the 
immunoprecipitation had worked. In addition, the interaction between hnRNP G and 
T-STAR has already been described. For example, their interactions to regulate CD44 
minigene alternative splicing have been reported (Venables et al., 1999; Stoss et al., 
2001). Therefore, it was encouraging to see hnRNP G protein in the IP sample as one of 
the T-STAR interacting protein partners. But it was the first time that RHA was 
detected as an interacting protein partner for T-STAR. The presence of RHA in the T-
STAR IP samples was confirmed by using an anti DHX9 (RHA) antibody and Western 
blot. 
 
RHA is one member of the DEXH helicase superfamily (Lee and Hurwitz, 1993; Zhang et 
al., 1995). DNA or RNA helicases are important in resolving double stranded of nucleic 
acids (Zhang and Grosse, 2004). Using an RNA unwinding activity, the members of the 
DExD/H family are involved in different roles including RNA secondary structure 
modulation, translation and RNA transportation (Rocak and Linder, 2004; Fuller-Pace, 
2006). While the helicase parts of these proteins are highly conserved, the N- and C- 
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terminal domains of the DExD/H family members are different. These diversities seem 
to be important in their interactions (Fuller-Pace, 2006). 
 
RNA helicase A has been detected in human cells (Lee and Hurwitz, 1992), and an 
orthologue of this protein has been detected in Drosophila melanogaster called MLE 
(Kuroda et al., 1991). In Drosophila MLE protein has some roles in dosage 
compensation of the X chromosome (Kuroda et al., 1991). It seems that the role of 
MLE is to increase the transcriptional activity of X chromosome in male Drosophila 
(Kuroda et al., 1991). RHA also is called nuclear DNA helicase II (NDH II) (Friedemann et 
al., 2005). RHA also interacts with SMN which is important for small nuclear 
ribonucleoprotein assembly (snRNPs) (Pellizzoni et al., 2001; Terns and Terns, 2001). 
RHA is a component of the prespliceosomes (Hartmuth et al., 2002) and its localization 
is similar to hnRNPs (Zhang et al., 1999b). This protein is localized mostly in the 
nucleoplasm in human cells and the nucleolus in mouse cells (Zhang et al., 1999a).  
 
RHA and Sam68 play a role in RNA transportation (Reddy et al., 2000). There are two 
routes for nuclear-cytoplasmic transportation of retroviral mRNA. Complex 
retroviruses such as HIV (Human Immunodeficiency Virus) have a protein called Rev 
containing a sequence called a NES (Nuclear Export Sequence). The NES can bind to a 
RRE (Rev Response Element) in RNA and to the nuclear export receptor called CRM1. In 
this way, Rev protein acts as an adaptor between nuclear export receptor and viral 
mRNA (Pollard and Malim, 1998).  The second route of retroviral RNA transport is 
mediated by the CTE (Constitutive Transport Element) of type D retroviruses (Bray et 
al., 1994; Zolotukhin et al., 1994; Tabernero et al., 1996; Ernst et al., 1997; Pasquinelli 
et al., 1997; Saavedra et al., 1997). RHA is able to bind to the CTE of retroviral RNAs 
(Tang et al., 1997). The CTE is involved in promotion of nuclear export of viral RNA and 
it seems that RHA has a role in this transportation. There is a C-terminal region in the 
structure of RHA which is involved in translocation across the nuclear membrane (Tang 
et al., 1999). In addition, there is another protein called Tap (an RNA binding protein) 
which can bind to the CTE (Yoon et al., 1997; Gruter et al., 1998). RHA and Tap interact 
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with each other (Tang and Wong-Staal, 2000) . Therefore, it seems that these two 
proteins are involved in nuclear transportation of CTE-containing RNAs (both viral and 
cellular RNAs) (Reddy et al., 2000).  
 
On the other hand, it has been reported that Sam68 can independently of Rev protein 
mediate transportation of RNA (Reddy et al., 1999). RHA binds to Sam68 and Tap, and 
all of these proteins are involved in nuclear transportation of RNAs which contain 
either an RRE or CTE.  For example while there is a Rev protein pathway for HIV as an 
efficient way for nuclear export of RNA, this retrovirus and D retroviruses can use 
another pathway which include Sam68,Tap and RHA. It seems that this pathway is 
used by cellular mRNA as well (Reddy et al., 2000). 
 
In addition to the roles of RHA in RNA transportation and processing (Tang et al., 1997), 
RHA protein is involved in other activities as well including translation of mRNA 
(Hartman et al., 2006), transcription (Kuroda et al., 1991; Nakajima et al., 1997), DNA 
repair (Schlegel et al., 2003) and tumorigenesis (Abdelhaleem, 2004). Generally, 
members of the DExD/H family have roles in transcription regulation through 
recruiting transcription factors and stabilization of  the transcriptional initiation 
complex (Fuller-Pace, 2006). For example, RHA is involved in activation of transcription 
by interacting with CBP (CREB-binding protein) and RNA polymerase II. RHA acts as a 
bridge between these two components (Nakajima et al., 1997). RHA also interacts with 
topoisomerase IIα and double-stranded DNA, and it can also activate transcription by 
unwinding the structure of chromatin in transcription activated site (Zhou et al., 2003; 
Fuller-Pace, 2006).  
 
Interestingly, it has been shown that RHA acts as a bridge between Pol II holoenzyme 
and BRCA1 (breast cancer-specific tumour suppressor) (Miki et al., 1994; Rowell et al., 
1994; Anderson et al., 1998). The transcription of some genes involved in apoptosis, 
cell cycle and DNA repair is regulated by BRCA1 (Starita and Parvin, 2003; Yoshida and 
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Miki, 2004; Rosen et al., 2006). It hence seems that RHA has both specific and general 
roles in transcription (Fuller-Pace, 2006).  
 
Also there are some known roles for RHA protein in cancer as well. For example, RHA is 
over-expressed in lung cancer cells (Wei et al., 2004). RNA helicase A by increasing the 
transcription level of MDR1 (multidrug-resistant) gene in cancer cells seems to help 
cancer cells to be resistant to chemotherapeutic treatments (Zhong and Safa, 2004). 
 
There are two RNA binding domains ( dsRBDs) and one RGG box in the N and C termini 
of RHA respectively for binding to RNA (Zhang and Grosse, 1997). In RHA, the dsRBDs 
regardless of their roles in binding to RNA are involved in protein-protein interactions 
as well (Reichman et al., 2003). On the other hand, the RGG box in RHA is involved in 
physical contacts with different proteins such as RNA polymerase II, small nuclear 
ribonucleoproteins, and spliceosomes (Pellizzoni et al., 2001; Terns and Terns, 2001). It 
seems that in addition to the roles of RHA protein in transcription regulation, RHA is 
involved in the spliceosome assembly (Pellizzoni et al., 2001). 
 
I also detected another protein in wild type and P439R mutant Sam68 IP samples 
called CCAR1 (cell cycle and apoptosis regulatory protein is also known as CARP-1 
(Jiang et al., 2010)). CCAR1 is involved in gene expression regulation (Kim et al., 2008). 
One group of transcription activators are called nuclear receptors (NRs) including  
steroid and thyroid receptors (Tsai and O'Malley, 1994). Also, some co-activators have 
the ability to change chromatin structure and activate RNA polymerase II, and can be 
recruited by nuclear receptors (Kim et al., 2008). p160 co-activators  after binding to 
nuclear receptors function as scaffolds for gathering co-activator complexes on 
promoters (Stallcup et al., 2003). p160 co-activators also have the role of recruiting 
other co-activators such as CoCoA (Coiled-coil coactivator), histone methyltransferases 
and  histone acetyltransferases such as CARM1 (Coactivator-Associated Arginine 
Methyltransferase 1) and CBP/p300 respectively (Kim et al., 2003; Stallcup et al., 2003). 
Generally, a set of co-activator complexes make a group of proteins called the 
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Mediator. The proteins in the Mediator complex interact with nuclear receptors and 
other transcription activators (Fondell et al., 1996; Ito et al., 1999; Naar et al., 1999; 
Kang et al., 2002). CCAR1 not only is involved in coordination with p160 co-activators, 
but also has role in recruiting the Mediator complex. CCAR1 has direct and indirect 
interactions (through CoCoA) with nuclear receptors (Kim et al., 2008) (figure 26). 
 
Since Sam68 and P300/CBP also interact with each other (Hong et al., 2002), there is a 
possibility to consider Sam68 as a mediator between CCAR1 and P300/CBP. It seems 
that presence and interaction of Sam68 with these proteins might be able to play a 
role to recruit other co-activators. This idea needs to be tested by more experiments. 
Figure 26 shows the role of CCAR1 in transcription. The possible role of Sam68 also is 
shown in this figure: that Sam68 also acts to recruit CCAR1 and P300. 
 
 
Figure 26 : Role of CCAR1 in transcription. CCAR1 coordinates with both p160 co-activators 
and Mediator complex. CCAR1 recruits the Mediator complex. CCAR1 has also a direct and 
indirect interaction (through CoCoA) with nuclear receptors (Kim et al., 2008). NR: nuclear 
receptors. Possible role of Sam68 in having interaction with CCAR1 and P300/CBP plus 
recruiting other co-activators of transcription is shown in the picture. 
 
 
CCAR1 acts as a P53 co-activator (Kim et al., 2008). CCAR1 has roles in apoptosis, cell 
proliferation regulation (Ou et al., 2009) and breast cancer (Kim et al., 2008). CCAR1 
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functions as an intracellular transducer in these pathways (Ou et al., 2009). The Wnt/β-
catenin signalling pathway is involved in different kinds of cancers especially colorectal 
cancers. Some target genes of Wnt/β-catenin signalling pathway have roles in cell 
proliferation regulation. CCAR1 seems to help β-catenin in increasing transcription 
level of these genes. Interestingly, CCAR1 seems to have a role in controlling the 
growth of cancer cells for example in colon cancer cells (Ou et al., 2009). 
 
To summarise, in this project RHA was detected as interacting with T-STAR, wild type 
and P439R mutant Sam68. In addition, CCAR1 interacts with both wild type and P439R 
mutant Sam68. Interestingly although wild type and P439R mutant Sam68 have 
different localization, both have same interacting partners (CCAR1 and RHA). To follow 
up these results I needed to check whether or not the interactions of these proteins 
might happen only after induction and over-expression of the gene of interest, or if 
these interactions happen at endogenous levels of expression as well. To achieve this 
aim I carried out more experiments. In the next Chapter more investigations regarding 
T-STAR, wild type and P439R mutant Sam68 interactions with endogenous CCAR1 and 
RHA will be described. 
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Chapter 3 
 
3 Investigating the functional importance of  T-SAR, wild type and 
P439R Sam68 
 
3.1 Introduction 
 
In the previous Chapter, I described some new interacting partners for T-STAR, wild 
type and P439R mutant Sam68. These partner proteins were RHA (RNA helicase A) 
which interacted with T-STAR and P439R mutant Sam68 proteins, and CCAR1 (Cell 
division cycle and apoptosis regulator protein 1) which interacted with both wild type 
and mutant Sam68 immunoprecipitated proteins. Both of these proteins, as 
mentioned in the previous Chapter, have important roles within the cell.  
 
Since the interactions between the proteins were only observed after over-expression 
of T-STAR or Sam68, it was necessary to check for interactions between these proteins 
expressed at endogenous levels. The first aim of this Chapter was to test the 
interactions of endogenous RHA and CCAR1 with T-STAR and Sam68. My second aim 
was to get more information regarding the localization of these proteins within cells, 
which would enable us to achieve more information about the roles of these protein 
interactions. The third aim was to identify the interacting domains by making short 
forms of these proteins and seeing if these also interacted. 
 
Addressing these aims would enable us to learn more about the interaction networks 
of T-STAR and Sam68. The final aim of this Chapter was investigation of possible links 
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between Sam68 and RHA in terms of their roles in the transcription and alternative 
splicing regulation of some target genes.  
 
There are some studies showing the role of Sam68 and RHA in transcription regulation. 
One possibility that Sam68 is involved in transcription is through binding the Cap 
Binding Protein (CBP). Sam68 and CBP interact and co-localise with each other (Hong 
et al., 2002; Babic et al., 2004). CBP and P300 act as transcriptional adaptors (Blobel, 
2000; Goodman and Smolik, 2000; Chan and La Thangue, 2001). CBP has a histone 
acetyltransferase activity (Bannister and Kouzarides, 1996). It seems that Sam68 
competes with other cofactors to bind to CBP and after binding, this RNA binding 
protein acts such a bridge to link CBP to TF (transcription repressor factor). In this way 
Sam68 represses the transcription of CBP targets (Bielli et al., 2011) (figure 27).   
 
 
Figure 27: Role of Sam68 in repression of CBP targets. Sam68 might compete with other 
cofactors to bind to CBP. Sam68 acts like a bridge to link CBP and transcription repressor factor 
(TF). In this case, Sam68 has repression role in transcription of CBP targets. The figure is 
modified from (Bielli et al., 2011). 
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RHA and CBP also interact with each other. In addition, RNA helicase A belongs to the 
holoenzyme complex which contains RNA polymerase II as well (Nakajima et al., 1997). 
In another experiment using glycerol density gradient analysis RHA and CBP were 
detected as interacting partners but RNA polymerase II did not co sediment with RHA 
(Kitagawa et al., 2002). Since both of these proteins, Sam68 and RHA are involved in 
transcription I also wanted to know whether RHA and Sam68 interact with each other 
to regulate transcription or not.  
 
RHA seems to be involved in transcription regulation not only by changing the 
chromatin structure but also by acting like a bridge to mediate interaction between 
RNA polymerase II and CBP (Nakajima et al., 1997). RNA helicase A has similar role to 
mediate interactions between Breast cancer-specific tumor suppressor protein 1 
(BRCA1) (a transcription factor) and RNA polymerase II (Anderson et al., 1998). 
Transcription of some genes which have roles in apoptosis, cell cycle and chromatin 
remodelling is regulated by BRCA1 (Mullan et al., 2006).  
 
One of the genes that RHA has a role in its transcription regulation is cyclin D1. It has 
been shown that in breast cancer cells there is a positive correlation between the 
expression level of RHA , cyclin D1 and EGFR (epidermal growth factor receptor) (Huo 
et al., 2010). After binding of epidermal growth factor (EGF) to EGFR, this receptor 
translocates to the nucleus. ATRS (AT-rich sequence) within the promoter of target 
genes are bound by EGFR. This binding can lead to transcription activation of the target 
gene. Huo et al showed the presence of EGF leads to interaction of RHA and EGFR and 
these two proteins make a complex. RNA helicase A then binds to the ATRS and acts as 
a mediator (Huo et al., 2010) (figure 28). 
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Figure 28: Role of RHA in transcription regulation. A) RHA seems to be involved in 
transcription regulation by acting as a bridge to mediate an interaction between RNA 
polymerase II and CBP (Nakajima et al., 1997). B) In breast cancer after binding of EGF to 
EGFR, this receptor translocates to the nucleus. Then RNA helicase A binds to the ATRS 
within the promoter and acts as a mediator. This binding can lead to transcription 
activation of the target gene.  (Huo et al., 2010). 
 
I planned to check the role of these two proteins (Sam68 and RHA) in transcription 
regulation of the same target gene (cyclin D1/CCND1). Cyclin D1 has an important role 
in the regulation of the cell cycle and is involved in different kind of cancers such as 
breast cancer (Xu et al., 2013). On the other hand, Sam68 seems to be over expressed 
in breast and prostate cancers (Elliott and Rajan; Busa et al., 2007; Rajan et al., 2008b; 
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Elliott and Rajan, 2010). Also, in breast cancer cell lines RHA and cyclin D1 expression 
level have positive correlations with each other (Huo et al., 2010). 
 
To extend my studies on the RHA and Sam68 interaction, I also looked at their role in 
alternative splicing regulation of a target gene called NRXN3. By using these different 
approaches there would be an opportunity to investigate Sam68 interaction networks 
and their roles within the cell. 
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3.2 Methods and Materials 
3.2.1 Standard molecular biology  
Some of standard molecular biology techniques including restriction digestion, 
purification of DNA and plasmid DNA, ligations, re-cleavage, dialysis, agarose gel 
electrophoresis and sequencing are described in the methods section in the previous 
Chapter (Chapter2, method section). 
 
3.2.1(a) PCR amplification of short forms of Sam68 and RHA 
 
The PCR amplification protocols to make short forms of Sam68 comprising the N-KH, 
N-KH-RG, KH-RG and RG-tyrosine rich domains were identical to the Sam68 PCR 
amplification described previously (more information is available in Chapter 2, method 
section, tables 2 and 5). 
 
RHA was amplified by PCR using a similar combination of reagents and protocol to that 
used for T-STAR amplification (previously described in Chapter 2, method section, 
tables 1 and table 4). The primers used for these amplifications are shown in table 14. 
 
Primer name Sequence (5’-3’) Restriction 
Enzyme 
site 
WSam68 F-KH-RG-BamHI  AAA AAA AAA GGATCC TTCAATTTTGTGGGGAAGATTCTTGGACCA BamHI 
WSam68 F-RG-Tyrosine BamHI AAA AAA AAA GGATCC CCTGAACCCTCTCGTGGTCGTG BamHI 
Wt MSam68 R-SalI AAAAAAAAAGGATCCTTAATAACGTCCATATGGATGCTCTCTGTATG SalI 
WSam68 R-N-KH-SalI AAAAAAAAAGTCGACTTATTCCTCCTTGGCTTTGTCTCTCATTG SalI 
WSam68 R-N-KH-RG-SalI AAAAAAAAAGTCGACTTATGTCCGAGCTCTTGGTGTTGG AG SalI 
WRHA-F-BamHI AAA AAA AAA GGATCC ATGGGTGACGTTAAAAATTTTCTGTATGCCTG BamHI 
WRHA-R-SalI AAA AAA AAAGTCGACTTAATAGCCGCCACC TCCTCTTCC  SalI 
MSam68 F-BamHI AAAAAAAAAGGATCC ATGCAGCGCCGGGACGATCCT BamHI 
BGHrev TAGAAGGCACAGTCGAGG --------- 
 
Table 14: Primers used to make RHA and short forms of Sam68. 
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3.2.1(b) Heat shock transformation 
 
10µl of the plasmid DNA was added to 100µl of E. coli cells, DH5α (provided in 
Professor Elliott’s lab) and mixed. The sample was left on ice for 30 minutes and then 
incubated firstly at 42°C for 1 minute and secondly on ice for 2 minutes. 1 ml of the LB 
medium was then added, and the sample was incubated at 37°C for 1 hour. After 
centrifugation, the excess LB medium was removed and the cell pellets were mixed 
with the remaining medium. These resuspended cells were then plated out on the LB 
agar plates which contained 50μg/ml ampicillin. The plates were incubated at 37°C 
overnight (LB broth and LB Agar mixtures are shown in Chapter2, method section, 
table 8). 
 
 
3.2.2 Cell culture (HEK 293 cells) 
 
HEK293 cells (provided in Professor Elliott’s lab, IGM, Newcastle University) were 
seeded in 10% FBS DMEM (Dulbecco’s MEM) with glutamax-1 medium. They were 
incubated at 37°C in 5% CO2. The Generation of stable cell lines and harvesting cells 
are described previously (Chapter2, method section). 
 
3.2.3 Protein based methods 
 
SDS polyacrylamide gel electrophoresis (SDS-PAGE), Western blot (Protein immunoblot 
analysis), immunoprecipitation using α-FLAG affinity resin, and immunofluorescence 
have been already described (Chapter2, method section).  Table 15 shows the 
antibodies used in Western blot, immunofluorescence and immunoprecipitation. 
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Primary Antibody Source Monoclonal 
/Polyclonal 
Species Dilution for 
 Western Blot 
Dilution  for 
immunofluorescence 
Anti  T-STAR Made in Elliott’s Lab Polyclonal Rabbit 1:1000 - 
Control  IgG Santa Cruz Polyclonal Rabbit 1:1000 - 
Anti Sam68 (C-20) Santa Cruz Polyclonal Rabbit 1:1000 - 
Rabbit Anti DHX9 (RHA) ProteinTech Group Polyclonal Rabbit 1:2000 1:200 
Rabbit anti CCAR1 Sigma Polyclonal Rabbit 1:500 1:200 
Anti hnRNP L(4D11) Sigma Monoclonal Mouse - 1:200 
  
 
Secondary Antibody Source Monoclonal 
/Polyclonal 
Species Dilution for 
 Western Blot 
Dilution  for  
immunofluorescence 
Anti-mouse-HRP Amersham Polyclonal Sheep 1:1000 - 
Anti-rabbit-HRP Jackson lab Polyclonal Goat 1:1000 - 
Anti-rabbit-
488(Green) 
Molecular Probes Polyclonal Donkey - 1:400 
Anti-mouse-594(Red) Molecular Probes Polyclonal Donkey - 1:400 
 
 
3.2.3(a) Immunoprecipitation of endogenous T-STAR and Sam68 proteins using 
protein A Dynabeads 
 
In order to detect interacting protein partners of T-STAR and Sam68, HEK293 cells 
were harvested and the IP lysis buffer (50mM Tris pH 7.4, 5mM NaF, 5mM MgCl2, 
100mM KCl, 1X Roche Complete Protease Inhibitor Cocktail and 0.1% NP-40) used to 
resuspend the cell pellets, followed by a 20 minutes incubation on ice. Then, the 
samples were centrifuged for 15 minutes at 4°C at maximum speed. 30 μl of the 
          Table 15: Primary antibodies. Antibodies used for Western blot and immunofluorescence. 
      Table 16: Secondary antibodies used for Western blot and immunofluorescence. 
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supernatant was kept and labelled as Input. 1200 μl of the soluble cell lysate was 
added to a 1.5 ml centrifugation tubes containing an appropriate amount of rabbit 
polyclonal Sam68/rabbit T-STAR (table 15). There were two control groups as well: (i) 
1200 μl of the soluble cell lysate was added to a 1.5 ml centrifugation tubes which had 
appropriate amount of normal rabbit IgG; (ii) in the no antibody control group, cell 
lysate was incubated with no antibody. All the samples were incubated at 4°C on a 
rotator overnight.  
 
The following day, a magnetic rack and 250 μl of 0.1M sodium phosphate (pH 8.1) 
were used for washing 50 μl of protein A Dynabeads (Invitrogen). The cell lysates were 
added to the beads followed by one hour incubation on a rotator at room 
temperature. Using a magnetic rack, 30 μl of the supernatants were kept and labelled 
SupIP. 1X PBS was then used for washing the beads. In order to check the 
immunoprecipitation of proteins, 2X SDS sample loading dye was added to samples for 
loading on SDS-PAGE gels, followed by Western blotting. 
 
 
3.2.4 RNA-based methods 
 
3.2.4(a) RNA extraction 
 
Trizol® (Invitrogen) was used for extracting RNA according manufacturer's instructions. 
After adding 100µl of Trizol® to the harvested cells, samples were mixed for 10 
minutes at the maximum speed on a shaker. Samples were then incubated for 5 
minutes at room temperature. This step was followed by the addition of 20µl of 
chloroform to samples, shaking for a few seconds and incubation for 3 minutes at 
room temperature. After centrifugation of samples at 4°C for 15 minutes at maximum 
speed, the clear layers were transferred to new 1.5 ml centrifuge tubes. Nucleic acids 
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were precipitated by adding 50µl of isopropanol to the tube and incubation of sample 
for 10 minutes at room temperature, followed by another centrifugation (at 4°C) for 10 
minutes.  After removing the supernatant, 75% ethanol-25% nuclease free dH2O 
(provided in Professor Elliott’s lab) was used for washing the RNA pellet. After 
centrifugation of samples (at 4°C) for 5 minutes, the supernatant was removed and the 
tube was left with an open top on a hot block (at 65°C) for 5 minutes. Then 30-50 µl of 
nuclease free dH2O was added to the tube, and the sample was incubated on the hot 
block (at 55°C) for 5 minutes and then vortexed. A nanoDrop Spectrophotometer 
(NanoDrop Technologies) was used for quantifying the RNA concentration. 
 
 
3.2.4(b) RT-PCR (Reverse transcriptase PCR) 
 
A SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen) was used to make cDNA from 
RNA samples according to the manufacturer’s instructions. Table 17 shows the 
reaction mixture used.  
 
Reagent Quantity for a 10µl reaction 
(Diethylpyrocarbonate) DEPC-treated water 
(nuclease free dH2O) 
Up to 10l 
5X VILO™ Reaction Mix 2µl 
10X SuperScriptR Enzyme Mix 1µl 
RNA (500ng/µl) Xµl 
 
Table 17: RT-PCR recipe. Based on SuperScript® VILO™ cDNA Synthesis Kit recipe. 
 
 
RT-PCR reactions were incubated firstly at 25°C for 10 minutes and this step was 
followed by two other steps, 42°C for 120 minutes and 85°C for 5 minutes respectively. 
A DNA Engine DYAD thermal cycler (MJ Research) was used for RT-PCR amplifications. 
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3.2.4(c) Real time PCR (estimation of Cyclin D1 /CCND1 transcript level) after 
induction of gene of interest 
 
After RNA extraction, making cDNA from RNA (500ng/µl) and diluting cDNA in a ratio 
of 1:10, real time PCR was carried out to estimate the level of cyclin D1/CCND1 mRNA 
in different samples. The amplicon was 81bp in length. The forward and reverse 
primers had a 10µM concentration in 10µl PCR reactions. SYBR® Green PCR Master Mix 
(5ml) (part no: 4309155) was used as the master mix.  Reagents and primers used in 
the real time PCR reaction are shown in table 18 and table 19. The company which 
supplied primers was Integrated DNA Technology (IDT).   
 
 
Reagent Quantity for a 10l reaction 
Nuclease free dH2O 2µl 
SYBR® Green PCR Master Mix(5ml) 5µl 
10M Forward primer 1l 
10M Reverse primer 1l 
cDNA (1:10 diluted) 1µl 
 
Table 18: Real time PCR recipe to check level of cyclin D1/CCND1 mRNA in different samples. 
The reagents and PCR programmes used in a typical 10l reaction are shown. 
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Primer name Sequence (5’-3’) 
Cyclin D1 F TCTACACCGACAACTCCATCC 
Cyclin D1 R TTCCACTTGAGCTTGTTCACC 
α Actin (F) SYBR CATCGAGCACGGCATCGTCA 
α Actin (R) SYBR TAGCACAGCCTGGATAGCAAC 
GAPDH (F) SYBR CATACCAGGAAATGAGCTTGACAA 
GAPDH (R) SYBR AACAGCGACACCCATCCTC 
βTubulin (F) SYBR CTTCGGCCAGATCTTCAGAC 
βTubulin (R) SYBR AGAGAGTGGGTCAGCTGG AA 
 
 
All reactions were repeated three times using an ABI 7900 HT Fast real-time PCR 
system (Applied Biosystems). The amplification protocol is shown in table 20. The ΔCt 
method was used to estimate the relative expression level of cyclin D1/CCND1 mRNA. 
After calculating the average of Ct value of samples, the mean Ct value of endogenous 
expression of α Actin, βTubulin and GAPDH (control genes) were used for 
normalization of the cyclin D1/CCND1 Ct value in different samples. Data were 
analysed using Excel software (Student's t-test). 
 
 
1 Heat activation 50 °C 2 minutes   
2 Initial denaturation 95°C 10 minutes   
3 Denaturation 95°C 15 seconds   
4 Annealing/elongation 60 °C 1 minute Cycling to step 3 45 
Table 19: Primers used in real time PCR. 
             Table 20: PCR Programme for real time PCR. 
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3.2.4(d) Splicing assay 
 
After RNA extraction, synthesis of cDNA from RNA (500ng/µl) (RT-PCR) and dilution of 
cDNA (ratio of 1:5), a 25 µl polymerase chain reaction was carried out to measure 
splicing patterns. The amplification protocol, PCR programmes and the primers used in 
these reactions are shown in tables 21, 22 and 23 respectively. A DNA Engine DYAD 
thermal cycler (MJ Research) was used for PCR amplifications. GoTaq® DNA 
Polymerase and dNTPs were from the Promega company. The company which 
supplied primers was Integrated DNA Technology (IDT).  
 
 
 
Reagent Quantity for a 25l reaction 
Nuclease free dH2O 17.35µl 
5X Green Go Taq Reaction Buffer 5µl 
10M Forward primer 0.5l 
10M Reverse primer 0.5l 
cDNA (1:5 diluted) 1µl 
GoTaq® DNA Polymerase 0.15l 
10mM dNTPs (Deoxyribonucleotide 
triphosphates) 
0.5l 
 
Table 21: PCR recipe to check alternative splicing patterns of a target gene (NRXN3). The 
reagents and PCR programmes used in a typical 25l reaction are shown. 
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Step Function Temperature Time Number of  cycles  
1 Heat Activation 94 °C 2 minutes   
2 Denaturation 94°C 1 minute   
3 Annealing 60°C 1 minute   
4 Extension 72 °C 1 minute Cycling to step 2 30 
5 Final Extension 72 °C 10 minutes   
6 Cooling 4°C ∞   
Table 22: PCR Programme used to analyse alternative splicing patterns followed by the 
target gene (NRXN3). 
 
 
Primer name Sequence (5’-3’) 
NRXN3 F TTGGCACAGTTGACATCTCC 
NRXN3 R GTCCTTTGTCCTTTCCACCA 
Table 23: Primers used in the PCR reaction to check the alternative splicing patterns followed 
by the target genes (NRXN3). 
 
 
Both agarose gel electrophoresis explained previously (Chapter2, method section) and 
the QIAXCEL multi-capillary electrophoresis system were used for running PCR 
products. To estimate PCR product sizes and their relative concentrations, the Bio 
calculator software was used.  
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3.3 Results 
 
3.3.1 Do RHA and CCAR1 proteins co-localise with Sam68 nuclear bodies (SNBs) 
within the cell?  
 
After identification of RHA and CCAR1 proteins as candidate interacting proteins for 
Sam68 and T-STAR, the next aim was to check the localisation of these proteins within 
the cell. Specifically I was interested to see whether or not these proteins co-localized 
with Sam68. Sam68 seems to be exclusively nuclear in most somatic cells. Sam68 
protein has also been observed in the cytoplasm of secondary spermatocytes. In 
addition, Sam68 has some interactions with signalling molecules which are known to 
be cytoplasmic (Lukong and Richard, 2003; Paronetto et al., 2006; Paronetto et al., 
2009). Some signalling components and splicing regulators such as Sam68 and hnRNP L 
(Rajan et al., 2009) are present in Sam68 Nuclear Bodies (SNBs). In cancer cells, Sam68 
protein has a general nucleoplasmic distribution and is also concentrated in nuclear 
SNB structures (Chen et al., 1999b). The literature suggests that RHA and CCAR1 (Fujita 
et al., 2005; Kotani et al., 2010; Lu et al., 2012) are mostly nuclear.  
 
HeLa cells and appropriate antibodies (tables 15 and 16) were used to check the 
localisation of RHA, CCAR1 and Sam68. In our lab we had just rabbit polyclonal 
antibodies against Sam68, CCAR1 and RHA proteins. Therefore, there was no 
possibility to test the co-localisation of these proteins at the same time in the same 
cells. Rajan et al in 2009 had shown that Sam68 and hnRNP L are both present within 
the SNBs (Sam68 Nuclear Bodies) and the nucleoplasm, and co-localise with each other 
(Rajan et al., 2009). Therefore, a monoclonal mouse hnRNP L antibody was used as a 
marker instead of a Sam68 antibody, to gauge where Sam68 protein would be. 
 
HeLa cells were grown on coverslips. When cells were confluent coverslips were 
washed with PBS and then fixed in 4% (w/v) PFA (paraformaldehyde). Cells were then 
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incubated in 1%Triton X-100 to be permeabilised. Cells were incubated in blocking 
solution (10% Horse serum/Triton X-100). This step was followed by incubation of cells 
in primary and fluorescent conjugated secondary antibodies respectively, diluted in 
blocking solution. PBS was used for washing the cells. Cells were mounted using 
VectaShield Mounting Medium with 4’,6-diamidino-2-phenylindole (DAPI) and pictures 
were taken by a fluorescence Axioplan2 microscope. None of RHA or CCAR1 were 
detected in SNBs as labelled by hnRNP L (figure 29 and 30). However, endogenous RHA 
(mostly), CCAR1 and Sam68 were each localised within the nucleoplasm.  
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Figure 29 : Localization of endogenous RHA and hnRNP L/Sam68 in HeLa cells. Rajan 
et al in 2009 showed that Sam68 and hnRNP L are present within the SNBs and the 
nucleoplasm. They showed these protein co-localise with each other (Rajan et al., 
2009). Therefore, monoclonal mouse hnRNP L antibody was used instead of Sam68 
antibody to enable co-localization with SNBs. All these proteins including RHA (mostly), 
hnRNP L /Sam68 are distributed within the nucleoplasm. SNBs (Sam68 Nuclear Bodies) 
are shown with white arrows. A) DAPI staining of nuclear DNA B) HnRNP L localization. 
Mouse anti hnRNP L (4D11) and anti-mouse-594 (Red) antibodies were used as primary 
and secondary antibodies respectively. C) RHA localisation. Rabbit anti DHX9 (RHA) and 
anti-rabbit-488 (Green) were used as primary and secondary antibodies respectively. D) 
Merged picture of localization of both hmRNPL /Sam68 and RHA proteins. These results 
show that although RHA and hnRNP L/Sam68 do not co-localize in SNBs, they co-
localise within the nucleoplasm. The scale bars are equal to 20µm. 
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Figure 30: Localization of endogenous CCAR1 and hnRNP L/Sam68 in HeLa cells. 
Monoclonal mouse hnRNP L antibody was used as a surrogate of Sam68 antibody to 
enable co-localization. CCAR1 and hnRNP L/Sam68 were distributed within the 
nucleoplasm and are nuclear. SNBs (Sam68 Nuclear Bodies) are shown with white arrows, 
labelled by hnRNP L stainintg. A) DAPI staining B) HnRNP L localization. Mouse anti hnRNP 
L (4D11) and anti-mouse-594(Red) antibodies were used as primary and secondary 
antibodies respectively. C) CCAR1 localization. Rabbit anti CCAR1 and anti-rabbit-488 
(Green) were used as primary and secondary antibodies respectively. D) Merged picture 
of localization of both hmRNPL and CCAR1 proteins. These results show that although 
CCAR1 and hnRNP L do not co-localize in SNBs, they co-localize in the nucleoplasm. The 
scale bars are equal to 20µm. 
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3.3.2 Does endogenous Sam68 interact with both RHA and CCAR1 proteins? 
 
Following confirmation of Sam68 protein interactions with RHA and CCAR1 after 
induction with tetracycline, I tested whether or not the interactions between these 
proteins happen in an endogenous situation as well. One third of a soluble HEK293 cell 
lysate was incubated overnight at 4°C with appropriate amounts of either Sam68, 
rabbit IgG (first control) or no antibody (second control). The next day, these soluble 
cell lysates were then incubated with protein A dynabeads for one hour at room 
temperature. This step was followed by washing the beads with 1X PBS. To check the 
efficiency of co-immunoprecipitation, 2X SDS sample loading dye was added to the 
samples for loading on SDS-PAGE, followed by Western blotting. Anti Sam68 (C-20) and 
anti-rabbit-HRP as primary and secondary antibodies (tables 15 and 16) were used 
respectively to probe the Western blots to confirm precipitation of Sam68 protein 
(figure 31-A).  
 
The immunoprecipitated (IP) samples were then probed with either rabbit anti-DHX9 
(RHA) or rabbit anti CCAR1 as primary and anti-rabbit IgG (HRP) as the secondary 
antibodies (tables 15 and 16) respectively. As shown in figure 31-B, RHA was only 
detected in the Sam68 IP lane and not in any of the control IP lanes. This experiment 
shows that endogenous RHA interacts with Sam68 at both endogenous and induced 
expression levels of Sam68. 
 
On the other hand, in contrast to RHA, endogenous CCAR1 was not detected in the 
Sam68 immunoprecipitated (IP) lane. This means that the interaction between Sam68 
and CCAR1 only happens after over-expression of Sam68 in cells, and there is not any 
detectable interaction between these two proteins when Sam68 is at endogenous 
level of expression (figure 31-C). This most likely means that the interaction between 
Sam68 and CCAR1 only occurs when Sam68 has a high level of expression and not in 
the normal cellular situation. 
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Figure 31: Testing for co-immunoprecipitation of RHA and CCAR1 with Sam68. One third 
of the soluble cell lysate was incubated overnight at 4°C with appropriate amounts of 
Sam68 antibody, rabbit IgG or no antibody. The next day, soluble cell lysates were 
incubated with protein A dynabeads for one hour at room temperature. 1X PBS was then 
used for washing the beads. The next steps were adding 2X SDS loading dye to samples, 
loading samples on SDS-PAGE, Western blotting and probing blot using appropriate 
antibodies. A) Proving the presence of Sam68 in the IP lane but not the control lanes to 
show the efficiency of immunoprecipitation. Anti Sam68 (C-20) and anti-rabbit-HRP as 
primary and secondary antibodies were used respectively. B) Proving the presence of RHA 
in the Sam68 IP samples. Rabbit anti-DHX9 (RHA) and anti-rabbit IgG (HRP) were used as 
primary and secondary antibodies to check the presence of RHA. The presence of RHA in 
the immunoprecipitated (IP) lane is shown by a red asterisk in the Sam68 IP sample. C) 
Testing presence of CCAR1 in the Sam68 IP sample using rabbit anti CCAR1 as primary and 
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anti-rabbit IgG (HRP) as secondary antibodies. CCAR1 was not detected in the Sam68 IP 
lane. The size markers are in kDa. 
 
3.3.3 Mapping interacting domains of Sam68 with RHA via preparation of stable 
cell lines expressing short forms of Sam68 
 
After proving the interaction of RHA and Sam68 at both endogenous and induced 
levels of expression of Sam68, the next step was to test which domain/domains of 
Sam68 might interact with RHA. To achieve this aim four short forms of Sam68 protein 
were made. The short forms had different domain content within their structures. 
These four truncated proteins were called N-KH (short form 1), N-KH-RG (short form 
2), KH-RG (short form 3) and RG-tyrosine (short form 4) respectively. 
 
Short form 1 (N-KH) contained the N-terminus, Qua1 and KH domains of Sam68 (figure 
32-A). Short form2 in addition to these domains contained the Qua2 and RG-rich 
(arginine and glycine) domain (figure 32-B). Short form 3 (KH-RG) contained the KH, 
Qua2 and RG domains (figure 32-C). In the structure of short form 4 (RG-tyrosine), only 
the RG-rich domain and tyrosine-rich C-terminus were present (figure 32-D). 
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Figure 32 : Four different short forms of Sam68. Four different short forms of Sam68 were 
made to be cloned into the pcDNA5 vector. Different domains are shown in different 
colours. Dark green: extended N-terminal domain of Sam68; green: proline rich sequences 
(SH3 binding sits); red: N-terminus; bold and underlined: Qua1 domain; bold, blue and 
underlined: KH Domain; blue font color with under line: Qua2 domain; yellow: RG-rich 
domain; purple: tyrosine-rich C-terminal domain; gray: Tyrosine residues (candidate SH2 
binding sites). The picture is modified from (Ehrmann and Elliott, 2010). 
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3.3.3(a) Short forms of Sam68 cloned in pcDNA5 
 
Forward and reverse primers (table 14) were used to PCR amplify the open reading 
frames encoding different Sam68 short forms, using Sam68 cloned into a pACT2 AD 
construct as a template. The cloning strategy of these short forms of Sam68 was similar 
to the cloning strategy of wild type Sam68 (explained previously, Chapter 2, result 
section 2-3-2). Briefly, PCR amplification resulted in different sizes of PCR products. 
Short form 1 (N-KH): 630bp; short form 2 (N-KH-RG): 1047bp; short form 3 (KH-RG): 
549bp; and short form 4 (RG-tyrosine rich): 501bp (figure 33).  
 
 
 
Figure 33: PCR amplification of short forms of Sam68 for cloning into the pcDNA5 vector. 
Agarose gel electrophoresis of PCR reaction products showing: (1) Short form 1 (N-KH). 
MSam68 F-BamHI and WSam68 R-N-KH-SalI were used as the forward and reverse primers 
respectively. The PCR product size was 630bp. (2) short form 2 (N-KH-RG). MSam68 F-
BamHI and WSam68 R-N-KH-RG-SalI were used as the forward and reverse primers 
respectively. The PCR product size was 1047bp. (3) Short form 3 (KH-RG). WSam68 F-KH-
RG-BamHI and R-N-KH-RG-SalI were used as the forward and reverse primers respectively. 
The PCR product size was 540bp. 4) Short form 4 (KH-tyrosine). WSam68 F-RG-Tyrosine 
BamHI and Wt MSam68 R-SalI were used as the forward and reverse primers respectively. 
The PCR product size was 501bp. The 1kb plus DNA ladder was run in parallel and is also 
shown in this picture. 
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Digestion of the short forms of Sam68 (insert) and the pcDNA5 vector was carried out 
by restriction enzymes (BamHI, SalI) and (BamHI, XhoI) respectively. This step was 
followed by ligation of the digested PCR products into the digested sites of pcDNA5. 
NotI was used for the re-cleavage process to remove the ligated vectors which did not 
contain an insert. 10 µl of plasmid DNA was then used for heat shock transformation 
into E. coli. LB agar plates which contained 50μg/ml ampicillin were used for plating 
out the cells. Plates were incubated at 37°C overnight to select colonies. Insert forward 
primers including: MSam68 F-BamHI (for short form 1 and 2), WSam68 F-KH-RG-BamHI 
(for short form 3), WSam68 F-RG-Tyrosine BamHI (for short form 4) and vector reverse 
primer, BGHrev were used to screen the colonies by PCR. Colonies which contained the 
insert were grown in the LB medium plus 50μg/ml ampicillin. After overnight 
incubation at 37°C on a shaker, plasmid purification was carried out. 
 
To confirm the correct presence of inserts in the pcDNA5 vector, 100ng/µl of 
constructs were sequenced. The results confirmed the presence of inserts containing 
the open reading frames of short forms 1 (N-KH), 2 (N-KH-RG), 3 (KH-RG) and 4 (RG-
tyrosine) in the constructs. The sequencing results are shown in the Appendix A. 
 
 
3.3.3(b) Establishment of stable cell lines encoding short forms of FLAG-tagged 
Sam68 
 
Dr Andrew Knox and Dr Nicholas Watkins (Institute for Cell and Molecular Biosciences, 
Newcastle University) gave us the pcDNA5 vector and Flp-In HEK293 cell. In Flp-In 
HEK293 cells there was tet repressor expression. Tetracycline promoter in these cells 
which could control gene cloned downstream of this promoter could control the 
expression of gene of interest. Therefore, addition of tetracycline antibiotic to the 
medium could lead to high level of expression of short forms of Sam68.  When cells 
were 60%-70% confluent, the open reading frame of the short forms of Sam68 (short 
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form1: N-KH; short form2: N-KH-RG; short form3: KH-RG; and short form4: RG-tyrosine 
rich) cloned in pcDNA5 were co-transfected with pOG44 plasmid.  Flp recombinase was 
encoded by pOG44, for integration of each gene of interest into the FRT site of the 
genome of these cells. Hygromycin B was used for selection of the transfected cells. 
Transfected cells were resistant to the hygromycin antibiotic. Therefore, after few 
weeks of washing dead cells from the medium and addition of antibiotic, stably 
transfected HEK 293 cells were growing. Single colonies were transfered to new plates. 
After establishment of the cells in a new plate they were ready to be induced by 
tetracycline to express the FLAG tagged short forms of Sam68. 
 
 
3.3.3(c) Testing gene expression of short forms of Sam68 after induction 
 
Before mapping the interacting domains of Sam68 with RHA using 
immunoprecipitation, the expression of these short forms of Sam68 was tested after 
72 hours induction with tetracycline.  When stable cell lines expressing different short 
forms of Sam68 were confluent enough, expression of the genes of interest were 
induced by adding tetracycline to the cell culture medium. After 3 days cells were 
harvested and sonicated. Samples were loaded on a 13% running gel, electrophoresed 
and analysed by Western blotting. Predicted sizes of these short forms proteins were 
30.38kDa (short form 1: N-KH); 37.60kDa (short form2: N-KH-RG); 19.22kDa (short 
form3: KH-RG); and 18.02kDa (short form4: RG-tyrosine).  
 
Wild type Sam68 was also loaded as the positive control. Figure 34 shows the resulting 
Western, in which bands for wild type, short forms1 and 2 could be detected. Since the 
stable cell line expressing Sam68 short forms 3 and 4 were resistant to antibiotic, the 
absence of Sam68 short form 3 and 4 proteins on the gel could be because of 
instability of these proteins in these cells. This instability could be because of either 
their small sizes being unable to fold properly or being not functional proteins.  
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Figure 34: Induced expression of FLAG tagged short forms of Sam68 in their respective stable 
cell lines as monitored by Western blotting. The presence of FLAG tagged protein (wild type, 
short forms1 and 2) expressions were confirmed after 72 hours induction in comparison with 
negative control (pcDNA5). Because there are FLAG tags and His tags in these recombinant 
proteins, their weights were higher than expected. The predicted weight of wild type Sam68 
and short forms 1 and 2 are 68kDa, 30.38kDa and 37.60kDa respectively. It seems that short 
forms 3 and 4 were not stable and could be degraded quickly after their production. 
Monoclonal anti FLAG and anti-mouse-HRP were used as the primary and secondary 
antibodies respectively to detect the presence of FLAG tagged proteins. Blots were re-probed 
with α-β actin and α-rabbit IgG (HRP) as the primary and secondary antibodies respectively to 
confirm that the samples had been loaded equally. Equal levels of actin loading control were 
present in each lane. Size markers are in kDa. 
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3.3.3(d) Purifying protein partners of short forms of FLAG tagged Sam68 using 
immunoprecipitation  
 
One of the aims in this project was to detect which part/parts of Sam68 might be 
involved in mediating the interaction with RHA. Since just two short forms of Sam68 
were stable, it was possible to continue this analysis only with short forms 1 and 2. 
While short form 1 had RG and tyrosine domain deletions, in the structure of short 
forms 2 only the tyrosine domain was deleted. The plan was to immunoprecipitate 
Sam68 short forms 1 and 2 to test whether they interact with RHA or not.  
 
Therefore, stable Flp-In HEK293 cells expressing Sam68 short forms 1 and 2 were 
induced by tetracycline for three days. Cells were then harvested, followed by the 
immunoprecipitation of FLAG-tagged proteins. α-FLAG affinity resin was used for 
immunoprecipitation of these proteins.  
 
After harvesting cells, 1.5ml of the IP lysis buffer was added to samples followed by 
incubation of the cells on ice. FLAG resin washed with TBS buffer was added to the cell 
pellets and samples were centrifugated at 4°C. 30μl of the supernatant was kept as the 
input. After on overnight incubation of the rest of the supernatant with FLAG resin, 
samples were centrifuged and 30μl of the supernatant was kept as the IP sup. Then the 
FLAG resin was washed with the IP washing buffer. To check immunoprecipitation 
efficiency, after adding 2XSDS sample loading dye, samples were loaded on SDS-PAGE 
and probed with appropriate antibodies. 
 
I tested firstly the presence of FLAG tagged proteins in Immunoprecipitated (IP) 
samples using Western blotting to analyse whether the immunoprecipitation had been 
successful. Monoclonal anti FLAG antibody was used as the primary antibody to probe 
the Western blots. IP lanes of FLAG tagged proteins in comparison with the control 
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samples (stable cell lines made with pcDNA5) showed that the immunoprecipitations 
were successful in retrieving the tagged proteins (figure 35). 
 
 
 
 
Figure 35: Testing immunoprecipitation (IP) of FLAG tagged proteins from stable cell 
lines. Western blotting was carried out to determine IP efficiency. Monoclonal anti FLAG 
antibody and HRP-conjugated anti-mouse were used as the primary and secondary 
antibodies. In the above picture 1, 2 and 3 show the input (soluble supernatants before 
immunoprecipitation), IP (immunoprecipitated sample) and IP Sup (soluble supernatants 
after immunoprecipitation) respectively. IP lanes of the FLAG tagged proteins in 
comparison with the negative control sample (pcDNA5) showed that co-
immunoprecipitations were successful. The size markers are in kDa. The position of the 
FLAG tagged proteins on the Western blots are indicated by arrows. 
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3.3.3(e) Which domain/domains of Sam68 are involved in interaction with RHA? 
 
After confirming that the experiment was recovering the Flag tagged proteins, the next 
step was to probe the blots with anti RHA antibody. The aim was to detect which 
domain/domains of Sam68 is involved in interaction with RHA protein. In the short 
form 1, just the tyrosine-rich C-terminal domain was deleted. This means that in the 
structure of this protein all parts of Sam68 except tyrosine rich domain were present. 
On the other hand, in short form 2 in addition to the tyrosine domain, the RG 
(arginine-glycine rich) domain was deleted as well. Western blots were probed with 
anti-DHX9 (RHA), and anti-rabbit IgG (HRP) were used as secondary antibody. RHA was 
present in the immunoprecipitated (IP) lane of the positive control (full length Sam68-
Flag protein). RHA protein was also present in the Input and IPsup lanes of all other 
samples. However, there was no RHA band in the immunoprecipitated (IP) lanes of 
Sam68 short forms 1 and 2, meaning that neither of these two shorter Sam68 protein 
isoforms interacts with RNA helicase A. Since in the short form 2 all domains except 
tyrosine rich domain were present, it seems that this tyrosine rich domain has an 
important role in the interaction between Sam68 and RHA (figure 36).  
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Figure 36: Testing the presence of RHA in immunoprecipitated (IP) samples of Sam68 
short forms 1 and 2. (A) Western blot showing the presence of RHA protein in the IP lane 
of the positive control (wild type Sam68). After confirming the presence of FLAG tagged 
Sam68 (pink asterisk), Western blots were re-probed with anti RHA antibody. RHA was 
present in the Input and IPsup lanes of both positive and negative controls and only in the 
IP lane of the positive control (shown by red asterisks). (B) This picture shows that RHA 
was not present in the IP lanes of Sam68 short forms1 and 2. After confirming the 
presence of FLAG tagged short forms 1 and 2 (pink asterisks), Western blots were re-
probed with RHA antibody. Although RHA was present in Input and IPsup samples of 
Sam68 short forms 1 and 2 (shown by red asterisks), RHA protein was not present in any 
of the IP lanes. The size marker is in kDa. Anti-DHX9 (RHA) and anti-rabbit IgG (HRP) were 
used as primary and secondary antibodies respectively. 
 
 
3.3.4 Functional analysis of whether Sam68 and RHA cooperate in the cell 
 
To find out more about the links between Sam68 and RHA, firstly the open reading 
frame of RHA was cloned in the pcDNA5 vector. Then a stable cell line expressing FLAG 
tagged RHA protein was made. The presence of induced RHA was confirmed after 72 
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hours of induction by tetracycline. The aim was to investigate more about the possible 
roles of RHA and Sam68 in transcription and alternative splicing regulation. Therefore, 
the transcription level of CyclinD1 and alternative splicing regulation (exon inclusion) 
of NRXN3 after induction of Sam68 and RHA with tetracycline were tested to answer 
some of the questions regarding any potential cooperation between these two 
proteins.   
 
 
3.3.4(a) Cloning the open reading frame of RHA in pcDNA5 vector 
 
Forward and reverse primers (table 14) were used to PCR amplify the open reading 
frame of RHA from a pcDNA3-HA (GAT) construct (gifted from Professor Nakajima, 
Institute of Medical Science, Tokyo Medical University). WRHA-F-BamHI and WRHA-R-
SalI were used as forward and reverse primers. The cloning strategy of RHA was similar 
to cloning strategy of wild type Sam68 (explained previously, Chapter 2, result section 
2-3-2). The PCR amplification resulted in a 3818bp size of PCR product (figure 37).  
 
 
 
Figure 37: PCR amplification of RHA for cloning into pcDNA5 vector. WRHA-F-BamHI and 
WRHA-R-SalI were used as forward and reverse primers respectively. The PCR product size was 
3818bp. The migration of the 1kb plus DNA ladder is also shown in this picture. 
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Digestion of RHA (insert) and the pcDNA5 vector was carried out by using restriction 
enzymes (BamHI, SalI) and (BamHI, XhoI) respectively. This step was followed by 
ligation of the digested PCR products into the complementary digested sites of 
pcDNA5. NotI was used for the re-cleavage process to remove the ligated vectors 
which did not contain an insert. Transformation of the ligation mixes into E.coli, plating 
out, and screening the colonies by PCR, as well as plasmid purification were carried out 
similarly to what had been done for the short forms of Sam68. 
 
To confirm the correct presence of RHA in the pcDNA5 vector, 100ng/µl of the 
constructs were sequenced. The results confirmed the presence of inserts containing 
the open reading frames of RNA helicase A in the constructs. These sequencing results 
are shown in the Appendix A. 
 
3.3.4(b) Establishment of stable cell line encoding FLAG-tagged RHA 
 
When Flp-In HEK293 cells were 60%-70% confluent, the open reading frame of RHA 
cloned in the pcDNA5 was co-transfected with pOG44 plasmid. Hygromycin B was used 
for selection of the transfected cells. Transfected cells were resistant to the 
hygromycin antibiotic. Therefore, after few weeks of washing dead cells from the 
medium and addition of new antibiotic, stably transfected HEK 293 cells were forming 
colonies. Single colonies were transferred to the new plates. After establishment of 
cells on a new plate they were ready to be induced by tetracycline to express the FLAG 
tagged RHA. 
 
3.3.4(c) RHA makes FLAG-tagged proteins of the appropriate size after induction 
 
When stable cell lines expressing RHA were confluent enough, tetracycline was added 
to the medium to induce expression of FLAG tagged RHA. After 3 days induction, cells 
were harvested and sonicated. The samples were loaded on an 8% running gel. The 
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predicted size of this tagged RHA protein was 140kDa plus the mass of the tag. A 
protein of exactly this size was visible on the Western (figure 38). 
 
Figure 38: Induced expression of FLAG tagged RHA in the stable cell lines as monitored by 
Western blotting. The presence of FLAG tagged RHA expression was confirmed after 72 hours 
induction in comparison with the negative control (Flp-In HEK293 cells stably transfected with 
pcDNA5, empty vector). Monoclonal anti FLAG and anti-mouse-HRP were used as the primary 
and secondary antibodies respectively to detect the presence of FLAG tagged proteins. Blots 
were re-probed with α-β actin and α-rabbit IgG (HRP) as the primary and secondary antibodies 
respectively, to confirm that the sample had been loaded equally. Equal levels of actin loading 
control were present in each lane. The size markers are in kDa. 
 
3.3.4(d) Experiment to test the role of Sam68 and RHA in regulation of cyclin 
D1/CCND1 transcript level  
 
To find out more about the roles of Sam68 and RHA in transcription regulation and 
also to investigate more about any possible links between these two proteins, their 
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roles in transcription regulation of a target gene (cyclin D1/CCND1) was tested. Cyclin 
D1 has an important role in regulation of the cell cycle, and is involved in several kinds 
of cancers including breast cancer (Xu et al., 2013). In prostate and breast tumours 
Sam68 is also over expressed (Elliott and Rajan; Busa et al., 2007; Rajan et al., 2008b; 
Elliott and Rajan, 2010), and it seems that in breast cancer cells there is positive 
correlation between the expression level of RHA and cyclin D1 (Huo et al., 2010). 
Therefore, it was interesting to test whether the level of cyclin D1/CCND1 mRNA 
changed after over expression of Sam68 and RHA in Flp-In HEK293 cells.  
 
After 3 days of induction with tetracycline, induced cells were harvested. This step was 
followed by RNA extraction and preparation of cDNA from RNA (500ng/µl). cDNA 
samples of stable cell lines made with pcDNA5 (empty vector), wild type Sam68, P439R 
mutant Sam68 and RHA were then diluted  1:10 in dH2O. Real time PCR was then 
carried out in triplicate to estimate the level of cyclin D1/CCND1 mRNA in each sample. 
 
The ΔCt method was used to estimate the relative expression level of cyclin D1/CCND1 
mRNA. After calculating the average of Ct value of samples, the mean Ct value of 
endogenous expression of α Actin, βTubulin and GAPDH (control genes) was used for 
normalization of the cyclin D1/CCND1 Ct value. Figure 39 shows the level of cyclinD1 
mRNA in wild type Sam68, P439R mutant Sam68 and RHA after induction with 
tetracycline in comparison with pcDNA5 (empty vector, control group). Data were 
analysed using Excel software (Student's t-test). While there was no significant 
difference between wild type and control groups (P > 0.05), interestingly the level of 
cyclin D1/CCND1 mRNA was significantly higher in the P439R mutant Sam68 group in 
comparison with the control group (pcDNA5, empty vector) (P < 0.05). Discussed in 
Chapter 2, P439R mutant Sam68 is cytoplasmic in localisation. However, the level of 
cyclin D1/CCND1 mRNA in a stable cell line expressing RHA after addition of 
tetracycline was not significantly different from the control group (pcDNA5) (P > 0.05). 
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Figure 39: Cyclin D1/CCND1 expression level after 3 days induction with tetracycline. After 3 
days of induction with tetracycline antibiotic, the level of cyclin D1/CCND1 mRNA was 
estimated in stable cell lines expressing pcDNA5 (empty vector, control group), WSam68 (wild 
type Sam68), P439RmSam68 (mutant Sam68), and RHA (RNA helicase A) using real time PCR. 
There was no significant difference between the control group (pcDNA5) and WSam68 (wild 
type Sam68) (P>0.05). Interestingly, I could detect significant differences between the control 
group (pcDNA5) and P439RmSam68 (mutant Sam68) (P<0.05). In addition, the level of cyclin 
D1/CCND1 expression in the cells with induced expression of RHA was not significantly 
different from control group (P>0.05). All samples were tested in triplicate. The asterisk 
shows that the difference between two groups was significant.  
 
 
3.3.4(e) Do Sam68 and RHA co-regulate the same target genes at the splicing level?  
 
To investigate more about the roles of Sam68 and RHA, role of these proteins was 
tested in alternative splicing regulation of a target gene called Neurexin3 (Nrxn3). 
Using alternative promoters and the presence of alternatively spliced exons within the 
mRNAs of Neurexin1-3 can lead to production of many different proteins (Missler and 
Sudhof, 1998; Craig and Kang, 2007; Loya et al., 2010). It has been shown that Sam68 
has role in alternative splicing of Neurexin1 in the cerebellum (Iijima et al., 2011). In 
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addition, T-STAR and Sam68 are involved in regulation of alternative splicing of 
Neurexin3 (Ehrmann et al., 2013) . The question was whether Sam68 and RHA had 
roles in splicing regulation of alternatively spliced segment 4 (AS4) into Neurexin3 
mRNAs in human cells (Flp-In HEK293 cells). Therefore, primers were designed for this 
cassette exon (figure 40). As shown in this figure there are alternative promoters, two 
alternatively spliced segments (cassette exons), an alternative five prime splice site 
and also two alternative finishes. These alternative events mean that from the same 
gene, many different proteins can be produced. The question was whether or not 
Sam68 and RHA have roles in AS4 exon splicing. 
 
 
 
Figure 40: NRXN3 can make different types of mRNA using different alternative promoters, 
cassette exons and alternative 3’ends. NRXN3 has an alternative promoter (A), 2 cassette 
exons (B and D), an alternative 5’ splice site (C) and two alternative 3’ ends (E and F). Roles of 
Sam68 and RHA were tested in inclusion of the AS4 exon (shown by red asterisk). Here a 
screenshot from UCSC shows the sizes of the expected PCR products with or without this 
cassette exon. 
After 3 days of induction with tetracycline, induced Flp-In HEK293 cells containing 
pcDNA5 (empty vector, negative control), wild type Sam68, P439R mutant Sam68 and 
RHA were harvested. This step was followed by RNA extraction, cDNA synthesis from 
RNA (500ng/µl) and diluting the cDNA (at a ratio of 1:5). Then 25 µl polymerase chain 
reactions were carried out. GoTaq® enzyme, NRXN3 F and NRXN3 R were used as DNA 
polymerase, forward and reverse primers respectively. Both the QIAXCEL multi-
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capillary electrophoresis system and agarose gel electrophoresis were used to analyse 
PCR products. While wild type Sam68 was confirmed to have a role in repression of 
exon inclusion of cassette exon 1 (AS4 exon) (there was a decrease in inclusion of the 
AS4 exon, so the upper exon included band was weaker after Sam68 induction), the 
P439R mutant Sam68 and RHA did not play any role in splicing regulation of this target 
(figure 41). Since P439R mutant Sam68 is cytoplasmic, this protein is not present in the 
nucleus to be involved in regulation of splicing of this cassette exon. Furthermore, it 
seems that RHA also does not play any role in splicing regulation of this target gene 
(NRXN3). 
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Figure 41 : Testing the role of Sam68 and RHA in splicing regulation. To check the possible 
role of these two proteins in splicing regulation of the NRXN3 cassette exon 1 (AS4 exon), 
HEK293 cells were harvested which over-expressed these proteins and RNA samples were 
extracted. After making cDNA, RT-PCR was used to check for the presence of this cassette exon 
in mRNA. A) PCR samples loaded on agarose gel. RT-PCR products made with and without this 
specific exon would be 294 and 209 bp. The 1kb plus DNA ladder also has been shown in this 
picture. B) The QIAXCEL multi-capillary electrophoresis system was also used to check the exon 
inclusion in each sample. C) This graph shows the percentage of exon inclusion in each sample. 
pcDNA5: 27.8%, WSam68 (wild type Sam68): 14.2%, P439RmSam68 (mutant Sam68): 22.4%, 
RHA: 26.7%. Together these data show while wild type Sam68 has role in repression of exon 
inclusion of AS4 exon, p439R Sam68 and RHA do not play any detectable role. 
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3.3.5 Testing the interaction between endogenous T-STAR and RHA proteins 
 
Following the confirmation of a protein interaction between T-STAR and RHA using 
FLAG-tagged protein bait after induction with tetracycline, there was still another 
question to be answered: whether or not the interaction between these two proteins 
happens in an endogenous situation. Since T-STAR is expressed only in brain, testis and 
very small amount in kidney (Venables et al., 1999; Venables et al., 2004), HEK293 cell 
line (derived from Human Embryonic Kidney cells) was chosen to check the interaction 
between T-STAR and RHA. 
 
Immunoprecipitation of endogenous T-STAR protein using protein A Dynabeads was 
carried out to test this hypothesis. One third volume of a soluble HEK293 cell lysate 
was incubated overnight at 4°C with appropriate amounts of either T-STAR, rabbit IgG 
(first control) or no antibody (second control). The next day, soluble cell lysates were 
incubated with protein A dynabeads for one hour at room temperature. 1X PBS was 
then used for washing the beads. To check the efficiency of co-immunoprecipitation, 
2X SDS sample loading dye was added to the samples before loading on SDS-PAGE and 
followed by Western blotting.  
 
Since the heavy chains of both T-STAR and the rabbit IgG used for 
immunoprecipitation have similar weights, it was not possible to directly check the 
efficiency of T-STAR immunoprecipitation. Therefore, for testing this efficiency, 
investigation of the presence of one of already known interacting partner of T-STAR in 
the IP samples could be used for proving the efficiency of T-STAR immunoprecipitation. 
 
Since T-STAR has a known protein interaction with Sam68 (Venables et al., 1999), 
Sam68 rabbit polyclonal IgG and anti-rabbit IgG (HRP) were used as primary and 
secondary antibodies respectively to look for Sam68 protein in the 
immunoprecipitates. A very small amount of Sam68 was co-immunoprecipitated with 
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T-STAR (figure 42) which showed that probably the small amount of T-STAR expression 
in HEK293 cells is a barrier for highly efficient co-immunoprecipitation.  
 
To test for co-immunoprecipitation of RHA, the IP samples were probed with rabbit 
anti-DHX9 (RHA) and anti-rabbit IgG (HRP) as primary and secondary antibodies 
respectively. Although RHA was not detected in the T-STAR IP lane, this may be 
because of negligible expression of T-STAR in kidney cells and not because of a lack of 
any interaction of T-STAR with RHA (figure 43). Therefore, to check the endogenous 
interaction between T-STAR and RHA it would probably be better to use other cell lines 
or tissues which express higher amounts of T-STAR such as testis tissue in future 
experiments. 
 
 
 
Figure 42: Experiment to test the presence of Sam68 protein in the T-STAR 
IP sample. One third of a soluble HEK293 cell lysate was incubated overnight 
at 4°C with appropriate amounts of either T-STAR antibody, rabbit IgG or no 
antibody. The next day, soluble cell lysates were incubated with protein A 
dynabeads for one hour at room temperature. 1X PBS was then used for 
washing the beads. After washing 2X SDS loading dye was added to samples, 
followed by SDS-PAGE, Western blotting and probing blots with appropriate 
antibodies. Presence of Sam68 is shown by red asterisk. The size marker is in 
kDa. Pageruler prestained protein ladder was used as the marker which has 
range from 10kDa to 250 kDa.  
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Figure 43: Testing the presence of RHA protein in the T-STAR cell lysate IP samples. IP 
samples were probed with Rabbit anti-DHX9 (RHA) and anti-rabbit IgG (HRP) as primary and 
secondary antibodies respectively.  The size markers shown are in kDa. 
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3.4 Summary and Discussion: 
 
In this Chapter the aim was to investigate more about T-STAR, Sam68 and their newly 
identified interacting candidates.  
 
To compare the distribution of Sam68 relative to RHA and CCAR1 the localization of 
these proteins was monitored within the cell. Specifically, to see whether or not these 
proteins co-localized with Sam68. Appropriate antibodies were used to check 
localization of RHA, CCAR1 and Sam68 in HeLa cells. Rajan et al in 2009 had shown that 
Sam68 and hnRNP L are present within SNB (Sam68 Nuclear Bodies) and the 
nucleoplasm and co-localized with each other (Rajan et al., 2009). Therefore, 
monoclonal mouse hnRNP L antibody was used instead of Sam68 antibody. Consistent 
to the findings of Denegri et al (Denegri et al., 2001) in this study SNBs were also 
detected in HeLa cells. The results showed RHA or CCAR1 were not present in the SNBs, 
but endogenous RHA, CCAR1 and Sam68 were localized within the nucleoplasm. Since 
Sam68 was present both in the SNBs and nucleoplasm it seems that Sam68 
interactions with RHA and CCAR1 occur in the nucleoplasm instead of SNBs.  
 
To investigate more about CCAR1 and RHA, endogenous interaction of Sam68 was 
tested with these proteins. A Sam68 co-IP using protein A Dynabeads was carried out, 
and the IP samples were probed with appropriate antibodies. These results suggest 
that CCAR1 interacts with Sam68 only after Sam68 over-expression and not in the 
endogenous situation. Based on these results while normal level of Sam68 does not 
stimulate CCAR1 interaction, an increased level of Sam68 expression can lead to 
interaction with CCAR1 protein. Other studies have shown the role of Sam68 and 
CCAR1 proteins separately in transcription and cancer. Sam68 and CCAR1 are both 
over-expressed in breast cancer (Busa et al., 2007; Kim et al., 2008; Rajan et al., 2008b; 
Elliott and Rajan, 2010). Therefore, there could be a possible link between expression 
level of Sam68 and CCAR1 which needs to be tested. 
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The interaction between RHA and Sam68 can occur at both endogenous and over 
expressed levels of Sam68. This means that the interaction between these two 
proteins is not dependent on expression level of Sam68. Based on these results the 
next step was testing the possible links between RHA and Sam68 proteins. 
 
To answer which domain/domains of Sam68 is/are interacting with RHA, short forms 
of Sam68 (short forms 1, 2, 3 and 4) were produced by expression in stable cell lines. 
The drawback of this approach was out of four truncated proteins only two short 
forms had detectable expression level. This could be because short forms 3 and 4 were 
not stable in these cells and could possibly be degraded quickly after their production. 
This suggests these proteins were degraded because of either their small sizes or being 
not functional proteins within the cells.  
 
Immunoprecipitation was carried out to identify protein partners of Sam68 short forms 
1 and 2. Then after confirmation of the presence of these two short forms in cell lysate 
IP samples, these samples were probed with anti-DHX9 (RHA) antibody. Although the 
positive control full length Sam68 clearly interacted with RHA, there was not any band 
in IP lanes of Sam68 short forms 1 and 2, so it seems that neither of these two 
isoforms interacts with RNA helicase A. In fact, short form 2 contained all domains of 
Sam68 except the tyrosine rich domain. This shows that tyrosine rich domain has a 
functional role in the interaction between Sam68 and RHA. Figure 44 shows the 
structure difference between full length Sam68 and Short form 2 Sam68 (N-KH-RG). 
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Figure 44:  Sam68 full length and short form 2. Deletion of Tyrosine-rich domain of Sam68 
interrupts the interaction between Sam68 and RHA. These results show that this region plays 
an important role in mediating the interaction of these two proteins. A) The picture of full 
length Sam68. B) The picture of Sam68 short form 2 (N-KH-RG).  
 
According to the important role of tyrosine rich domain to act as a substrate for 
tyrosine kinase enzymes, this domain can lead to interaction of Sam68 protein with 
proteins which contain SH2 domains (Najib et al., 2005). Tyrosine-rich sites can be 
phosphorylated by tyrosine kinases. Phosphorlation of Sam68 is important for its roles 
in signal transduction within the cell (Vernet and Artzt, 1997). There seem to be two 
possibilities that may explain why deletion of tyrosine rich domain could disrupt the 
interaction between Sam68 and RHA. The most obvious explanation is that the 
tyrosine rich domain is the important one for Sam68 interactions. It is possible that by 
deletion of the Sam68 tyrosine rich domain, Sam68 interaction with one of the 
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proteins involved in signal transduction and activation of Sam68-RHA interaction was 
disrupted and therefore, Sam68 was not able to interact with RHA. The second 
explanation could be that the deletion of tyrosine-rich domain of Sam68 could change 
folding of Sam68 protein structure which could negatively affect Sam68 interaction 
with RHA.  
 
As mentioned in the discussion section of the previous Chapter, RHA, Sam68 and Tap 
have been implicated in nuclear transport of RNAs which contain either an RRE or CTE 
(Reddy et al., 2000). Therefore, the plan was to test whether or not these two proteins 
(Sam68 and RHA) might be involved in other events within the cell such as 
transcription or alternative splicing regulations. One hypothesis was that there may be 
links between the roles of Sam68 and RHA in transcription regulation of target genes. 
Separate studies related to the role of Sam68 and RHA in transcription. In this study 
the plan was to find a common transcription target to see whether its transcription 
regulation can be influenced by both Sam68 and RHA proteins. One target gene 
(known to be regulated by Sam68 and RHA) was cyclin D1/CCND1. There was no study 
to test the role of Sam68 and RHA at the same time in transcription regulation of cyclin 
D1. Therefore, in this study the roles of Sam68 and RHA proteins were tested in 
transcription regulation of cyclin D1 after over-expression of Sam68 and RHA in Flp-In 
HEK293 cells. 
According to the previous studies Sam68 has mostly a repressive role in transcription 
(Hong et al., 2002). Mouse fibroblasts arrest their cell cycle after Sam68 over 
expression. Levels of cyclin D1/CCND1 mRNA are reduced after over expression of 
Sam68, suggesting Sam68 protein might repress expression of cyclin D1/CCND1 (Hong 
et al., 2002). Small ubiquitin-like modifier (SUMO) is involved in a post translational 
modification of Sam68 called sumoylation. It has been shown that sumoylation of 
Sam68 promotes the role of this protein in inhibition of cyclin D1/CCND1 gene 
expression (Babic et al., 2006). Therefore the level of cyclin D1/CCND1 mRNA  was 
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tetsted by real time PCR after over-expression of RHA, wild type and mutant Sam68 in 
Flp-In HEK293 cells.  
 
The results in this study showed that while wild type Sam68 does not repress cyclin 
D1/CCND1 transcription, P439R mutant Sam68 which is a cytoplasmic protein, 
increases the level of cyclin D1/CCND1 mRNA in comparison with the control group 
(pcDNA5, empty vector). It might be possible that mutant Sam68 (P439R mutant 
Sam68) helps the accumulation of cyclin D1 /CCND1 transcripts. The study previously 
carried out by Taylor et al had shown that Sam68 seems to have a role to inhibit cyclin 
D1/CCND1 transcript accumulation (Taylor et al., 2004).  
 
On the other hand, the level of cyclin D1/CCND1 mRNA in a stable cell line expressing 
RHA after addition of tetracycline was higher than in the control group but it was not 
significantly different from the control group (pcDNA5).  
 
The last experiment to investigate the potential roles of Sam68 and RHA proteins was 
testing the role of Sam68 and RHA in alternative splicing regulation of a target gene 
(NRXN3). It has been shown that Sam68 is involved in regulation of alternative splicing 
of the Neurexin1 gene in the cerebellum (Iijima et al., 2011) and Neurexin3 (Ehrmann 
et al., 2013) . Therefore, in this study the roles of Sam68 and RHA were tested in 
inclusion regulation of alternatively spliced segment 4 (AS4) into Neurexin3 mRNAs in 
human cells. After induction of stable cell lines expressing empty vector (negative 
control, pcDNA5), RHA, wild type and P439R mutant Sam68, the percentage of exon 
inclusion in each sample was calculated. Similar to our group’s previous study 
(Ehrmann et al., 2013) in this study it was found out that wild type Sam68 has a role in 
alternative splicing of NRXN3. P439R Sam68 does not seem to have a role, likely 
caused by cytoplasmic location of this protein. In addition, although RHA has a role in 
splicing regulation of some genes such as its role in splicing of glutamate receptor 
(Bratt and Ohman, 2003), RNA helicase A protein had no effect on alternative splicing 
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of NRXN3 cassette exon 1 (AS4). In conclusion, although RHA and Sam68 have some 
reported roles in transcription and alternative splicing, more studies are needed to 
evaluate their common effects on other target genes.  
 
In this study also the interaction of T-STAR and RNA helicase A was tested at their 
endogenous level of expression. Firstly, HEK293 cells were used to check this 
interaction. Immunoprecipitation of endogenous T-STAR protein using protein A 
Dynabeads was carried out and immunoprecipitated (IP) samples were probed with 
appropriate antibodies, but no RHA was detected in the immunoprecipitated (IP) or 
the input lanes. This might be because of negligible expression of T-STAR in kidney 
cells. Although in this study the interaction of RHA with T-STAR was detected after 
over-expression of this member of STAR family, to investigate more about the 
interaction between T-STAR and RHA at the endogenous level of T-STAR protein 
expression, using other cell lines or tissues which have more T-STAR expression might 
be a better option to try. 
 
To summarise, opposite to Sam68-CCAR1 interaction which happens after over-
expression of Sam68, in this study it was found out that RHA and Sam68 interact with 
each other in both endogenous and over-expressed situation. In addition, the tyrosine 
rich domain of Sam68 seems to be involved in this interaction. Even just deletion of 
tyrosine rich domain of Sam68 can inhibit the interaction of this protein with RHA. It 
should be emphasised that more studies are needed to be carried out to investigate 
common roles and possible links of these two proteins in signal transduction, 
transcription and splicing.  
 
In the next Chapter, the investigations regarding hnRNP G, hnRNP G-T and Tra2β 
protein interaction networks will be described. 
 
protein interaction networks will be described.
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Chapter 4 
4 Investigation into the cellular roles of hnRNP G (RBMX), hnRNP G-T 
(RBMXL2) and Tra2β using inducible cell lines 
 
4.1 Introduction 
 
As mentioned previously in Chapter 1, a major aim of this project was to investigate 
the interacting protein partners of the RNA binding proteins T-STAR, Sam68, hnRNP G, 
hnRNP G-T and Tra2β. In the two previous Chapters (Chapters 2 and 3), the main focus 
was on findings regarding T-STAR and Sam68. In the present Chapter main focus will be 
on similar approaches to investigate protein partners of hnRNP G, hnRNP G-T and 
Tra2β. The important roles of these RNA binding proteins within cells have been 
explained in the introduction Chapter. Briefly, hnRNPs not only play key roles in 
regulation of transcript packaging and translation, but also are involved in alternative 
splicing (Han et al., 2010). Tra2β also has an important role in alternative splicing 
regulation (Elliott et al., 2012). Therefore, the primary objective of study was to make 
stable cell lines expressing FLAG tagged hnRNP G, hnRNP G-T and Tra2β, followed by 
identification and analysis of interacting groups of these proteins, and analysis of 
splicing patterns. 
 
To achieve these aims, the open reading frames of hnRNP G, hnRNP G-T and Tra2β 
were cloned into the pcDNA5 vector and made stable cell line expressing the FLAG 
tagged proteins, similar to what had been carried out for T-STAR and Sam68. The 
stable transfected cells had a hygromycin resistance gene, therefore they would 
survive after adding hygromycin to the media. After few weeks of selection by 
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hygromycin B, colonies were re-plated. When the cells were confluent enough, 
expression of the genes of interest were induced by adding tetracycline to the cell 
culture medium. The next step was purification of hnRNP G, hnRNP G-T and Tra2β 
proteins plus their partners using immunoprecipitation. Finally, immunoprecipitated 
proteins were identified by mass spectrometry. The presence of FLAG tagged proteins 
and some of the candidate protein partners were confirmed using Western blotting. 
 
As will be explained in the result sections, after over expression of hnRNP G-T, there 
were also some morphological changes identified in the cells. Cells became unattached, 
circular and floating within the media. One of the aims of the study was testing 
alternative splicing regulation of some target genes in comparison with control groups 
to identify some targets responding to hnRNP G-T. It should be mentioned that hnRNP 
G, hnRNP G-T and Tra2β are the protein names for RBMX, RBMXL2 and TRA2B gene 
products respectively. In this Chapter the appropriate names will be used for the 
protein or gene. 
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4.2 Methods and Materials 
 
4.2.1 Standard molecular biology  
 
Some of the standard molecular biology techniques including purification of DNA and 
plasmid DNA, ligations  , re-cleavage, dialysis, transformation into E.coli, agarose gel 
electrophoresis and sequencing have already been described (Chapter2, method 
section). 
 
4.2.1(a) PCR amplification of RBMX, RBMXL2 and TRA2B 
 
The PCR recipes used to amplify RBMX and TRA2B were identical to those used for the 
T-STAR amplification (table 1). The RBMXL2 PCR amplification was similar to that used 
for Sam68 (table 2). The DNA Engine DYAD thermal cycler (MJ Research) was used for 
PCR amplifications. The amplification protocols are identical to table 4 (for RBMX and 
TRA2B) and table 5 (for RBMXL2) (more information is available in Chapter 2, method 
section). Primers used for amplifying the open reading frames of RBMX, TRA2B and 
RBMXL2 are shown in table 24. 
Primer name Sequence (5’-3’) Restriction 
Enzyme 
Tra2B-FLBamHF AAAAAAAGGATCC ATGAGCGACAGCGGCGAGCAGA BamHI 
Tra2B-FL-SalI AAAAAAAGTCGACTTAATAGCGACGAGGTGAGTATGATCGA SalI 
RBMX-BamhI-F AAAAAAAGGATCC ATGGTTGAAGCAGATCGCCCAGGA BamHI 
RMBX-SalI-R AAAAAAAGTCGACCTAGTATCTGCTTCTGCCTCCCC SalI 
RBMXL2-BamhI-F AAAAAAAGGATCCATGGTTGAAGCGGATCGCCCG BamHI 
RMBXL2-SalI-R AAAAAAAGTCGAC TTA GTATCTGCTCCGGCCTCCTC SalI 
BGHrev TAGAAGGCACAGTCGAGG --------- 
 
Table 24:Primers used to amplify TRA2B, RBM and RBMXL2 
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4.2.1(b) Restriction digests 
 
The restriction enzymes BamHI and XhoI were used for digestion of plasmid DNA 
(pcDNA5). BamHI and SalI were also used for digestion of PCR products.  BSA (Bovine 
Serum Albumin) was used for enzymes to work efficiently. PCR products were 
incubated with each restriction enzyme separately for 3 hours. Digestion mixes are 
shown in table 25: 
 
PCR product  Plasmid (pcDNA5 vector) 
 First     
digestion 
Second  
digestion 
  First          
digestion 
Second 
digestion 
dH2O 9µl ……  dH2O 32 µl ….. 
Purified DNA 20 µl 30µl  Purified DNA 5 µl 38 µl 
BSA (10X) 4 µl 3µl  BSA (10X) 5 µl 3µl 
Buffer 4 µl 4µl  Buffer 5 µl 5µl 
Enzyme 3 µl 3µl  Enzyme 3 µl 4µl 
Total 40 µl 40 µl  Total 50µl 50 µl 
 
Table 25: First and second digestion strategy used for PCR Products (left) and Plasmid 
digestions (right) mixtures. 
 
 
4.2.2 Cell culture  
 
Generation of stable cell lines and harvesting of cells have been described previously 
(Chapter 2, method section). 
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4.2.3 Protein based methods 
 
SDS polyacrylamide gel electrophoresis (SDS-PAGE), Western blot (Protein immunoblot 
analysis), immunoprecipitation using α-FLAG affinity resin and mass spectrometry have 
been described previously (Chapter 2, method section). Tables 27 and 28 show the 
antibodies used for Western blots and immunoprecipitations. 
 
Primary Antibody Source Monoclonal 
/Polyclonal 
Species Dilution for 
Western Blot 
Monoclonal anti Flag Sigma Monoclonal Mouse 1:1000 
Anti  Actin Sigma Polyclonal Rabbit 1:1000 
Anti Sam68 (C-20) Santa Cruz Polyclonal Rabbit 1:1000 
Anti hnRNP C1/C2(4F4) Santa Cruz Monoclonal Mouse 1:200 
Anti Tra2β antibody (ab31353) Abcam Polyclonal Rabbit 1:2000 
 
  Table 26: Primary antibodies. Antibodies used for Western blot. 
  
 
Secondary Antibody Source Monoclonal 
/Polyclonal 
Species Dilution for 
Western Blot 
Anti-mouse-HRP Amersham Polyclonal Sheep 1:1000 
Anti-rabbit-HRP Jackson lab Polyclonal Goat 1:1000 
 
  Table 27: Secondary antibodies. Secondary antibodies used for Western blot  
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4.2.4 RNA based methods 
 
The RNA extraction procedure has been explained in the previously (Chapter 3, 
method section). 
 
4.2.4(a) RT-PCR (Reverse transcriptase PCR) 
 
RT-PCR using the SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen) has been 
mentioned already (Chapter 3, method section). In addition, the Maxima First Strand 
cDNA Synthesis Kit for RT-qPCR (Thermo scientific) was used to transcribe cDNA from 
RNA samples. Table 28 shows the reaction set up.  
 
 
Reagent Quantity for a 10µl reaction 
(Diethylpyrocarbonate) DEPC-treated water 
(nuclease free dH2O) 
Up to 50l 
5X Reaction Mix 
 
10µl 
Maxima Enzyme Mix 5µl 
RNA (15µg) Xµl 
 
Table 28: RT-PCR recipe. Based on Maxima First Strand cDNA Synthesis Kit for RT-qPCR 
recipe. 
 
 
RT-PCR reactions were incubated firstly at 25°C for 10 minutes and this step was 
followed by two other steps, 50°C for 30 minutes and 85°C for 5 minutes respectively. 
The DNA Engine DYAD thermal cycler (MJ Research) was used for RT-PCR 
amplifications. 
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4.2.4(b) Splicing assay 
 
Splicing assay steps including PCR recipe and programme have been described in the 
previous Chapter (Chapter 3, method section). Table 29 shows the primers used in PCR 
reactions. To estimate PCR product sizes and their relative concentrations, the Bio 
calculator software was used. 
 
 
 
 
 
 
 
 
 
 
 
4.2.5 MTT cell proliferation assay 
 
For this experiment an MTT cell proliferation assay kit (Cambridge bioscience, item 
number 10009365) was used. 10000 cells/well were seeded in 100µl of 10% FBS 
DMEM with glutamax-1 medium in six 96-well plates (plates 1-6, one plate for each 
day). Cells were incubated at 37°C in a 5% CO2 incubator overnight. Next day, 2 µl of 
0.05mg/ml tetracycline was added to each well of all plates and cells were incubated 
Primer name Sequence (5’-3’) 
MINK1F ACCTCATCTATCGCCACTGC 
MINK1R AGGCTGGAAGGACGCTGTC 
ACOT9 CAAAGGGCAGCTTACTCCTG 
ACOT9R CTCCCGCAACTTATCTCGAA 
ENAHF GAGCCTGTAACTTCTAAGGCCTC 
ENAHR GCTGTGATAAGGGTGTGGATTT 
MYOFF AGTGGAATCAGGTCGTCAATCT 
MYOFR TCAGGTAACAAGGTCCAAACG 
Table 29: Primers used in PCR reactions to check alternative splicing 
patterns of target genes. 
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for 24 hours. After 1 day, 10 µl of MTT reagent was added and mixed gently with the 
media of all wells in one of the plates. Also, 2 µl of 0.05mg/ml tetracycline was added 
to each well of the other plates and they were incubated at 37°C. After 4 hours 
incubation of cells with MTT reagent at 37°C, dark crystals called formazan (cell 
metabolization products), were present in each well. Media was removed gently and 
100µl of crystal dissolving solution was added to each well and mixed. By adding this 
solution crystals were dissolved and a purple colour solution was produced. This 
procedure was continued for 6 days and the Microplate reader was used to measure 
the absorbance of all samples at 570nm. All samples were tested in triplicate. Also, 
there were blank wells for all samples which did not contain any cells but MTT reagent 
was added to them as a background control. Data were analysed using Excel software 
(Student's t-test). 
 
4.2.6 Apoptosis, cell proliferation and DNA damage assay 
 
An apoptosis, DNA damage and cell proliferation kit (BD Biosciences) was used to 
check the percentage of apoptotic and DNA damaged cells. Seeding cells was carried 
out at a density of 1×105 /ml. After induction of cells with tetracycline for 3 days, 100µl 
of 1mM BrdU in 1XPBS was added gently to the cells and they were incubated for 1 
hour at 37°C in a 5% CO2 incubator. To keep the floating cells, the media were 
transferred to appropriate 15ml falcon tubes and cells were harvested and transferred 
to 15ml falcon tubes (for more information regarding harvesting the cells see Chapter  
2, method section). Falcon tubes were then centrifuged at 1000rpm for 2 minutes and 
the supernatant was removed. 1ml 1XPBS was added to the cell pellets and mixed 
gently. Cells were then transferred to FACS (fluorescence activated cell sorting) tubes. 
According to the manufacturer’s instructions (apoptosis, DNA damage and cell 
proliferation kit, BD Biosciences), cells were fixed and permeabilized using BD 
cytofix/cytoperm fixation/permeabilization solution, and then incubated with BD 
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cytofix/cytoperm plus permeabilization buffer. The next steps were re-fixation of cells 
and their treatment with DNase. Fluorescent antibodies were used for staining BrdU, 
cleaved PARP and H2AX. Also, DAPI solution (1µg/ml) was used for staining DNA. 
Finally, 1ml of 1XPBS was added to resuspend cells. Unstained induced Flp-In HEK293 
cells were also used as the control to set up the instrument. All samples were 
performed in triplicate. A flow cytometer (BD FACSCanto II flow cytometer) was used 
for cell sorting. BD Facsdiva version 6.1.3 and Excel software (Student's t-test) were 
used for analyzing the data. Setting up the instrument for analyzing the samples was 
carried out by Mr Ian Dimmick, flowcytometry core facility manager (Newcastle 
University, Bioscience centre, International centre for life). Table 30 shows the 
components of the apoptosis, DNA damage and cell proliferation kit.  
 
 
Kit components Working stock solution 
BrdU (10 mg/ml) 10 µl of 1mM BrdU/ml 
PerCP-Cy™5.5 Mouse Anti-BrdU 5µl/test 
PE Mouse Anti-Cleaved PARP (Asp214) Antibody 5µl/test 
Alexa Fluor 647 Mouse Anti-H2AX (pS139) 5µl/test 
BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution 100 µl/test 
BD Perm/Wash™ Buffer (10X) 100 µl/test 
BD Cytofix/Cytoperm™ Plus Permeabilization Buffer 100 µl/test 
DNase (1mg/ml) 300µg/ml 
DAPI (1mg/ml) 1µg/ml 
 
Table 30: Apoptosis, cell proliferation and DNA damage kit components. 
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4.2.7 Cell viability analysis 
 
Seeding cells was carried out at a density of 2×105 /ml. After induction of cells with 
tetracycline for 5 days, media were transferred to 15ml falcon tubes, and cells were 
harvested (as already described, Chapter 2, method section) and transferred to falcon 
tubes. This step was followed by centrifugation at 1000rpm, removing the media, 
adding fresh 10% FBS media and mixing cells. Then 500 µl of cell mixture was 
transferred to a sample cup and placed in the carousel position in the cell viability 
analyzer. Vi-CELL Cell Viability Analyzer (Beckman coulter) was used for checking the 
percentage of cell viability. 
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4.3 Results: 
4.3.1 Cloning the open reading frame of RBMX, RBMXL2 and TRA2B into pcDNA5 
 
Forward and reverse primers were used to PCR amplify the open reading frames of 
RBMX (encodes hnRNP G), RBMXL2 (encodes hnRNP G-T) and TRA2B (encodes Tra2β). 
The cloning strategies for these three genes were similar to those used for T-STAR and 
Sam68, which are explained previously in Chapter 2 (method section). To amplify the 
open reading frame of RBMX, RBMX-BamhI-F, RMBX-SalI-R and image clone no 
1891274 were used as forward primer, reverse primer and template respectively. PCR 
amplification resulted in a 1Kb product (figure 45-A). To amplify the open reading 
frame of RBMXL2, the forward primer RBMXL2-BamhI-F, the reverse primer RBMXL2-
SalI-R and RBMXl2 in the pGFP3 construct as template were used. PCR amplification 
resulted in a 1Kb product (figure 45-B). To amplify the open reading frame of TRA2B, 
Tra2B-FL-BAMHF, Tra2B-FL-SalI and TRA2B in the pGFP3 construct were used as 
forward primer, reverse primer and template respectively. PCR amplification resulted 
in a ~ 0.8Kb product (figure 45-C).  
 
 
 
 
 
 
Chapter 4: Investigation into the cellular roles of hnRNP G (RBMX), hnRNP G-T (RBMXL2) and 
Tra2β using inducible cell lines 
 
 
137 
 
 
 
Figure 45: PCR amplification of RBMX, RBMXL2 and TRA2B for cloning into the pcDNA5 
vector. PCR products were visualised using ethidium bromide stained agarose gels.  A) The PCR 
product size of RBMX was 1176bp. B) Size of RBMXL2 PCR product was 1179bp. C) The PCR 
product size of TRA2B was 867bp. The red arrows show PCR products. 1kb plus DNA ladder 
also has been shown in these pictures. 
 
A combination of BamHI and SalI were used for digestion of PCR amplified RBMX, 
RBMXL2 and TRA2B.  Also, BamHI and XhoI were used to digest pcDNA5 (vector). NotI 
and XhoI were used for the re-cleavage process to remove the ligated vectors which 
did not contain RBMX and TRA2B respectively. 2μl of dialysed ligation mixtures for 
cloning RBMX, RBMXL2 and TRA2B were mixed separately with 20 μl of electro-
competent cells and transferred to electroporation cuvettes. After electroporation, 
cells were incubated in 1 ml LB broth for 1 hour at 37°C enable them to recover. LB 
agar plates which contain 50μg/ml ampicillin were used for plating out competent cells. 
Plates were incubated at 37°C overnight to enable colonies to grow.  
 
After overnight incubation, insert forward primers including: RBMX-BamhI-F, RBMXL2-
BamhI-F, Tra2B-FL-BAMHF and vector reverse primer, BGHrev were used to screen the 
colonies by PCR. Colonies which contained the insert were grown in LB medium plus 
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50μg/ml ampicillin. After overnight incubation at 37°C on a shaker, plasmid purification 
was carried out. To confirm the correct presence of inserts in the pcDNA5 vector, 
100ng/µl of constructs were sequenced. The results confirmed the presence of inserts 
containing the open reading frames of RBMX, RBMXL2 and TRA2B within the 
constructs. The sequences of each construct are shown in Appendix A. 
 
 
4.3.2 Generation of stable cell lines expressing hnRNP G, hnRNP G-T and Tra2β 
 
The establishment of stable cell lines expressing hnRNP G, hnRNP G-T and Tra2β FLAG-
tagged proteins were carried out similarly to how stable cell lines expressing T-STAR, 
wild type and P439R Sam68 were made (explained in Chapter 2, result section 3-3). 
Briefly, when Flp-In HEK293 cells were 60% confluent, the constructs containing the 
open reading frames of RBMX, RBMXL2, TRA2B and pcDNA5 (empty vector) were co-
transfected with pOG44 plasmid (which encodes Flp recombinase) into the cells. 
Selection of stable transfected cells was carried out using hygromycin. After few weeks 
of selection by hygromycin B, colonies were re-plated. When the cells were confluent 
enough, tetracycline was added to the cell culture medium to induce expression of the 
genes of interest. To describe proteins, the names hnRNP G and hnRNP G-T are used 
instead of RBMX and RBMXL2 respectively (figure 46). 
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Figure 46: Induced expression of FLAG tagged proteins (hnRNP G, hnRNP G-T and 
Tra2β) monitored by Western blotting. The presence of the FLAG tagged proteins 
(hnRNP G, hnRNP G-T and Tra2β) was confirmed in the stable cell lines after 24, 48 and 
72 hours induction in comparison with empty vector (pcDNA5) as the negative control. 
No expression was seen before induction (0h). Because there are FLAG tags and His tags 
contained within these recombinant proteins, their molecular weights were higher than 
endogenous proteins. Monoclonal anti FLAG and anti-mouse-HRP were used as the 
primary and secondary antibodies respectively to detect the presence of FLAG tagged 
proteins. Blots were re-probed with α-β actin and α-rabbit IgG (HRP) as the primary and 
secondary antibodies respectively to confirm that the samples had been loaded equally.  
Equal levels of actin loading control were present in each lane. 
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4.3.3 Role of hnRNP G-T in cell morphology regulation 
 
While control cells (stable cell line expressing empty FLAG tag vector) were flat and 
attached to the cell culture surface, after induction of the hnRNP G-T expressing stable 
cell line with tetracycline, some cell morphological changes occurred. Most of the 
expressing cells became rounded, and floated into the media after tetracycline 
induction. Since the RBMXL2 gene is derived from transcript retrotransposition of the 
RBMX gene (Elliott et al., 2000b), hnRNP G was used as an extra control group to study 
these morphological changes. No morphological changes were observed in the control 
groups (expressing pcDNA5 and hnRNP G). The observed cell densities after 
tetracycline induction indicated that growth rates may have been reduced after hnRNP 
G, and specifically hnRNP G-T, over expression (figure 47).  
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Figure 47: Morphological changes induced after 3 days tetracycline induction of the hnRNP 
G-T expressing stable cell line. After induction with tetracycline for 3 days some cell 
morphological changes happened. While the hnRNP G-T stable cell line became round and 
floated in the media, control cell lines expressing empty vector (pcDNA5) and hnRNP G did not 
show any changes. These latter two groups of cells remained attached to the cell culture 
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surface. In addition, cell growth seemed to be reduced in both cell lines expressing hnRNP G 
and hnRNP G-T in comparison with the cell line expressing the empty vector. The scale bars are 
equal to 100µm.  A) 10X magnification B) 20X magnification. 
 
 
 
Also the progress of these morphological cell changes was tested over a longer period 
of time. Cells were induced for 9 days with tetracycline and pictures were taken by 
light microscopy to check the effect of hnRNP G-T over this longer expression time. 
While control groups expressing pcDNA5 (empty vector) and hnRNP G cells remained 
attached to the cell culture surface and had normal shapes, cells expressing hnRNP G-T 
again were mostly circular and released within the media (figure 48). 
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Figure 48: Morphological changes after 9 days induction of the hnRNP G-T stable cell line. 
After 9 days induction with tetracycline, while control cells including empty vector (pcDNA5) 
and hnRNP G had normal morphological shapes and were attached to the cell culture surface, 
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stable cell lines expressing hnRNP G-T had circular shapes and were released within the media. 
In addition, cell growth was hugely reduced in the hnRNP G-T group in comparison with the 
control cells. The scale bars are equal to 100µm. A) 10X magnification B) 20X magnification. 
 
 
 
4.3.4 Testing role of the hnRNP G-T in cell viability of FLP-In HEK293 cells using the 
MTT assay 
 
To test the cell viability rate of stable cell lines expressing empty FLAG tagged vector 
(pcDNA5), hnRNP G and hnRNP G-T proteins, 10000 cells/well were seeded in 100µl of 
10% FBS DMEM media in six 96-well plates (plates 1-6, one plate for each day). Also, 
there was one row of wells in all the plates which contained only 10% FBS DMEM 
media to be considered as a background control.  
 
Each day the cell density on one of the plates was measured and rest of other plates 
were induced for another 24 hours using tetracycline. Induction was carried out for 6 
days, and cell viability of cells during this period of time was measured using a MTT 
assay. Using this method, the more cells present in the wells, the stronger a purple 
colour would appear. The cell viability rate in the hnRNP G-T expressing clone of cells 
was lower and significantly different in comparison with both control groups (pcDNA5 
and hnRNP G) (P<0.05). In addition, between the two control groups (hnRNP G and 
pcDNA5), the cell confluence and colour strength of the hnRNP G group were less and 
significantly different in comparison with pcDNA5 (P<0.05). In agreement with the 
above observations, over-expression of hnRNP G and hnRNP G-T proteins reduced cell 
viability rates and this reduction was significantly different from cell lines expressing 
empty vector (pcDNA5) (figure 49). 
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Figure 49: Cell viability of the stable cell lines using an MTT assay. The cell viability rate of 
stable cell lines expressing pcDNA5, hnRNP G and hnRNP G-T were measured using an MTT 
assay during 6 days after induction with tetracycline. The cell viability rate of the stable cell line 
expressing hnRNP G-T was less than the controls (P<0.05). Also the control groups (pcDNA5 
and hnRNP G) were significantly different from each other in proliferation (P<0.05). Expression 
of hnRNP G and hnRNP G-T reduce the cell viability rate. The blank control only had media and 
MTT reagent and its absorbance was measured as background control. All samples were 
performed in triplicate.   
 
 
4.3.5 HnRNP G-T has a role in apoptosis, DNA damage and cell proliferation in 
stable FLP-In HEK293 cells 
 
To investigate more about the role of hnRNP G-T on morphological changes, and also 
to find out whether the circular floating cells expressing hnRNP G-T are apoptotic or 
DNA damaged, a kit (apoptosis, DNA damage and cell proliferation kit) was used. Cells 
were seeded and induced for 3 days with tetracycline. 100µl of 1mM BrdU (an analog 
of thymidine) in 1XPBS was added gently to the cells to test the cell cycle kinetics. After 
one hour incubation at 37°C in a 5% CO2 incubator, both floating and attached cells 
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were harvested. According to the manufacturer’s instructions cells were fixed, 
permeabilized and treated with DNase. Phosphorylated histone H2AX 
(phosphorylation of C-terminal serine 139) was used as a biomarker to measure cell 
response to DNA damage (Valdiglesias et al., 2013).  
 
This kit also measured apoptosis, through a nuclear enzyme called PARP (poly [ADP-
ribose] polymerase) which has role in transcription regulation and DNA repair,           
and which can be cleaved by caspase-3 and -7. After cleavage, the 116kDa PARP will be 
divided to two smaller fragments, and can be used as a marker of apoptosis (Kaufmann 
et al., 1993; Lazebnik et al., 1994; Nicholson et al., 1995; Los et al., 1997; Los et al., 
1999). Fluorescent antibodies were used for staining BrdU, cleaved PARP and H2AX to 
test cell proliferation, apoptosis and DNA damage. Also DAPI solution (1µg/ml) was 
used for staining DNA. Finally cells were resuspended in 1ml of 1XPBS and samples 
were analyzed by flow cytometry.   
 
The percentage of cells in S phase in the hnRNP G-T expressing group of cells was 
lower and significantly different in comparison with both control groups (stable cell 
lines with pcDNA5 and hnRNP G) (P<0.05). The two control groups were significantly 
different from each other as well (P<0.05). These results showed that over expression 
of hnRNP G and hnRNP G-T causes reduction of cell proliferation. Furthermore, hnRNP 
G-T has stronger effect on this reduction since the percentage of cells in S phase in this 
group was significantly lower than percentage of S phase cells in hnRNP G-expressing 
group (P<0.05) (figure 50-B).  
 
The total percentage of apoptotic cells in the hnRNP G-T expressing group of cells was 
less than 2% of the total cell population, but still was higher and significantly different 
in comparison with both control groups (pcDNA5 and hnRNP G) (P<0.05). In addition, 
the control groups (pcDNA5 and hnRNP G) were significantly different from each other 
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(P<0.05). These results showed that over-expression of hnRNP G and hnRNP G-T 
proteins can lead to a higher percentage of cell apoptosis (figure 50-C), although this 
effect is very small.  
 
Also DNA damage percentage was investigated in the different clones of cells. 
Interestingly, while the control groups (expressing empty pcDNA5 and hnRNP G) were 
not significantly different (P<0.05), the percentage of cells with DNA damage in the 
hnRNP G-T group was less and significantly different in comparison with both control 
groups (pcDNA5 and hnRNP G) (P<0.05) (figure 50-D). Although statistically significant, 
this effect was very small. 
 
In summary, expression of hnRNP G and specifically hnRNP G-T causes a reduction in 
cell growth rate and increases the level of apoptosis. Although cells expressing hnRNP 
G-T became circular and floated within the media, only very few cells (less than 2%) 
were apoptotic cells. The apoptosis number is very small so might not be biologically 
significant, even if it is statistically significant. 
 
Specifically regarding to lower percentage of DNA damage within these cells in 
comparison with control groups, expression of the hnRNP G-T protein not only has no 
adverse effect on DNA stability, but might also lead to a reduction in the amount of 
DNA damage possibility, although this effect is very small. We could not therefore 
consider hnRNP G-T as an apoptosis inducer. However the S phase numbers might be 
more biologically significant and were much stronger. 
 
 
 
Chapter 4: Investigation into the cellular roles of hnRNP G (RBMX), hnRNP G-T (RBMXL2) and 
Tra2β using inducible cell lines 
 
 
148 
 
 
Figure 50: Percentages of S phase, apoptotic and DNA damaged cells in stable cell lines 
expressing pcDNA5, hnRNP G and hnRNP G-T. A) Summarised percentages of cells with 
DNA damage, apoptosis and in S phase from induced clones of cells expressing empty 
pcDNA5 vector, hnRNP G, hnRNP G-T. B) Percentage of cells in S phase in the cells stably 
expressing hnRNP G-T was significantly lower from both control groups (P<0.05). Also, 
the percentage of S phase cells in hnRNP G group was significantly different from the 
pcDNA5 group (P<0.05). These results indicate that expression of hnRNP G and hnRNP G-
T reduce cell growth rate. C) Although less than 2% of total cells expressing hnRNP G-T 
were apoptotic, this group was significantly different from the two control groups 
(P<0.05). Also, the two control groups were significantly different from each other 
(P<0.05). It seems that an increasing level of apoptosis results from the over-expression 
of hnRNP G and hnRNP G-T. D) DNA damage was less but significantly different in hnRNP 
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G-T expressing cells in comparison with control groups (pcDNA5 and hnRNP G) (P<0.05). 
The control groups were not significantly different from each other (P>0.05). All samples 
were tested in triplicate. The asterisk shows that the difference between two groups was 
significant. 
 
4.3.6 How many stable cells expressing hnRNP G-T are still alive? 
 
The round, floating state of the hnRNP G-T expressing cells suggested they may be 
dead. To test the percentage of live cells expressing hnRNP G and hnRNP G-T after 
induction with tetracycline after 5 days, cells were harvested and transferred to falcon 
tubes. Cells were resuspended in 3mls of 10% FBS DMEM media and mixed. 500 µl of 
the cell mixture was transferred to a sample cup and placed in the carousel position in 
a cell viability analyzer. The percentage of cell viability was measured. Around 93.8% of 
cells expressing hnRNP G-T were viable but this percentage of live cells was lower and 
significantly different in comparison with both control groups (pcDNA5 [97.8%] and 
hnRNP G [98.9%]) (P<0.05). Control groups were not significantly different from each 
other in this case (P>0.05) (figure 51). Although the hnRNP G-T group was significantly 
different from the control groups, still around 94% of cells were viable and the 
difference was small. Hence, even though cells over-expressing hnRNP G-T were 
circular and released within the media the majority of them were still alive. 
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Figure 51: Cell viability percentage of stable cells expressing pcDNA5, hnRNP G and 
hnRNP G-T. Although cells expressing hnRNP G-T were significantly different from 
control groups (P<0.05), the percentage of viable cells was 93.8%. The two control 
groups (pcDNA5 and hnRNP G) were not significantly different from each other 
(P>0.05). All samples were tested in triplicate. The asterisk shows that the difference 
between two groups was significant. 
 
 
4.3.7 Are there any effects of over-expression of hnRNP G and hnRNP G-T at the 
splicing level?  
 
According to the important roles of hnRNP G and hnRNP G-T in splicing regulation and 
because cells stably expressing hnRNP G-T seemed to exhibit morphological changes 
rather than cell death, there was a question to be answered that what would happen 
at the splicing level after over-expression of hnRNP G-T. It seemed that after 
expression of hnRNP G-T cell motility and cell-cell adhesion would be changed. In 
response to Dr Julian P Venables’ suggestion (Institute of Genetic Medicine), we 
analysed splicing patterns using a high throughput platform. After induction of stable 
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cell lines expressing pcDNA5, hnRNP G and hnRNP G-T with tetracycline, cells were 
harvested and RNA was extracted. The Maxima First Strand cDNA Synthesis Kit for RT-
qPCR (Thermo scientific) was used to transcribe cDNA from RNA samples (see method 
section). 
 
0.3µg/µl of the RNA samples were then sent to a lab in Canada 
(Laboratoire de génomique fonctionnelle de l'Université de Sherbrooke, Sherbrooke, 
Québec) for analysis.  Alternative splicing patterns in 26 genes associated with EMT 
(epithelial–mesenchymal transitions) were monitored between the three groups of 
stably expressing clones (pcDNA5, hnRNP G and hnRNP G-T) using a high-throughput 
RT-PCR screen. Data was then analyzed by Dr Venables and four target genes 
including:  MINK1 (misshapen-Like Kinase 1), ACOT9 (acyl-CoA thioesterase 9), ENAH 
(enabled homolog) and MOYF (myoferlin) were detected to be alternatively spliced in 
the presence of hnRNP G-T since their PSI (percentage of splicing inclusion) was 
different in the hnRNP G-T group in comparison with the control groups (figure 52).  
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Figure 52: Alternative splicing pattern of detected cassette exons regulated by hnRNP G-T in 
MINK1 (misshapen-Like Kinase 1), ACOT9 (acyl-CoA thioesterase 9), ENAH (enabled homolog) 
and MOYF (myoferlin). Exons in these genes were detected to be alternatively spliced in the 
presence of hnRNP G-T. Here a screenshot from UCSC shows the sizes of the expected PCR 
products with or without these cassette exons. Cassette exons are shown by red asterisks. A) 
MINK1 short form: 136bp, MINK1 long form: 247bp. B) ACOT 9 short form: 103bp, ) ACOT 9  
long form: 130bp. C) ENAH short form: 133bp, ENAH long form: 196bp. D) MYOF short form: 
216bp, MYOF long form: 255bp. 
 
 
The next step was to reproduce these results in our lab. To do this, 1×10 6 cells (1×10 5/ 
ml) were seeded, induced with tetracycline antibiotic and then harvested. RNA 
extraction and RT-PCR using SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen) were 
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carried out to make cDNA. 1µg/µl of sample RNA was then used for making cDNA. This 
step was followed by diluting the obtained cDNA (at a ratio of 1:4) and setting up 25 µl 
polymerase chain reactions using GoTaq polymerase. Forward and reverse primers 
(table 29) were used for PCR amplifications of MINK1, ACOT9, ENAH and MYOF. All 
RNA samples were analysed using three independently isolated RNA samples. The 
QIAXCEL multi-capillary electrophoresis system was used for analysing the relative 
quantities of the different PCR products. In each case the percentages of splicing 
inclusion of the variable exons in the ACOT9 and MYOF genes were significantly 
different in stable cells expressing hnRNP G-T group from the control groups 
(expressing pcDNA5 and hnRNP G) (P<0.05). This suggests that the expression of 
hnRNP G-T has a role in preventing exon inclusion within these two genes (figure 53). 
These effects could be direct or indirect. If direct, then hnRNP G-T might directly bind 
to these pre-mRNAs and change their splicing pattern. If indirect, it could be that 
expressing hnRNP G-T affects the cells, which then affects the splicing pattern. It seems 
that hnRNP G-T is acting as a repressor (less exon is included in each of the three 
replicates), and the result is specific to hnRNP G-T (no effect seen for hnRNP G). 
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Figure 53: Role of hnRNP G-T in controlling exon inclusion of ACOT9 and MYOF. A) 
While the percentage of exon inclusion values for the pcDNA5 and hnRNP G groups 
were 71.72% and 70.84% respectively, in the hnRNP G-T group this inclusion was 
significantly different from both control groups (P<0.05) and was 48.36%. The two 
control groups (stably expressing empty pcDNA5 or hnRNP G) were not significantly 
different from each other (P>0.05). These data show that hnRNP G-T has role to 
prevent exon inclusion of ACOT9. B) Percentage of exon inclusion in the stable cell 
lines expressing empty pcDNA5, hnRNP G and hnRNP G-T groups were 96.67%, 96.96% 
and 75.56% respectively. While the two control groups (empty pcDNA5 and hnRNP G) 
showed similar percentages of exon inclusion, the hnRNP G-T group was significantly 
different from both of these two groups (P<0.05). This showed that hnRNP G-T has 
role in exon exclusion of MYOF as well. All samples were performed in triplicate. The 
asterisk shows that the difference between two groups was significant. 
 
 
Despite the high throughput results from the Canadian group showing the role of 
hnRNP G-T in splicing regulation of MINK1, in this study it was found out that the 
percentage of splicing inclusion of MINK1 in stable cell lines over-expressing hnRNP G-
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T were not significantly different from the control groups (expressing empty pcDNA5 
and hnRNP G) (P>0.05) (figure 54-A). 
 
Similar experiments was  carried out to analyse ENAH splicing, also predicted to be an 
hnRNP G-T splicing target by the Canadian group. The percentage of splicing inclusion 
of ENAH, not only was significantly different in hnRNP G-T group from both control 
groups (pcDNA5 and hnRNP G) (P<0.05), but also the control groups were significantly 
different from each other (P<0.05). It means that both hnRNP G and hnRNP G-T have 
role in variable exon exclusion of ENAH (figure 54-B). Both hnRNP G and hnRNP G-T 
function as the splicing repressors for the ENAH exon. 
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Figure 54: Role of hnRNP G-T in exon inclusion of MINK1 and ENAH. A) 
HnRNP G-T has no role in regulation of MINK1 exon inclusion. The 
percentages of exon inclusion in the stable cell lines expressing of pcDNA5, 
hnRNP G and hnRNP G-T were 91.73%, 93.21% and 88.93% respectively. 
These percentages were not significantly different from each other (P>0.05). 
B) Interestingly both hnRNP G and hnRNP G-T promote exon exclusion of the 
variable exon in ENAH (P<0.05). While the PSI value for this ENAH exon in the 
stable cell lines expressing pcDNA5 were 63.91%, the percentages in stable 
cell lines expressing hnRNP G and hnRNP G-T were 38.42% and 24.63% 
respectively. All samples were tested in triplicate. The asterisk shows that the 
difference between two groups was significant. 
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4.3.8 Presence of possible RNA binding sites within the detected cassette exons and 
their flanking introns 
 
UCSC genome browser and RBPDB (database of RNA binding protein specificities) 
programmes were used to identify the presence of possible RNA binding sites within 
the detected alternatively spliced cassette exons and their flanking introns of target 
genes (ACOT9, ENAH and MYOF) after over-expression of hnRNP G and hnRNP G-T. 
Among the different RNA binding proteins, T-STAR, hnRNP G and some members of SR 
proteins such as SRSF1 and SRSF9 were detected to have potential binding sites 
specifically within the upstream and downstream flanking introns of detected cassette 
exons (figure 55). The full lists of RNA binding proteins which have potential binding 
sites have been shown in the Appendix B. 
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Figure 55: Presence of possible binding sites within the detected alternatively spliced 
cassette exons of ACOT9, ENAH and MYOF after over-expression of hnRNP G and hnRNP G-T. 
The binding sites and the names of RNA binding proteins which can bind to the cassette exons 
or flanking upstream and downstream introns of target genes including A) ACOT9, B) ENAH, C) 
MYOF. T-STAR, hnRNP G and some member of SR proteins are present among the RNA binding 
proteins which are able to bind these binding sites. The data are from RBPDB website: 
http://rbpdb.ccbr.utoronto.ca/ . 
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4.3.9 Purification of FLAG-tagged proteins (hnRNP G, hnRNP G-T and Tra2β) and 
their partners using immunoprecipitation 
 
Same stable cell lines (Flp-In HEK293 cells) were used to identify proteins interacting 
with hnRNP G, hnRNP G-T and Tra2β. 72 hours after tetracycline induction of stably 
transfected Flp-In HEK293 cells, cells were harvested and lysed, followed by the 
immunoprecipitation of FLAG-tagged proteins (hnRNP G, hnRNP G-T and Tra2β) using 
α-FLAG affinity resin (for more information see Chapter2, method section). Briefly, 1.5 
ml of IP +Benzonase lysis buffer was added to cell pellets followed by 20 minutes 
incubation on ice. Samples were then centrifuged at 4°C for 10 minutes. 30μl of the 
supernatant was kept as Input and rest of the supernatant was incubated with FLAG 
resin for an overnight step at 4°C. The FLAG tagged proteins and their interacting 
protein partners were pulled out by this way. Next day, samples were centrifuged at 
1000rpm for 30 seconds and 30μl of the supernatant was kept and labelled as Sup. 
This step was followed by washing the FLAG resin with IP wash buffer and adding 2X 
SDS loading dye to samples. Immunoprecipitated samples were analysed by Western 
blotting. Monoclonal anti FLAG antibody was used as the primary antibody to probe 
the Western blots and analyse whether the immunoprecipitation was successful. IP 
lanes of FLAG tagged proteins in comparison with the control sample (pcDNA5, empty 
vector) showed that co-immunoprecipitations had been successful in retrieving the 
tagged proteins (figure 56).  
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Figure 56: Immunoprecipitation of FLAG tagged proteins from stable cell lines 
expressing hnRNP G, hnRNP G-T and Tra2β.  Western blotting was carried out to 
determine IP efficiency. Monoclonal anti FLAG antibody and HRP-conjugated anti-mouse 
IgG were used as the primary and secondary antibodies. In the above picture lanes 1, 2 
and 3 show the Input, IP and Sup samples respectively. The IP lanes of FLAG tagged 
proteins in comparison with the control sample (cells stably transfected with pcDNA5) 
showed that the immunoprecipitations were successful.  The size markers are in kDa. 
 
 
4.3.10 Identification of candidate interacting protein partners of hnRNP G and Tra2β 
using mass spectrometry 
 
After confirmation that the immunoprecipitation of the FLAG tagged proteins were 
successful, the IP samples were loaded onto SDS-PAGE gels and electrophoresed to 
identify any candidate interacting protein partners of hnRNP G, hnRNP G-T and Tra2β. 
This step was followed by staining the gels with Simply Blue stain for one hour. Gels 
were de-stained by using dH2O overnight. Protein bands were cut and sent for mass 
spectrometry.  
 
For the Tra2β experiment, no new band was detected in the IP lane in comparison with 
the control group (pcDNA5). However, there were some extra protein bands in the 
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hnRNP G IP lane (figure 57). The bands were cut and sent for analysis. Based on the 
sequencing results (table 31), six proteins including hnRNP G, RNA binding motif 
protein X-Linked-Like 1 (RBMXL1), hnRNP C, hnRNP CL1, RPL6 and hnRNP H3 were 
detected in hnRNP G lane by mass spectrometry. Table 31 shows information including 
Swiss-Prot entry name, Accession  number, Gene name, Recommended Name and 
Nominal mass (Mr) of these proteins.  Also, shown in figure 58 the peptide sequences 
of the detected proteins and matched peptides by mass spectrometry are in red. 
 
 
 
Figure 57: Simply Blue staining for detection of candidate interacting protein partners 
of hnRNP G. After loading the IP samples on 4-12% gradient gels and gel electrophoresis, 
Simply Blue safe stain was used for staining the gels. Stained gels were washed with 
dH2O and protein bands were cut. Bands within the area highlighted by asterisks were 
cut and sent for sequencing by mass spectrometry. Based on mass spectrometry, hnRNP 
G, RNA binding motif protein X-Linked-Like 1 (RBMXL1), hnRNP C, hnRNP CL1, RPL6 and 
hnRNP H3 were detected. The presence of hnRNP G showed the immunoprecipitation 
had worked, since this is the protein immunoprecipitated.  
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 Swiss-Prot entry 
name 
Accession 
number 
Gene name Recommended  Name Nominal 
mass(Mr) 
1 RBMX_HUMAN P38159 RBMX RNA-binding motif 
protein,  
X chromosome 1 
42275 
2 RMXL1_HUMAN Q96E39  RBMXL1  Heterogeneous nuclear  
ribonucleoprotein G-
like 1  
42173  
3 HNRPC_HUMAN  
 
P07910 
 
HNRNP C 
 
Heterogeneous nuclear  
ribonucleoproteins 
C1/C2 
32004 
4 HNRCL_HUMAN  
 
O60812 
 
HNRNP CL1 Heterogeneous nuclear  
ribonucleoprotein C-
like 1 
22695  
 
5 RL6_HUMAN Q02878 RPL6 60S ribosomal protein 
L6  
32928 
6 HNRH3_HUMAN P31942 HNRNP H3  Heterogeneous nuclear  
ribonucleoprotein H3 
31505 
 
Table 31: Candidate protein partners of hnRNP G identified by FLAG immunoprecipitation.  
Based on mass spectrometry results, the presence of hnRNP G shows the IP has worked. In 
addition, some other candidate proteins including RNA binding motif protein X-linked-like 1 
(RBMXL1), hnRNP C, hnRNP CL1, RPL6 and hnRNP H3 were detected. Information about these 
proteins such as : Swiss-Prot entry name, Accession  number, Gene name, Recommended 
Name and Nominal mass (Mr) are from two websites:  http://www.genecards.org/ and  
http://www.uniprot.org/ 
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Figure 58: MASCOT search results for candidate interacting protein partners of 
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hnRNP G. Swiss-Prot entry names and Accession numbers have been shown for all 
samples. In addition, matched peptides identified by mass spectrometry are shown in 
red. The peptide coverages on identified proteins were 27%, 6%, 10% and 16% for 
hnRNP G, RBMXL1, 60S ribosomal protein L6 and heterogenous nuclear 
ribonucleoprotein H3 respectively. 
 
4.3.11 Identification of candidate interacting protein partners of hnRNP G-T using 
mass spectrometry 
 
Similar to the experiments carried out for hnRNP G, the PAGE gel was stained with 
Simply Blue safe stain to analyse the hnRNP G-T immunoprecipitation. Some extra 
bands were detected in the IP lane of hnRNP G-T in comparison with the control group 
(pcDNA5 (figure 59). These bands were cut from the gel and sent for analysis. Based on 
the sequencing results (table 32), ten proteins were detected in the hnRNP G-T lane by 
mass spectrometry including hnRNP G-T, RNA binding motif protein X-Linked-Like 1 
(RBMXL1), H2AFY, hnRNP C, hnRNP CL1, RPS6, RPL7, RPL7A, RPLP2 and RPS20. Table 
31 shows some information for these candidate protein interaction partners including 
Swiss-Prot entry name, Accession  number, Gene name, Recommended Name and 
Nominal mass (Mr) of these proteins.  Also, in figure 60 the sequences of the detected 
proteins have been shown and matched peptides by mass spectrometry are in red. 
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Figure 59: Simply Blue staining for detection of candidate interacting protein partners of 
hnRNP G-T. After loading IP samples on the 4-12% gradient gels and gel electrophoresis, 
Simply Blue safe stain was used for staining the gels. Stained gels were washed with dH2O and 
the protein bands were cut and sent for sequencing. The bands highlighted by asterisks were 
cut out of the gel and sent for the sequencing by mass spectrometry. Based on mass 
spectrometry results, ten proteins were detected including:  hnRNP G-T, RNA binding motif 
protein X-Linked-Like 1 (RBMXL1), H2AFY, hnRNP C, hnRNP CL1, RPS6, RPL7, RPL7A, RPLP2 and 
RPS20. The presence of hnRNP G-T in the IP lane showed that the immunoprecipitation had 
worked.  
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 Swiss-Prot entry 
name 
Accession 
number 
Gene name Recommended  Name Nominal 
mass(Mr) 
1 HNRGT_HUMAN O75526 RBMXL2 RNA-binding motif 
protein, X-linked-like-2 
42929 
2 RBMXL_HUMAN Q96E39 RBMXL1 Heterogeneous nuclear 
ribonucleoprotein G-
like 1 
42173 
3 HNRPC_HUMAN P07910 HNRNP C Heterogeneous nuclear 
ribonucleoproteins 
C1/C2 
32004 
4 HNRCL_HUMAN O60812 HNRNP CL1 Heterogeneous nuclear 
ribonucleoprotein C-
like 1 
22695  
5 H2AY_HUMAN O75367 H2AFY Core histone macro-
H2A.1  
39748 
 
6 RS6_HUMAN P62753 RPS6 40S ribosomal protein 
S6 
28842 
 
7 RL7_HUMAN P18124 RPL7 60S ribosomal protein 
L7 
29221 
 
8 RL7A_HUMAN P62424 RPL7A 60S ribosomal protein 
L7a 
30148 
 
9 RLA2_HUMAN P05387 RPLP2 60S acidic ribosomal 
protein P2    
11658 
10 RS20_HUMAN P60866 RPS20 40S ribosomal protein 
S20 
13478 
 
Table 32: Candidate protein partners of hnRNP G-T identified by FLAG 
immunoprecipitation.  Based on the mass spectrometry results, the presence of hnRNP G 
shows the IP has worked. In addition some other candidate proteins were detected including 
RNA binding motif protein X-Linked-Like 1 (RBMXL1), hnRNP C, hnRNP CL1, RPL6 and hnRNP 
H3. Information about these proteins such as : Swiss-Prot entry name, Accession  number, 
Gene name, Recommended Name and Nominal mass (Mr) are from two websites:  
http://www.genecards.org/ and  http://www.uniprot.org/ 
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Figure 60: MASCOT search results for candidate interacting protein partners of hnRNP G-
T. Swiss-Prot entry names and Accession numbers have been shown for all samples. In 
addition, matched peptides identified by mass spectrometry are shown in red. The 
percentage of the identified proteins that were covered by the peptide sequences were 
35%, 6%, 15%, 12%, 10%, 14%, 12%, 12%, 39% and 19% for hnRNP G-T, RBMXL1, hnRNP C, 
hnRNP CL1, core histone maco-H2A.1, 40S ribosomal protein S6, 60S ribosomal protein L7, 
60S ribosomal protein L7a, 60S acidic ribosomal protein P2 and 40S ribosomal protein S20 
respectively. 
 
4.3.12 Confirmation of the presence of hnRNP C in the hnRNP G and hnRNP G-T IP 
samples  
 
HnRNP C was a strong candidate since it was detected by IP of both hnRNP G and 
hnRNP G-T. After identification of proteins from the SDS-PAGE gels using mass 
spectrometry, Western blotting was used to further test the presence of hnRNP C in 
both the hnRNP G and hnRNP G-T IP samples. Western blots of all samples were 
probed with anti hnRNP C1/C2 (4F4) antibody. The presence of hnRNP C protein in 
both of the IP samples from hnRNP G-FLAG and hnRNP G-T-FLAG were detected, but 
not for the empty pcDNA5 stable cell line (figure 61). Mouse hnRNP C1/C2 (4F4) 
antibody and anti-mouse-HRP were used as the primary and secondary antibodies 
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respectively. These results mean that endogenous hnRNP C interacts with both 
hnRNP G-FLAG and hnRNP G-T-FLAG proteins. 
 
 
 
Figure 61: Confirmation of the presence of hnRNP C in the IP lanes of hnRNP G-FLAG and 
hnRNP G-T-FLAG samples. The presence of hnRNP C was confirmed in the input and IPsup 
lanes of all samples including the negative control (pcDNA5) (red asterisks). HnRNP C 
protein was also present in IP (immunoprecipitated) lanes of both hnRNP G and hnRNP G-
T samples (pink asterisks) but not in the IP lane of pcDNA5. Mouse hnRNP C1/C2 (4F4) 
antibody and anti-mouse-HRP were used as the primary and secondary antibodies 
respectively. 
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4.4  Summary and discussion:  
 
As a tool to investigate the functions of hnRNP G, hnRNP G-T and Tra2β, their open 
reading frames were cloned into the pcDNA5 vector so they produced FLAG tagged 
fusion proteins. After transfection of constructs into Flp-In HEK293 cells, hygromycin B 
was added to the cells for selection of transfected cells. The stable transfected cells had 
hygromycin resistance gene, therefore, they would survive after adding hygromycin to 
the media. Also, expression of the gene of interest was controlled by the tetracycline 
promoter. Therefore, a high level of gene expression would be achieved by adding 
tetracycline to the cell culture medium.  
 
Interestingly, in this study it was found out that after induction of RBMXL2 (name of the 
gene encoding hnRNP G-T protein), cells undergo morphological changes. These cells 
became round firstly and then released within the media. Since it has been shown that 
RBMXL2 gene is derived from transcript retrotransposition of RBMX (name of the gene 
encoding hnRNP G protein) (Elliott et al., 2000b) the cells expressing FLAG tagged 
hnRNP G were used as well as an extra control group expressing empty pcDNA5 to test  
morphological changes.  
 
It was found out that morphological changes only happened within the cells expressing 
hnRNP G-T. At longer stages after tetracycline induction the observed morphological 
changes were more obvious. In addition, cell growth rates were less in both groups 
expressing hnRNP G and hnRNP G-T in comparison with cells expressing the empty 
vector (pcDNA5). To address the basis of these morphological changes, firstly an MTT 
assay was used to check the cell proliferation rate. Stable cells over-expressing hnRNP 
G-T protein had a lower and significantly different cell proliferation rate in comparison 
with both control groups (pcDNA5 and hnRNP G) (P<0.05). In addition, cells expressing 
hnRNP G had lower cell growth rate in comparison with the control group (pcDNA5) 
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(P<0.05). No such effects were seen for Sam68 or T-STAR suggesting these changes 
might not be only because of nonspecific overproduction of proteins.  
 
To further examine the roles of hnRNP G and hnRNP G-T in the reduction of cell 
growth rate, percentage of apoptosis and DNA damage was analysed within the cells 
expressing hnRNP G and hnRNP G-T in comparison with the control group (cells 
expressing empty vector, pcDNA5). 
 
BrdU (an analogue of thymidine) incorporation was measured in parallel to test the cell 
proliferation rate since it detects cells in S phase. The percentage of cells going 
through S phase in the hnRNP G-T group (cells expressing hnRNP G-T) was lower and 
significantly different in comparison with both control groups (expressing empty 
pcDNA5 and hnRNP G) (P<0.05). The control groups were significantly different from 
each other as well (over-expression of hnRNP G also slows cell growth, P<0.05). These 
results showed that over-expression of hnRNP G and hnRNP G-T each affects cell 
proliferation and growth. HnRNP G-T had stronger effect on this reduction since the 
percentage of cells in S phase in this group was significantly lower than percentage of S 
phase cells in the hnRNP G group (P<0.05). 
 
Since cells expressing hnRNP G-T firstly became round and then released within the 
media I was important to test whether expression of hnRNP G-T might also lead to cell 
death.  The percentage of apoptotic cells was monitored based on cleavage of PARP 
into two smaller fragments. Binding of a fluorescent antibody against the 89kDa PARP 
fragment was used as a marker of apoptosis (Kaufmann et al., 1993; Lazebnik et al., 
1994; Nicholson et al., 1995; Los et al., 1997; Los et al., 1999). If cells were apoptotic 
they would produce a smaller fragment which would be recognized by this α- PARP 
antibody.  
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The percentage of apoptotic cells in the group of cells stably expressing hnRNP G-T was 
less than two percent of total cell population but still was higher and significantly 
different in comparison with both control groups (pcDNA5 and hnRNP G) (P<0.05). In 
addition, control groups (pcDNA5 and hnRNP G) were significantly different from each 
other (P<0.05). These results showed the over expression of hnRNP G and hnRNP G-T 
do lead to a higher percentage of cell apoptosis but this was not a very strong effect.  
 
The percentage of DNA damage was also tetsted after hnRNP G-T expression. 
Phosphorylated histone H2AX (phosphorylation of C-terminal serine 139) is a 
biomarker to show cell response to DNA damage (Valdiglesias et al., 2013). 
Phosphoinositide3-kinase-related protein kinases (PIKKs) including DNA-dependent 
protein kinase (DNA-PK), ataxia teleangiectasia mutated (ATM) and ATR (ATM and 
Rad3-related) can phosphorylate H2AX. In response to DNA double-strand break, ATM 
is one of the important kinases involved in H2AX phosphorylation (Kastan and Lim, 
2000; Bakkenist and Kastan, 2003). Also, ATR plays role in H2AX phosphorylation once 
replication fork arrest or single-stranded DNA breaks occur (Ward and Chen, 2001; 
Ward et al., 2004). DNA-PK also phosphorylates H2AX in response to apoptosis DNA 
fragmentation and hypertonic conditions (Reitsema et al., 2005; Mukherjee et al., 
2006). The presence of phosphorylated H2AX leads to localisation and accumulation of 
DNA damage repair proteins at the site of damage (Kouzarides, 2007; Taverna et al., 
2007). Therefore, if the cells expressing hnRNP G-T had DNA damage this would be 
detected using the kit antibody against H2AX. According to the percentage of DNA 
damage, cells expressing hnRNP G-T had less DNA damage than the other two lines of 
stable cells investigated in this Chapter (expressing pcDNA5 and hnRNP G) (P<0.05).  
 
Based on a low percentage of apoptosis (less than 2%) and higher DNA integrity 
compared to control groups, these data suggest that hnRNP G-T expression does not 
lead to significant cell death. The reason for the small increase in cell death could be 
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because the cells expressing hnRNP G-T protein are released within the media, and 
these floating cells perhaps are more vulnerable to environmental factors leading to a 
higher percentage of cell death in comparison with the control groups. Furthermore, it 
seems that hnRNP G-T protein not only has no adverse effect on DNA stability, but also 
acts to reduce the amount of the DNA damage. Interestingly it has been shown that 
hnRNP G plays an important role in protection of DNA ends from nucleases (Shin et al., 
2007). 
 
The percentage of live cells was measured using cell viability analyzer as another 
complementary experiment to test if the cells expressing hnRNP G-T were viable. Cell 
viability analyzer machine used trypan blue to detect percentage of the dead cells. 
Viable cells have intact cell membrane which is not penetrable to dye and they will not 
be coloured. Only dead cells will absorb the dye when trypan blue is able to pass 
through the cell membrane.  
 
Although the hnRNP G-T group was significantly different from the control groups, still 
around 94% of cells were viable. These results were consistent with previous findings 
of this study. It seems that when cells were circular and released within the media they 
were still alive.  
 
Regarding to the cell morphological changes in hnRNP G-T group in comparison with 
control groups, it seemed that these cells were losing their cell-cell adhesions and also 
their attachments to the tissue culture surface after gene induction.  These 
morphological changes were reminiscent of those described for epithelial–
mesenchymal transitions (EMTs), an important event during embryonic development 
(Thiery, 2002).  
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Unlike mesenchymal cells, epithelial cells are not able to carry out migration and 
invasion. Epithelial-mesenchymal transformation (EMT) can lead to cell movement 
both in development and in cancer (Hay, 1995; Thiery, 2002; Yang et al., 2004). Since 
during EMT cells can migrate to other organs to be involved in organ formation, this 
transition plays an important role in development (Thiery, 2002). Also this 
phenomenon occurs in cancer metastasis as well. Metastatic cells can migrate from a 
tumour and invade other tissues (Yang et al., 2004).  
 
Since hnRNP G-T has a role in alternative splicing regulation, there was a question ‘’are 
genes involved in EMT alternatively spliced by hnRNP G-T?’’. To answer this question, 
the differences were tested between the alternative splicing regulation of some genes 
involved in cell adhesion and attachment in comparison with the control groups (cells 
expressing the FLAG tagged hnRNP G and empty vector, pcDNA5). Following Dr Julian P 
Venables’ suggestion (Institute of Genetic Medicine, Newcastle University), after 
induction and harvesting the cells stably expressing pcDNA5, hnRNP G and hnRNP G-T, 
the RNA samples were extracted and cDNA synthesis was carried out to make cDNA 
from RNA. Samples were then sent to a lab in Canada (Venables et al., 2009). 
Alternative splicing was monitored between three groups (pcDNA5, hnRNP G and 
hnRNP G-T) in genes associated with EMT using a high-throughput RT-PCR screen. Data 
was then analyzed by Dr Venables and four EMT target genes including:  MINK1 
(misshapen-Like Kinase 1), ACOT9 (acyl-CoA thioesterase 9), ENAH (enabled homolog) 
and MOYF (myoferlin) were detected to be alternatively spliced. PSI (percentage of 
splicing inclusion) was different in hnRNP G-T group in comparison with the control 
groups.  
 
While MINK1 protein has important roles in cell morphology, motility, cytoskeletal 
organization and cytokinesis (Hu et al., 2004; Hyodo et al., 2012), the physiological 
roles of the ACOT proteins still need to be further investigated (Ohtomo et al., 2013). 
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ACOT9 belongs to the Acyl-CoA thioesterases (ACOTs) family which are involved in 
fatty acid metabolism (catalyzing the fatty acyl-CoA thioesters hydrolysis to coenzyme 
A and fatty acid). ACOT9 is encoded by the X chromosome (Kirkby et al., 2010).  This 
enzyme is localized within the mitochondria and associated with a mitochondrial 
disorder called MEHMO syndrome (Mental retardation, Epileptic seizures, 
Hypogenitalism, Microcephaly and Obesity) (Scharfe et al., 2009). 
 
The Enah (Enabled homolog) protein has an essential role in neural development 
(Gertler et al., 1990; Gertler et al., 1995). This protein belongs to Ena/VASP family 
which also include two other members: VASP and EVL (Krause et al., 2002; 
Kwiatkowski et al., 2003). This family is involved in linking the actin cytoskeleton 
remodelling to signal transduction (Urbanelli et al., 2006). 
 
The other target gene detected by the results was MOYF (myoferlin). Myoferlin 
belongs to the ferlin family (Xiong et al., 2013). Members of this family (myoferlin, 
otoferlin and dysferlin) are involved in calcium-mediated membrane fusion (Davis et al., 
2000). Also they have important roles in  plasma membrane repair (Xiong et al., 2013). 
Levels of both myoferlin mRNA and protein are up-regulated in myofiber damage 
(Demonbreun et al., 2010). Myoferlin protein is expressed in skeletal and cardiac 
muscle and has association with the plasma membrane (Davis et al., 2000). 
Furthermore, myoferlin interactions with other proteins may have a role in membrane 
fusion for rearrangements of the cytoskeleton where cells have connections with each 
other (Doherty et al., 2008). Therefore, all of these hnRNP G and hnRNP G-T target 
genes are involved in either plasma membrane or cytoskeleton rearrangement. 
 
To investigate more about the role of hnRNP G-T in alternative splicing regulation of 
some of genes involved in EMT, the next step was to reproduce the results in our lab. 
Cells were induced with tetracycline, harvested and splicing analysed by RNA 
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extraction and cDNA synthesis. PCR reactions were set up and the percentages of 
splicing inclusion (PSI) were measured. The PSI of ACOT9 and MYOF in the hnRNP G-T 
group were significantly different from the control groups (expressing pcDNA5 and 
hnRNP G) (P<0.05). This means that expression of hnRNP G-T has role in exon exclusion 
of these two genes. This role could be direct or indirect. It could be that expressing 
hnRNP G-T affects the cells, which then affects the splicing pattern. HnRNP G-T might 
be acting as a direct repressor – less exon is included in each of the three replicates. In 
the cases of ACOT9 and MYOF, the results are specific to G-T (no effect was seen for G). 
 
Although the results from the Canadian group predicted a role of hnRNP G-T in splicing 
regulation of MINK1, after reproducing the results it was found out that the 
percentage of splicing inclusion of MINK1 in hnRNP G-T group was not significantly 
different from the control groups (expressing pcDNA5 and hnRNP G) (P>0.05). 
Interestingly, the percentage of splicing inclusion of ENAH, not only was significantly 
different in the hnRNP G-T group from both control groups (expressing pcDNA5 and 
hnRNP G) (P<0.05), but also the control groups were significantly different from each 
other as well (P<0.05). This suggests that both hnRNP G and hnRNP G-T have role in 
exon exclusion of ENAH target gene. 
 
In summary, these data suggest that hnRNP G-T protein has important roles in 
regulation of alternative splicing of some genes involved in EMT including ACOT9, 
ENAH and MOYF. In addition, splicing of ENAH can be regulated by hnRNP G which 
means that this gene can be considered as a common target for both hnRNP G and 
hnRNP G-T. In future work it will be interesting to test whether these genes are direct 
or indirect targets of hnRNP G-T and hnRNP G. In addition, further steps can be 
generation of minigenes to check the effects on splicing regulation of RRM mutations, 
mapping binding sites and looking for more targets to investigate more about hnRNP 
G-T roles in splicing regulation. 
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One of the main aims of this project was to investigate more about new candidates as 
the protein partners for these RNA binding proteins (hnRNP G and hnRNP G-T and 
Tra2β). After confirming the efficiency of immunoprecipitation of the FLAG tagged 
proteins, IP samples were loaded on SDS-PAGE gels and electrophoresed. New bands 
were not detected in the Tra2β IP lane in comparison with the control group (pcDNA5). 
However, there were some extra protein bands in both the hnRNP G and hnRNP G-T IP 
lanes. Staining the gels with Simply Blue was followed by cutting the bands and 
sending them for mass spectrometry.  
 
As a result, five and nine candidates were detected respectively as the new candidate 
protein partners for hnRNP G (RBMXL1, hnRNP C, hnRNP CL1, RPL6, hnRNP H3) and 
hnRNP G-T (RBMXL1, H2AFY , hnRNP C, hnRNP CL1, RPS6, RPL7, RPL7A, RPLP2, RPS20). 
Among these proteins RBMXL1, hnRNP C and hnRNP CL1 were common interacting 
proteins for both hnRNP G and hnRNP G-T.  
 
HnRNP C belongs to the family of heterogeneous nuclear ribonucleoproteins . This 
protein has a nuclear localization within the cell but in tumour cells it can be 
cytoplasmic as well (Christian et al., 2008). HnRNP C is important in splicing regulation, 
covering cryptic splice sites and mRNA stability (Dreyfuss et al., 1993; Rajagopalan et 
al., 1998; Shetty, 2005; Zarnack et al., 2013). HnRNP C binding close to the splice site 
can lead to repression of alternative exon selection (Konig et al., 2010). The role of 
hnRNP C in repression of cryptic exons seems to be associated with evolution and 
disease (Zarnack et al., 2013). 
 
In tumours, hnRNP C expression has the potential to be used as a prognostic marker 
(Sun et al., 2007; Zhang et al., 2011). HnRNP G is over-expressed in breast cancer and 
hepatocellular carcinoma (Sun et al., 2007; Blume et al., 2010). It has also been shown 
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that repression of hnRNP C expression can lead to tumour growth suppression 
(Hossain et al., 2007; Meng et al., 2008). 
 
According to the important roles of hnRNP C and also considering this protein was 
detected as a common interacting partner for both hnRNP G and hnRNP G-T, the 
presence of hnRNP C was tested in IP samples of hnRNP G and hnRNP G-T by Western 
blot. In this study it was found out that hnRNP G and hnRNP G-T paly role as the 
repressor in splicing regulation of some target genes. Also, hnRNP C plays important 
roles in repression of alternative exon selection (Konig et al., 2010). I was interested to 
test whether these proteins could interact with each other or not. Finally, it was 
confirmed that hnRNP C interacts with both hnRNP G and hnRNP G-T proteins. In 
future work it will be useful to test whether these proteins have interactions at the 
endogenous level of expression of hnRNP G and hnRNP G-T as well. In addition, it 
should be investigated that whether these proteins are involved in alternative splicing 
regulation of common target genes.  
 
In summary, in this Chapter in addition to introducing the new detected interaction 
partners of hnRNP G and hnRNP G-T, some unique and important roles of hnRNP G 
and hnRNP G-T were described in alternative splicing regulation of some target genes. 
In vivo hnRNP G-T replaces hnRNP G expression when hnRNP G protein is inactivated 
after XY body formation during meiosis. However, the data in this study suggest some 
specific and unique roles which belong only to hnRNP G-T such as cell morphological 
changes after over-expression of this protein. 
 
Chapter 5: Summary and Future work 
 
 
180 
 
Chapter 5 
 
5 Conclusion and Future work: 
 
The main aim of this project was investigation of possible new interacting protein 
partners of the RNA binding proteins T-STAR, wild type and P439R Sam68, hnRNP G, 
hnRNP G-T and Tra2β.  All of these proteins play important roles within the cells and 
almost all of them are involved in some kinds of disease including cancer, SMA and 
infertility. Therefore, understanding their roles and interaction networks may be a 
good step towards the finding of new treatments for these diseases. Regulating gene 
expression at the post-transcriptional level including mRNA processing has the 
potential to be considered as a future tool for cancer therapy. One of the procedures 
involved in mRNA processing is alternative splicing. During this procedure RNA binding 
proteins play important roles to regulate gene expression and production of protein 
diversity from one pre-mRNA. The main achievements of this project are listed below: 
 
5.1 Establishment of stable cell lines expressing FLAG tagged proteins 
 
The open reading frames of the RNA binding proteins T-STAR, wild type and P439R 
Sam68, hnRNP G, hnRNP G-T and Tra2β were cloned in to the pcDNA5 vector. This 
vector encodes a FLAG epitope. These constructs were then transfected into Flp-
In HEK293 cells for integration into the genome. Hygromycin B was also used to select 
the transfected cells. The stable transfected cells had hygromycin resistance gene, 
therefore, they would survive after adding hygromycin to the media. In addition, tet 
repressor was expressed in these cells. Expression of the genes of interest was 
controlled by the tetracycline promoter. Therefore, a high level of gene expression 
would be achieved by adding tetracycline to the cell culture medium. After making 
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stable cell lines and inducing gene expression by using tetracycline antibiotic it was 
possible to express the protein of interest. 
 
5.2 Confirmation of Wild type and P439R Sam68 localizations 
 
These stable cell lines were firstly used for cell biological investigation of the 
localization of wild type and P439R mutant Sam68 after induction in the Flp-In HEK293 
cells. Wild type Sam68 was nuclear and P439R mutant Sam68 protein was completely 
cytoplasmic. These results were similar to the previous study carried out by Reddy et al 
in HeLa cells (Reddy, 2000). This means that because of a point mutation (P439R, 
changing proline to arginine) in the tyrosine-rich C-terminal domain of Sam68, 
localization of this Sam68 protein will be changed, and as a result Sam68 protein will 
be completely cytoplasmic. 
 
5.3 Investigation of RNA-protein interaction networks of wild type and P439R 
Sam68 
 
By generating stable cell lines expressing wild type and P439R FLAG-tagged Sam68 
which are nuclear and cytoplasmic protein isoforms respectively, more information 
regarding the interaction networks of Sam68 within the nucleus and cytoplasm were 
obtained. FLAG tagged proteins (wild type and P439R Sam68) and their partners were 
purified using immunoprecipitation and identified using mass spectrometry. 
 
5.3.1 Detection of Sam68 and RHA interaction 
 In this project the interactions of wild type and P439R Sam68 with RHA were detected 
after Sam68 protein induction. Previously, an interaction between Sam68 (wild type) 
and RHA was already known (Reddy et al., 2000) and in this project the interaction of 
RHA with completely cytoplasmic Sam68 (P439R) was further detected. 
Immunoprecipitation of endogenous Sam68 protein using protein A Dynabeads also 
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confirmed the interaction between wild type Sam68 and RHA at normal cellular levels 
of expression. Hence a major observation in this study is that RHA and Sam68 interact 
with each other both at endogenous and over-expressed levels of Sam68 protein. 
 
5.3.2 Role of tyrosine-rich C-terminal domain in Sam68 and RHA interaction 
In addition, by making short forms of Sam68 and testing if the protein-protein 
interactions still occur, it became clear that only deletion of tyrosine-rich C-terminal 
domain of Sam68 can disrupt the interaction with RHA. This domain therefore must 
play a fundamental role in enabling the interaction between these proteins. The 
tyrosine-rich C-terminal domain is also present within the structure of T-STAR as well. 
Tyrosine residues can be phosphorylated by protein kinases and then act like a dock 
for signalling proteins which contain SH2 domains (Ehrmann and Elliott, 2010). Both T-
STAR and Sam68 interacted with RHA, and there is a possibility that these interactions 
may be related to signal transduction pathways.  
 
5.3.3 Detection of Sam68 and CCAR1 interaction 
Interactions between wild type and P439R Sam68 with CCAR1 (Cell cycle and apoptosis 
regulatory protein) were detected after over-expression of Sam68. Both Sam68 and 
CCAR1 proteins have roles in apoptosis, cancer and cell proliferation regulation. Sam68 
and CCAR1 proteins only interact with each other after over-expression of Sam68, and 
not in the situation when Sam68 is expressed normally within the cell. It will be useful 
to check the influence of Sam68 expression on the level of expression of CCAR1 in 
breast cancer cells  since both of these proteins are over-expressed and also involved 
in breast cancer (Kim et al., 2008; Elliott and Rajan, 2010). There is a possibility that by 
testing the relation between expression levels of Sam68 and CCAR1 more information 
will be available regarding the roles of these proteins in breast cancer. 
 
In addition, in this study it was found out  that RHA or CCAR1 were not present in SNBs, 
but endogenous RHA (mostly), CCAR1 and Sam68 were localised within the 
nucleoplasm. Since Sam68 was present both in SNBs and the cytoplasm it seems that 
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Sam68 interactions with RHA and CCAR1 must occur in the nucleoplasm instead of 
SNBs.  
 
5.4 Investigation of RNA-protein interaction networks of T-STAR 
 
FLAG tagged protein (T-STAR) and its partners were purified using 
immunoprecipitation and identified using mass spectrometry. In addition to proving 
the presence of T-STAR in the immunoprecipitates, two other proteins (hnRNP G and 
RNA helicase A (RHA)) were detected as T-STAR protein partners by mass spectrometry.  
This was the first time that RHA was detected as an interacting protein partner of T-
STAR. The interaction of T-STAR and RNA helicase A was tested at the endogenous 
levels of T-STAR expression as well. Immunoprecipitation of endogenous T-STAR 
protein using protein A Dynabeads was carried out and immunoprecipitated (IP) 
samples were probed with appropriate antibodies, but no RHA was detected in the 
immunoprecipitated (IP) or input lanes. This might be because of negligible expression 
of T-STAR in kidney cells. Therefore, using other cell lines or tissues which have more 
T-STAR expression might be a better option to try to investigate more about the 
interaction between T-STAR and RHA. 
 
5.5 Investigation of RNA-protein interaction networks of hnRNP G and hnRNP G-T  
 
Potential protein interactions of hnRNP G and hnRNP G-T were investigated in this 
study. FLAG tagged proteins (hnRNP G and hnRNP G-T) and their partners were 
purified using immunoprecipitation and identified using mass spectrometry. The 
presence of RPL6 and hnRNP H3 were detect as the new candidate protein partners for 
hnRNP G after over-expression of this protein. H2AFY, RPS6, RPL7, RPL7A, RPLP2 and 
RPS20 were detected as candidate interacting partners for hnRNP G-T.  
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5.5.1 HnRNP C is a common protein partner of hnRNP G and hnRNP G-T 
 
X-Linked-Like 1 (RBMXL1), hnRNP C, and hnRNP CL1 were detected to be common 
protein partners for both of hnRNP G and hnRNP G-T proteins. It was the first time that 
the interaction between hnRNP G-T and hnRNP C has been detected.  HnRNP C plays a 
role in blocking U2AF65 (the core splicing factor) to prevent inclusion of cryptic exons 
and maintain transcriptome integrity (Zarnack et al., 2013). HnRNP proteins interact 
with other RNA binding proteins (see introduction). The role of hnRNP G protein is not 
fully understood in alternative regulation. This new protein interaction detected 
between hnRNP C and hnRNP G might help explain the role of hnRNP G protein in 
alternative splicing regulation in more details. 
 
HnRNP G, hnRNP G-T have roles in some diseases such as SMA and male infertility 
respectively (Elliott, 2004) and hnRNP C maintains repression of cryptic exons which 
seems to be associated to disease including cancer (Sun et al., 2007; Blume et al., 
2010; Zarnack et al., 2013). The diseases mentioned above are linked to splicing 
misregulation of some target genes. Therefore, the more data we could collect 
regarding these RNA binding proteins interactions, the more information will be 
achieved for designing future drugs and treatments such as gene therapy via splicing 
regulation of target genes involved in different diseases. 
 
5.6 Use of stable cell lines to probe RNA splicing patterns  
 
In this project, for the first time, a strong influence of hnRNP G-T over-expression on 
cell morphology was detected. HEK293 cells expressing hnRNP G-T developed firstly a 
circular shape, and then were released and floated within the media after increasing 
the level of expression of this protein. Alternative splicing is very important in cell 
morphology and also in changes which occur to cells in development and disease is 
called epithelial–mesenchymal transition (EMT).  
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5.6.1 Repressive roles of hnRNP G and hnRNP G-T in alternative splicing regulation 
of some EMT target genes 
 
HnRNP G-T over-expression repressed splicing regulation of some target genes 
involved in epithelial–mesenchymal transitions (EMT) including ACOT9 (acyl-CoA 
thioesterase 9), ENAH (enabled homolog) and MOYF (myoferlin). In addition, ENAH 
was detected to be the common target gene for both hnRNP G and hnRNP G-T.  
 
Since in this project the interaction of hnRNP G and hnRNP G-T with hnRNP C were 
detected and because of the roles of hnRNP C and hnRNP G in alternative splicing 
regulation (Hofmann and Wirth, 2002; Nasim et al., 2003; Zarnack et al., 2013), there 
are some future experiments to be carried out.  After confirming the endogenous 
interaction of hnRNP G and hnRNP G-T with hnRNP C, the next step will be testing the 
influence of these RNA binding proteins as direct or indirect regulators of target genes 
(ACOT9, MOYF and ENAH). 
 
5.7 Discovering the role of hnRNP G-T in cell morphology regulation of cells 
expressing this protein 
 
We know that EMT plays important role in development (Thiery, 2002). HnRNP G-T 
induces morphological changes for cells expressing this protein. Cells developed firstly 
a circular shape, and then were released and floated within the media after increasing 
the level of expression of hnRNP G-T. Also, in this project the role of hnRNP G-T was 
detected in splicing regulation of some target genes involved in EMT. HnRNP G-T has 
been shown to be only expressed in the nuclei of pachytene spermatocytes and round 
spermatids (Elliott et al., 2000b). Therefore, it seems that we could consider some 
unique roles for this protein in germ cell development. The question to be answered as 
future work is whether hnRNP G-T can play an important role in movement of 
spermatogonia from the basement membrane towards lumen of seminiferous 
tubules? 
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5.8 Future work 
 
Following on from the results achieved in this study there are some questions to be 
answered. These questions are listed below: 
 
5.8.1 Does endogenous T-STAR interact with RHA? 
After confirmation of interaction of T-STAR with RHA at over-expressed levels of T-
STAR protein, to confirm whether the interaction also happens at endogenous levels of 
T-STAR expression, we could use brain or testis tissues. If we could detect interaction it 
means that their association does not depend on a high level of T-STAR expression. If 
an interaction cannot be detected at the endogenous level of T-STAR expression, it will 
show us that higher level of T-STAR protein is needed for protein association. 
 
5.8.2 Does over-expressed Sam68 interact with over-expressed CCAR1 protein in 
breast cancer cells? 
The interaction of Sam68 was detected with CCAR1 only after over-expression of 
Sam68 protein and not at the endogenous level of Sam68 expression. Both Sam68 and 
CCAR1 proteins are involved in transcription regulation and also are over-expressed in 
breast cancer (Busa et al., 2007; Kim et al., 2008; Rajan et al., 2008b; Elliott and Rajan, 
2010). Therefore, there could be a link between the expression level of Sam68 and its 
interaction with CCAR1. To discover if there is such a link, one option will be to uncover 
the influence of Sam68 on CCAR1 expression in breast cancer cell line. The question 
will be whether knocking down Sam68 in cancer cells can lead to decreased level of 
CCAR1 expression as well or not. If yes, will cell proliferation rate be reduced regarding 
to the roles of CCAR1 and Sam68 in regulation of cell cycle and apoptosis (Taylor et al., 
2004; Paronetto et al., 2007; Ou et al., 2009)? 
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5.8.3 Do hnRNP C and hnRNP G proteins interact at endogenous levels of protein 
expression? 
As approved in this study, hnRNP G and hnRNP G-T interact with hnRNPC after over-
expression of hnRNP G and hnRNP G-T proteins. Therefore, one of the future works 
could be testing that whether these interactions occour at endogenous expression 
levels of hnRNP G and hnRNP G-T. According to the important roles of these proteins 
in alternative splicing regulation, detection of new interacting partners and 
characterization of interaction situation will help us to understand the roles of these 
RNA binding proteins in splicing regulation of target genes. 
 
5.8.4 Do hnRNP G and hnRNP G-T proteins interact with other identified partners 
from the proteomic screen? 
 
In this project plus hnRNP C there were some other detected new protein candidates 
as the protein partners of hnRNP G and hnRNP G-T (table 31 and 32). These 
interactions occurred after over-expression of hnRNP G and hnRNP G-T proteins. 
Therefore, confirmation of these interactions at endogenous level of hnRNP G and 
hnRNP G-T protein expression level can be considered as one the future work to 
achieve more information related to interaction networks of these members of 
hnRNPs family. 
 
5.8.5 Does hnRNP G-T protein regulate the splicing of identified target exons? 
 
HnRNP G-T role was detected as a repressor in exon inclusion of some EMT target 
genes including ACOT9, ENAH and MOYF. However, the direct or indirect role of this 
protein in splicing regulation of these target genes needs to be uncovered. If hnRNP G-
T is not effecting alternative splicing regulation of these target genes directly, it means 
that this protein might be playing an indirect role to recruit splicing factors involved in 
repression of these cassette exons’ inclusions.  
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However, if we could detect hnRNP G-T acts as a direct repressor it means that this 
protein binds directly to the cassette exons and its presence is necessary for repression 
of cassette exons’ inclusions of these target genes (ACOT9, ENAH and MOYF).  
According to the detected interaction of hnRNP G-T with hnRNP C and their roles in 
splicing regulation, if we can confirm the direct effect of hnRNP G-T in splicing 
regulation of these EMT target genes, we could then test whether hnRNP C also plays 
any role in inclusion regulation of these cassette exons. The other question will be 
whether hnRNP C acts synergistically or antagonistically to hnRNP G-T? Do they 
collaborate with each other to regulate alternative splicing of these target genes or do 
they repress each other’s activity? This question can be expanded to more common 
targets as well. 
 
5.8.6 Testing detected EMT target gene (ENAH) is direct targets of hnRNP G protein 
In addition a role for hnRNP G was detected in repression of cassette exon inclusion of 
ENAH. Therefore, similar to what has been mentioned in the previous section, one of 
the future works should be to test direct or indirect repressive roles of hnRNP G in 
splicing regulation of the ENAH cassette exon. If hnRNP G acts as a direct repressor, we 
could then test the role of hnRNP C as well in terms of possible collaboration and 
interaction between these two proteins to regulate alternative splicing of this target 
gene (ENAH). 
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Appendix A 
 
 (Sequencing results) 
 
1. Sequencing results of T-STAR, wild type Sam68 and P439R Sam68. ClustalW was 
used for generation of alignments. The stars show the identity. The stop codon is 
highlighted by red. 
 
5’ end of T-STAR insert showing the frame using CMVF primer 
 
T-STAR          ------------------------------------------------------------ 
Construct       NNNNNGNNNNNNNNNNNTNNNGCTNNTNTGACCTCCATAGNAGACACCGGGACCGATCCA 60 
                                                                             
 
T-STAR          ------------------------------------------------------------ 
Construct       GCCTCCGGACTCTAGCGTTTAAACTTAAGCTTGGTACCGATCCACCATGGACTACAAAGA 120 
                                                                             
 
T-STAR          ------------------------------------------------------------ 
Construct       CGATGACGATAAAGACTACAAAGACGATGACGATAAAGGTCACCCAGGATCACTGGAAGT 180 
                                                                             
 
T-STAR          -------------------------------------------ATGGAGGAGAAGTACCT 17 
Construct       TCTGTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCTATGGAGGAGAAGTACCT 240 
                                                           ***************** 
 
T-STAR          GCCCGAGCTGATGGCGGAGAAGGACTCCCTGGACCCCTCCTTCACGCACGCCCTGCGCCT 77 
Construct       GCCCGAGCTGATGGCGGAGAAGGACTCCCTGGACCCCTCCTTCACGCACGCCCTGCGCCT 300 
                ************************************************************ 
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3’ end of T-STAR insert  showing the frame using BGHrev primer 
 
                                                                          
T-STAR          GGAGTCCCCCCAACTGGGTACAGACCTCCACCGCCACCCCCGACACAAGAGACTTATGGA 801 
Construct       GGAGTCCCCCCAACTGGGTACAGACCTCCACCGCCACCCCCGACACAAGAGACTTATGGA 1139 
                ************************************************************ 
 
T-STAR          GAATATGACTATGATGATGGATATGGCACTGCTTATGATGAACAGAGTTATGATTCCTAT 861 
Construct       GAATATGACTATGATGATGGATATGGCACTGCTTATGATGAACAGAGTTATGATTCCTAT 1199 
                ************************************************************ 
 
T-STAR          GATAACAGCTATAGCACCCCAGCCCAAAGTGGTGCTGATTACTATGATTACGGACATGGA 921 
Construct       GATAACAGCTATAGCACCCCAGCCCAAAGTGGTGCTGATTACTATGATTACGGACATGGA 1259 
                ************************************************************ 
 
T-STAR          CTCAGTGAGGAGACTTATGATTCCTACGGGCAAGAAGAGTGGACTAACTCAAGACACAAG 981 
Construct       CTCAGTGAGGAGACTTATGATTCCTACGGGCAAGAAGAGTGGACTAACTCAAGACACAAG 1319 
                ************************************************************ 
 
T-STAR          GCACCTTCAGCGAGGACAGCAAAGGGCGTCTACAGAGACCAGCCATATGGCAGATACTGA 1041 
Construct       GCACCTTCAGCGAGGACAGCAAAGGGCGTCTACAGAGACCAGCCATATGGCAGATACTGA 1379 
                ************************************************************                                                                                                                                                                           
                                                                                                              Stop codon↑ 
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5’ end of wild type Sam68 insert  showing the frame using CMVF primer 
 
Sam68           ------------------------------------------------------------ 
Construct       NNNNNNNNNNTCNCGCTGTTTTGACCTCCNTAGAAGACACCGGGACCGATCCAGCCTCCG 60 
                                                                             
 
Sam68           ------------------------------------------------------------ 
Construct       GACTCTAGCGTTTAAACTTAAGCTTGGTACCGATCCACCATGGACTACAAAGACGATGAC 120 
                                                                             
 
Sam68           ------------------------------------------------------------ 
Construct       GATAAAGACTACAAAGACGATGACGATAAAGGTCACCCAGGATCACTGGAAGTTCTGTTC 180 
                                                                             
 
Sam68           ------------------------------------ATGCAGCGCCGGGACGATCCTGCC 24 
Construct       CAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGCAGCGCCGGGACGATCCTGCC 240 
                                                    ************************ 
 
Sam68           TCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTCAGGTGCCCACCCC 84 
Construct       TCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTCAGGTGCCCACCCC 300 
                ************************************************************ 
 
Sam68           TCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCCCCGGGGAGGGGGA 144 
Construct       TCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCCCCGGGGAGGGGGA 360 
                ************************************************************ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 192 
 
3’ end of wild type Sam68 insert showing the frame using pCDNArev primer  
 
                                                                          
Sam68           GGGTGCTCCAACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACCTTTGCCTCCCAC 1079 
Construct       GGGTGCTCCAACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACCTTTGCCTCCCAC 891 
                ************************************************************ 
 
Sam68           ACCTGCACCAGAAACATACGAAGATTATGGATATGATGATACATACGCAGAACAGAGTTA 1139 
Construct       ACCTGCACCAGAAACATACGAAGATTATGGATATGATGATACATACGCAGAACAGAGTTA 951 
                ************************************************************ 
 
Sam68           CGAAGGCTATGAAGGCTATTACAGCCAGAGTCAAGGGGAGTCAGAGTATTATGACTATGG 1199 
Construct       CGAAGGCTATGAAGGCTATTACAGCCAGAGTCAAGGGGAGTCAGAGTATTATGACTATGG 1011 
                ************************************************************ 
 
Sam68           ACATGGGGAGCTCCAAGATTCTTACGAAGCCTACGGACAAGATGACTGGAATGGGACCAG 1259 
Construct       ACATGGGGAGCTCCAAGATTCTTACGAAGCCTACGGACAAGATGACTGGAATGGGACCAG 1071 
                ************************************************************ 
 
Sam68           GCCATCACTGAAGGCTCCTCCAGCTAGGCCAGTGAAGGGAGCATACAGAGAGCATCCATA 1319 
Construct       GCCATCACTGAAGGCTCCTCCAGCTAGGCCAGTGAAGGGAGCATACAGAGAGCATCCATA 1131 
                ************************************************************ 
 
Sam68           TGGACGTTATTAA----------------------------------------------- 1332 
Construct       TGGACGTTATTAAGTCGAGTCTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGT 1191 
                ************* 
          Stop codon↑ 
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 5’ end of P439R mutant Sam68 insert showing the frame using CMVF primer  
 
Sam68           ------------------------------------------------------------ 
Construct       NNNNNNNNNNNNNNCNNNCTGTTTTGACCTCCNTAGAAGACACCGGGACCGATCCAGCCT 60 
                                                                             
 
Sam68           ------------------------------------------------------------ 
Construct       CCGGACTCTAGCGTTTAAACTTAAGCTTGGTACCGATCCACCATGGACTACAAAGACGAT 120 
                                                                             
 
Sam68           ------------------------------------------------------------ 
Construct       GACGATAAAGACTACAAAGACGATGACGATAAAGGTCACCCAGGATCACTGGAAGTTCTG 180 
                                                                             
 
Sam68           ---------------------------------------ATGCAGCGCCGGGACGATCCT 21 
Construct       TTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGCAGCGCCGGGACGATCCT 240 
                                                       ********************* 
 
Sam68           GCCTCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTCAGGTGCCCAC 81 
Construct       GCCTCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTCAGGTGCCCAC 300 
                ************************************************************ 
 
Sam68           CCCTCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCCCCGGGGAGGG 141 
Construct       CCCTCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCCCCGGGGAGGG 360 
                ************************************************************ 
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 3’ end of P439R mutant Sam68 insert showing the frame using pCDNArev primer 
Instead of CCA (highlighted by green) which encodes proline, there is CGA 
(highlighted by blue) which encodes arginine. 
 
Sam68           GGTGCTCCAACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACCTTTGCCTCCCACA 1080 
Construct       GGTGCTCCAACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACCTTTGCCTCCCACA 901 
                ************************************************************ 
 
Sam68           CCTGCACCAGAAACATACGAAGATTATGGATATGATGATACATACGCAGAACAGAGTTAC 1140 
Construct       CCTGCACCAGAAACATACGAAGATTATGGATATGATGATACATACGCAGAACAGAGTTAC 961 
                ************************************************************ 
 
Sam68           GAAGGCTATGAAGGCTATTACAGCCAGAGTCAAGGGGAGTCAGAGTATTATGACTATGGA 1200 
Construct       GAAGGCTATGAAGGCTATTACAGCCAGAGTCAAGGGGAGTCAGAGTATTATGACTATGGA 1021 
                ************************************************************ 
 
Sam68           CATGGGGAGCTCCAAGATTCTTACGAAGCCTACGGACAAGATGACTGGAATGGGACCAGG 1260 
Construct       CATGGGGAGCTCCAAGATTCTTACGAAGCCTACGGACAAGATGACTGGAATGGGACCAGG 1081 
                ************************************************************ 
 
Sam68           CCATCACTGAAGGCTCCTCCAGCTAGGCCAGTGAAGGGAGCATACAGAGAGCATCCATAT 1320 
Construct       CCATCACTGAAGGCTCCTCCAGCTAGGCCAGTGAAGGGAGCATACAGAGAGCATCGATAT 1141 
                ******************************************************* **** 
                                                             Mutation↑  
Sam68           GGACGTTATTAA------------------------------------------------ 1332 
Construct       GGACGTTATTAAGTCGAGTCTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTG 1201 
                ************  
                         Stop codon↑ 
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2. Sequencing results of different short forms of Sam68. ClustalW was used for 
generation of alignments. The stars show the identity. The stop codon is 
highlighted by gray. 
 
Dark green: extended N-terminal domain of Sam68; green: proline rich sequences 
(SH3 binding sits); red: N-terminus; bold and underlined: Qua1 domain; bold, blue 
and underlined: KH Domain; blue font color with under line: Qua2 domain; yellow: 
RG-rich domain; purple: tyrosine-rich C-terminal domain. 
 
Sam68 short form1 (N-KH) insert showing the frame using BGHrev primer 
 
Sam68           -------------------------------------------------ATGCAGCGCCG 11 
N-KH            GGAAGTTCTGTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGCAGCGCCG 660 
                                                                           *********** 
 
Sam68           GGACGATCCTGCCTCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTC 71 
N-KH            GGACGATCCTGCCTCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTC 720 
                ************************************************************ 
 
Sam68           AGGTGCCCACCCCTCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCC 131 
N-KH            AGGTGCCCACCCCTCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCC 780 
                ************************************************************ 
 
Sam68           CCGGGGAGGGGGAGGTGGGCCCAGAGGAGGCGCTCGGGCCTCGCCCGCCACCCAGCCGCC 191 
N-KH            CCGGGGAGGGGGAGGTGGGCCCAGAGGAGGCGCTCGGGCCTCGCCCGCCACGCAGCCGCC 840 
                *************************************************** ******** 
 
Sam68           GCCGCTGCTGCCTCCCTCCACCCCTGGTCCCGACGCGACGGTGGTGGGTTCCGCGCCGAC 251 
N-KH            GCCGCTGCTGCCTCCCTCCACCCCGGGTCCCGACGCGACGGTGGTGGGTTCCGCGCCGAC 900 
                ************************ *********************************** 
 
Sam68           CCCGCTGCTGCCCCCGTCAGCCACAGCCGCGGTCAAGATGGAGCCGGAGAATAAGTACCT 311 
N-KH            CCCGCTGCTGCCCCCGTCAGCCACAGCCGCGGTCAAGATGGAGCCGGAGAATAAGTACCT 960 
                ************************************************************ 
 
Sam68           GCCTGAACTCATGGCCGAGAAGGACTCGCTCGACCCGTCCTTCACTCACGCCATGCAGCT 371 
N-KH            GCCTGAACTCATGGCCGAGAAGGACTCGCTCGACCCGTCCTTCACTCACGCCATGCAGCT 1020 
                ************************************************************ 
 
Sam68           GCTGTCCGTAGAAATTGAGAAGATTCAGAAGGGAGAGTCAAAAAAAGATGACGAGGAGAA 431 
N-KH            GCTGTCCGTAGAAATTGAGAAGATTCAGAAGGGAGAGTCAAAAAAAGATGACGAGGAGAA 1080 
                ************************************************************ 
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Sam68           TTATTTGGATTTATTTTCTCATAAGAACATGAAGCTGAAAGAACGCGTGCTGATACCTGT 491 
N-KH            TTATTTGGATTTATTTTCTCATAAGAACATGAAGCTGAAAGAACGCGTGCTGATACCTGT 1140 
                ************************************************************ 
 
Sam68           CAAGCAGTATCCAAAGTTCAATTTTGTGGGGAAGATTCTTGGACCACAAGGAAATACAAT 551 
N-KH            CAAGCAGTATCCAAAGTTCAATTTTGTGGGGAAGATTCTTGGACCACAAGGAAATACAAT 1200 
                ************************************************************ 
 
Sam68           CAAAAGACTCCAGGAAGAGACTGGTGCAAAGATCTCTGTCTTGGGGAAGGGTTCAATGAG 611 
N-KH            CAAAAGACTCCAGGAAGAGACTGGTGCAAAGATCTCTGTCTTGGGGAAGGGTTCAATGAG 1260 
                ************************************************************ 
 
Sam68           AGACAAAGCCAAGGAGGAAGAGTTGCGCAAGGGTGGAGACCCCAAATATGCCCATTTAAA 671 
N-KH            AGACAAAGCCAAGGAGGAATAAGT------------------------------------ 1284 
                ******************* *. *                                     
                        Stop codon↑  
 
5’ end of Sam68 short form2 (N-KH-RG) insert showing the frame using CMVF primer 
 
  
Sam68           -----------------------------------------ATGCAGCGCCGGGACGATC 19 
NKHRG           TGTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGCAGCGCCGGGACGATC 240 
                                                                   ******************* 
 
Sam68           CTGCCTCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTCAGGTGCCC 79 
NKHRG           CTGCCTCGCGCCTCACCCGGTCCTCGGGCCGCAGCTGCTCCAAGGACCCGTCAGGTGCCC 300 
                ************************************************************ 
 
Sam68           ACCCCTCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCCCCGGGGAG 139 
NKHRG           ACCCCTCGGTGCGTCTGACCCCGTCTCGGCCGTCGCCGCTTCCTCACCGGCCCCGGGGAG 360 
                ************************************************************ 
 
Sam68           GGGGAGGTGGGCCCAGAGGAGGCGCTCGGGCCTCGCCCGCCACCCAGCCGCCGCCGCTGC 199 
NKHRG           GGGGAGGTGGGCCCAGAGGAGGCGCTCGGGCCTCGCCCGCCACGCAGCCGCCGCCGCTGC 420 
                ******************************************* **************** 
 
Sam68           TGCCTCCCTCCACCCCTGGTCCCGACGCGACGGTGGTGGGTTCCGCGCCGACCCCGCTGC 259 
NKHRG           TGCCTCCCTCCACCCCGGGTCCCGACGCGACGGTGGTGGGTTCCGCGCCGACCCCGCTGC 480 
                **************** ******************************************* 
 
Sam68           TGCCCCCGTCAGCCACAGCCGCGGTCAAGATGGAGCCGGAGAATAAGTACCTGCCTGAAC 319 
NKHRG           TGCCCCCGTCAGCCACAGCCGCGGTCAAGATGGAGCCGGAGAATAAGTACCTGCCTGAAC 540 
                ************************************************************ 
 
Sam68           TCATGGCCGAGAAGGACTCGCTCGACCCGTCCTTCACTCACGCCATGCAGCTGCTGTCCG 379 
NKHRG           TCATGGCCGAGAAGGACTCGCTCGACCCGTCCTTCACTCACGCCATGCAGCTGCTGTCCG 600 
                ************************************************************   
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3’ end of Sam68 short form2 (N-KH-RG) insert showing the frame using BGHrev 
primer 
 
 
Sam68           AGTACCTGAACCCTCTCGTGGTCGTGGGGTATCTGTGAGAGGACGAGGAGCTGCCCCTCC 887 
NKHRG           AGTACCTGAACCCTCTCGTGGTCGTGGGGTATCTGTGAGAGGACGAGGAGCTGCCCCTCC 1080 
                ************************************************************ 
 
Sam68           TCCTCCACCTGTTCCCAGAGGACGTGGTGTTGGACCACCTAGAGGAGCTTTGGTTCGTGG 947 
NKHRG           TCCTCCACCTGTTCCCAGAGGACGTGGTGTTGGACCACCTAGAGGAGCTTTGGTTCGTGG 1140 
                ************************************************************ 
 
Sam68           AACCCCAGTGAGAGGCTCCATCACCAGAGGTGCCACTGTGACTCGAGGAGTGCCACCCCC 1007 
NKHRG           AACCCCAGTGAGAGGCTCCATCACCAGAGGTGCCACTGTGACTCGAGGAGTGCCACCCCC 1200 
                ************************************************************ 
 
Sam68           ACCTACTGTGAGGGGTGCTCCAACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACC 1067 
NKHRG           ACCTACTGTGAGGGGTGCTCCAACACCAAGAGCTCGGACATAAG---------------- 1244 
                **************************************** .:*                 
                                                                                                             
                                             Stop codon↑  
 
 
Sam68 short form 3 (KH-RG) insert showing the frame using BGHrev primer 
 
Sam68           -TTCAATTTTGTGGGGAAGATTCTTGGACCACAAGGAAATACAATCAAAAGACTCCAGGA 139 
KHRG            CTTCAATTTTGTGGGGAAGATTCTTGGACCACAAGGAAATACAATCAAAAGACTCCAGGA 780 
                 *********************************************************** 
 
Sam68           AGAGACTGGTGCAAAGATCTCTGTCTTGGGGAAGGGTTCAATGAGAGACAAAGCCAAGGA 199 
KHRG            AGAGACTGGTGCAAAGATCTCTGTCTTGGGGAAGGGTTCAATGAGAGACAAAGCCAAGGA 840 
                ************************************************************ 
 
Sam68           GGAAGAGTTGCGCAAGGGTGGAGACCCCAAATATGCCCATTTAAATATGGATCTGCATGT 259 
KHRG            GGAAGAGTTGCGCAAGGGTGGAGACCCCAAATATGCCCATTTAAATATGGATCTGCATGT 900 
                ************************************************************ 
 
Sam68           CTTCATTGAAGTCTTTGGACCCCCGTGTGAAGCTTATGCTCTTATGGCCCATGCTATGGA 319 
KHRG            CTTCATTGAAGTCTTTGGACCCCCGTGTGAAGCTTATGCTCTTATGGCCCATGCTATGGA 960 
                ************************************************************ 
 
Sam68           AGAAGTCAAGAAGTTCCTAGTACCAGATATGATGGATGATATCTGTCAGGAGCAGTTTCT 379 
KHRG            AGAAGTCAAGAAGTTCCTAGTACCAGATATGATGGATGATATCTGTCAGGAGCAGTTTCT 1020 
                ************************************************************ 
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Sam68           AGAATTGTCCTACTTGAACGGAGTACCTGAACCCTCTCGTGGTCGTGGGGTATCTGTGAG 439 
KHRG            AGAATTGTCCTACTTGAACGGAGTACCTGAACCCTCTCGTGGTCGTGGGGTATCTGTGAG 1080 
                ************************************************************ 
 
Sam68           AGGACGAGGAGCTGCCCCTCCTCCTCCACCTGTTCCCAGAGGACGTGGTGTTGGACCACC 499 
KHRG            AGGACGAGGAGCTGCCCCTCCTCCTCCACCTGTTCCCAGAGGACGTGGTGTTGGACCACC 1140 
                ************************************************************ 
 
Sam68           TAGAGGAGCTTTGGTTCGTGGAACCCCAGTGAGAGGCTCCATCACCAGAGGTGCCACTGT 559 
KHRG            TAGAGGAGCTTTGGTTCGTGGAACCCCAGTGAGAGGCTCCATCACCAGAGGTGCCACTGT 1200 
                ************************************************************ 
 
Sam68           GACTCGAGGAGTGCCACCCCCACCTACTGTGAGGGGTGCTCCAACACCAAGAGCTCGGAC 619 
KHRG            GACTCGAGGAGTGCCACCCCCACCTACTGTGAGGGGTGCTCCAACACCAAGAGCTCGGAC 1260 
                ************************************************************ 
 
Sam68           AGCTGGGATTCAGAGAATACCTTTGCCTCCCACACCTGCACCAGAAACATACGAAGATTA 679 
KHRG            ATAAG----TCG------------------------------------------AGTNTA 1274 
                * .:*    **.                                          **:.** 
     Stop codon↑   
 
 
 
Sam68 short form4 (RG-tyrosine) inser showing the frame using CMVF primer 
 
Sam68           ------CGGAG------------------------------TACCTGAACCCTCTCGTGG 31 
RGTY            CTGTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCCCCTGAACCCTCTCGTGG 240 
                      *.*.*                               .***************** 
 
Sam68           TCGTGGGGTATCTGTGAGAGGACGAGGAGCTGCCCCTCCTCCTCCACCTGTTCCCAGAGG 91 
RGTY            TCGTGGGGTATCTGTGAGAGGACGAGGAGCTGCCCCTCCTCCTCCACCTGTTCCCAGAGG 300 
                ************************************************************ 
 
Sam68           ACGTGGTGTTGGACCACCTAGAGGAGCTTTGGTTCGTGGAACCCCAGTGAGAGGCTCCAT 151 
RGTY            ACGTGGTGTTGGACCACCTAGAGGAGCTTTGGTTCGTGGAACCCCAGTGAGAGGCTCCAT 360 
                ************************************************************ 
 
Sam68           CACCAGAGGTGCCACTGTGACTCGAGGAGTGCCACCCCCACCTACTGTGAGGGGTGCTCC 211 
RGTY            CACCAGAGGTGCCACTGTGACTCGAGGAGTGCCACCCCCACCTACTGTGAGGGGTGCTCC 420 
                ************************************************************ 
 
Sam68           AACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACCTTTGCCTCCCACACCTGCACC 271 
RGTY            AACACCAAGAGCTCGGACAGCTGGGATTCAGAGAATACCTTTGCCTCCCACACCTGCACC 480 
                ************************************************************ 
 
Sam68           AGAAACATACGAAGATTATGGATATGATGATACATACGCAGAACAGAGTTACGAAGGCTA 331 
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RGTY            AGAAACATACGAAGATTATGGATATGATGATACATACGCAGAACAGAGTTACGAAGGCTA 540 
                ************************************************************ 
 
Sam68           TGAAGGCTATTACAGCCAGAGTCAAGGGGAGTCAGAGTATTATGACTATGGACATGGGGA 391 
RGTY            TGAAGGCTATTACAGCCAGAGTCAAGGGGAGTCAGAGTATTATGACTATGGACATGGGGA 600 
                ************************************************************ 
 
Sam68           GCTCCAAGATTCTTACGAAGCCTACGGACAAGATGACTGGAATGGGACCAGGCCATCACT 451 
RGTY            GCTCCAAGATTCTTACGAAGCCTACGGACAAGATGACTGGAATGGGACCAGGCCATCACT 660 
                ************************************************************ 
 
Sam68           GAAGGCTCCTCCAGCTAGGCCAGTGAAGGGAGCATACAGAGAGCATCCATATGGACGTTA 511 
RGTY            GAAGGCTCCTCCAGCTAGGCCAGTGAAGGGAGCATACAGAGAGCATCCATATGGACGTTA 720 
                ************************************************************ 
 
Sam68           TTAA-------------------------------------------------------- 515 
RGTY            TTAAGTCGAGTCTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAG 780 
                ****                                                         
     Stop codon↑   
 
 
3. Sequencing results of RHA, RBM, RBMXL2 and TRA2B. ClustalW was used for 
generation of alignments. Stars show the identity. The stop codon is highlighted by 
red. 
 
5’ end of RHA construct insert the frame using CMVF primer 
 
RHA             ----------------------------------------ATGGGTGACGTTAAAAATTT 20 
RHA-a           GTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGGGTGACGTTAAAAATTT 240 
                                                        ******************** 
 
RHA             TCTGTATGCCTGGTGTGGCAAAAGGAAGATGACCCCATCCTATGAAATTAGAGCAGTGGG 80 
RHA-a           TCTGTATGCCTGGTGTGGCAAAAGGAAGATGACCCCATCCTATGAAATTAGAGCAGTGGG 300 
                ************************************************************ 
 
RHA             GAACAAAAACAGGCAGAAATTCATGTGTGAGGTTCAGGTGGAAGGTTATAATTACACTGG 140 
RHA-a           GAACAAAAACAGGCAGAAATTCATGTGTGAGGTTCAGGTGGAAGGTTATAATTACACTGG 360 
                ************************************************************ 
 
RHA             CATGGGAAATTCCACCAATAAAAAAGATGCACAAAGCAATGCTGCCAGAGACTTTGTTAA 200 
RHA-a           CATGGGAAATTCCACCAATAAAAAAGATGCACAAAGCAATGCTGCCAGAGACTTTGTTAA 420 
                ************************************************************ 
 
RHA             CTATTTGGTTCGAATAAATGAAATAAAGAGTGAAGAAGTTCCAGCTTTTGGGGTAGCATC 260 
RHA-a           CTATTTGGTTCGAATAAATGAAATAAAGAGTGAAGAAGTTCCAGCTTTTGGGGTAGCATC 480 
                ************************************************************ 
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RHA             TCCGCCCCCACTTACTGATACTCCTGACACTACAGCAAATGCTGAAGGAGATTTACCAAC 320 
RHA-a           TCCGCCCCCACTTACTGATACTCCTGACACTACAGCAAATGCTGAAGGAGATTTACCAAC 540 
                ************************************************************ 
 
RHA             AACCATGGGAGGACCTCTTCCTCCACATCTGGCTCTCAAAGCAGAAAATAATTCTGAGGT 380 
RHA-a           AACCATGGGAGGACCTCTTCCTCCACATCTGGCTCTCAAAGCAGAAAATAATTCTGAGGT 600 
                ************************************************************ 
 
 
3’ end of RHA insert showing the frame using BGHrev primer 
 
RHA             CGTCCTCCCAAGATGGCCCGATACGACAATGGAAGCGGATATAGAAGGGGAGGTTCTAGT 3537 
RHA-a           CGTCCTCCCAAGATGGCCCGATACGACAATGGAAGCGGATATAGAAGGGGAGGTTCTAGT 746 
                ************************************************************ 
 
RHA             TACAGTGGTGGAGGCTATGGCGGTGGCTATAGCAGTGGAGGCTATGGTAGCGGAGGCTAT 3597 
RHA-a           TACAGTGGTGGAGGCTATGGCGGTGGCTATAGCAGTGGAGGCTATGGTAGCGGAGGCTAT 806 
                ************************************************************ 
 
RHA             GGTGGCAGCGCCAACTCCTTTCGGGCAGGATATGGTGCAGGTGTTGGTGGAGGCTATAGA 3657 
RHA-a           GGTGGCAGCGCCAACTCCTTTCGGGCAGGATATGGTGCAGGTGTTGGTGGAGGCTATAGA 866 
                ************************************************************ 
 
RHA             GGAGTTTCCCGAGGTGGCTTTAGAGGCAACTCTGGAGGAGACTACAGAGGGCCTAGTGGA 3717 
RHA-a           GGAGTTTCCCGAGGTGGCTTTAGAGGCAACTCTGGAGGAGACTACAGAGGGCCTAGTGGA 926 
                ************************************************************ 
 
RHA             GGCTACAGAGGATCTGGGGGATTCCAGCGAGGAGGTGGTAGGGGGGCCTATGGAACTGGC 3777 
RHA-a           GGCTACAGAGGATCTGGGGGATTCCAGCGAGGAGGTGGTAGGGGGGCCTATGGAACTGGC 986 
                ************************************************************ 
 
RHA             TACTTTGGACAGGGAAGAGGAGGTGGCGGCTATTAA------------------------ 3813 
RHA-a           TACTTTGGACAGGGAAGAGGAGGTGGCGGCTATTAAGTCGAGTCTNNNGNNNNNNNNNNN 1046 
                ************************************ 
                                                                   Stop codon↑   
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5’ end of RBMX insert showing the frame using CMVF primer 
 
RBMX            ----------------------------------------ATGGTTGAAGCAGATCGCCC 20 
Construct       GTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGGTTGAAGCAGATCGCCC 240 
                                                        ******************** 
 
RBMX            AGGAAAGCTCTTTATTGGTGGGCTTAATACAGAGACGAATGAGAAAGCCCTTGAGGCAGT 80 
Construct       AGGAAAGCTCTTTATTGGTGGGCTTAATACAGAGACGAATGAGAAAGCCCTTGAGGCAGT 300 
                ************************************************************ 
 
RBMX            GTTTGGCAAATATGGACGAATAGTGGAAGTTCTTTTGATGAAGGACCGAGAAACGAATAA 140 
Construct       GTTTGGCAAATATGGACGAATAGTGGAAGTTCTTTTGATGAAGGACCGAGAAACGAATAA 360 
                ************************************************************ 
 
RBMX            GTCAAGAGGATTCGCTTTTGTCACTTTTGAAAGCCCAGCAGATGCAAAGGATGCTGCCAG 200 
Construct       GTCAAGAGGATTCGCTTTTGTCACTTTTGAAAGCCCAGCAGATGCAAAGGATGCTGCCAG 420 
                ************************************************************ 
 
RBMX            AGACATGAATGGAAAGTCCTTAGATGGGAAAGCCATCAAGGTGGAGCAAGCCACCAAACC 260 
Construct       AGACATGAATGGAAAGTCCTTAGATGGGAAAGCCATCAAGGTGGAGCAAGCCACCAAACC 480 
                ************************************************************     
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3’ end of RBMX insert showing the frame using BGHrev primer 
 
RBMX            TTATGGTAACTCACGTAGTGCTCCACCTACACGAGGGCCCCCGCCATCTTATGGTGGAAG 920 
Construct       TTATGGTAACTCACGTAGTGCTCCACCTACACGAGGGCCCCCGCCATCTTATGGTGGAAG 952 
                ************************************************************ 
 
RBMX            CAGTCGCTATGATGATTACAGCAGCTCACGTGACGGATATGGTGGAAGTCGAGACAGTTA 980 
Construct       CAGTCGCTATGATGATTACAGCAGCTCACGTGACGGATATGGTGGAAGTCGAGACAGTTA 1012 
                ************************************************************ 
 
RBMX            CTCAAGCAGCCGAAGTGATCTCTACTCAAGTGGTCGTGATCGCGTGGGCAGACAAGAAAG 1040 
Construct       CTCAAGCAGCCGAAGTGATCTCTACTCAAGTGGTCGTGATCGCGTGGGCAGACAAGAAAG 1072 
                ************************************************************ 
 
RBMX            AGGGCTTCCCCCTTCTATGGAAAGGGGGTACCCTCCTCCACGTGATTCCTACAGCAGTTC 1100 
Construct       AGGGCTTCCCCCTTCTATGGAAAGGGGGTACCCTCCTCCACGTGATTCCTACAGCAGTTC 1132 
                ************************************************************ 
 
RBMX            AAGCCGCGGAGCACCAAGAGGTGGTGGCCGTGGAGGAAGCCGATCTGATAGAGGGGGAGG 1160 
Construct       AAGCCGCGGAGCACCAAGAGGTGGTGGCCGTGGAGGAAGCCGATCTGATAGAGGGGGAGG 1192 
                ************************************************************ 
 
RBMX            CAGAAGCAGATACTAG--------------------------- 1176 
Construct       CAGAAGCAGATACTAGGTCGAGTCTAGAGNNNNNNNNNNNNNN 1235 
                ****************  
                               Stop codon↑   
 
 
5’ end of RBMXL2 insert showing the frame using CMVF primer 
 
RBMXL2           -------------------------------------------ATGGTTG 7 
Construct        TCTGTTCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGGTTG 150 
                                                            ******* 
 
RBMXL2           AAGCGGATCGCCCGGGGAAGCTGTTCATTGGGGGCCTCAACCTCGAAACC 57 
Construct        AAGCGGATCGCCCGGGGAAGCTGTTCATTGGGGGCCTCAACCTCGAAACC 200 
                 ************************************************** 
 
RBMXL2           GACGAGAAAGCCCTCGAAGCCGAGTTTGGCAAGTATGGCCGCATCGTCGA 107 
Construct        GACGAGAAAGCCCTCGAAGCCGAGTTTGGCAAGTATGGCCGCATCGTCGA 250 
                 ************************************************** 
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3’ end of RBMXL2 insert showing the frame using BGHrev primer 
 
RBMXL2          CGCGACCGTGACTACGGGGATCATCTGAGCAGAGGCTCCCATCGAGAGCCCTTTGAGAGC 855 
Construct       CGCGACCGTGACTACGGGGATCATCTGAGCAGAGGCTCCCATCGAGAGCCCTTTGAGAGC 896 
                ************************************************************ 
 
RBMXL2          TACGGAGAGCTGCGCGGCGCCGCCCCAGGACGGGGGACACCGCCATCTTACGGAGGAGGA 915 
Construct       TACGGAGAGCTGCGCGGCGCCGCCCCAGGACGGGGGACACCGCCATCTTACGGAGGAGGA 956 
                ************************************************************ 
 
RBMXL2          GGCCGCTACGAGGAGTACCGGGGCTACTCACCCGATGCCTACAGCGGCGGCCGCGACAGT 975 
Construct       GGCCGCTACGAGGAGTACCGGGGCTACTCACCCGATGCCTACAGCGGCGGCCGCGACAGT 1016 
                ************************************************************ 
 
RBMXL2          TACAGCAGCAGTTATGGCCGGAGCGACCGCTACTCGAGGGGCCGACACCGGGTGGGCAGA 1035 
Construct       TACAGCAGCAGTTATGGCCGGAGCGACCGCTACTCGAGGGGCCGACACCGGGTGGGCAGA 1076 
                ************************************************************ 
 
RBMXL2          CCAGATCGTGGGCTCTCTCTGTCCATGGAAAGGGGCTGCCCTCCCCAGCGTGATTCTTAC 1095 
Construct       CCAGATCGTGGGCTCTCTCTGTCCATGGAAAGGGGCTGCCCTCCCCAGCGTGATTCTTAC 1136 
                ************************************************************ 
 
RBMXL2          AGCCGGTCAGGCTGCAGGGTGCCCAGGGGCGGAGGCCGTCTAGGAGGCCGCTTGGAGAGA 1155 
Construct       AGCCGGTCAGGCTGCAGGGTGCCCAGGGGCGGAGGCCGTCTAGGAGGCCGCTTGGAGAGA 1196 
                ************************************************************ 
 
RBMXL2          GGAGGAGGCCGGAGCAGATACTAA--------------------------- 1179 
Construct       GGAGGAGGCCGGAGCAGATACTAAGTCGAGTCTAGAGNNNNNNNNNNNNNN 1247 
                ************************ 
                                             Stop codon↑   
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5’ end of TRA2B insert showing the frame using CMVF primer 
 
TRA2B           --------------------------------------ATGAGCGACAGCGGCGAGCAGA 22 
Construct       TCCAGGGGCCCCTGCATCACCACCATCACCATGGATCCATGAGCGACAGCGGCGAGCAGA 240 
                                                      ********************** 
 
TRA2B           ACTACGGCGAGCGGGAATCCCGTTCTGCTTCCAGAAGTGGAAGTGCTCACGGATCGGGGA 82 
Construct       ACTACGGCGAGCGGGAATCCCGTTCTGCTTCCAGAAGTGGAAGTGCTCACGGATCGGGGA 300 
                ************************************************************ 
 
TRA2B           AATCTGCAAGGCATACCCCTGCAAGGTCTCGCTCCAAGGAAGATTCCAGGCGTTCCAGAT 142 
Construct       AATCTGCAAGGCATACCCCTGCAAGGTCTCGCTCCAAGGAAGATTCCAGGCGTTCCAGAT 360 
                ************************************************************ 
 
TRA2B           CAAAGTCCAGGTCCCGATCTGAATCTAGGTCTAGATCCAGAAGAAGCTCCCGAAGGCATT 202 
Construct       CAAAGTCCAGGTCCCGATCTGAATCTAGGTCTAGATCCAGAAGAAGCTCCCGAAGGCATT 420 
                ************************************************************ 
 
TRA2B          ATACCCGGTCACGGTCTCGCTCCCGCTCCCATAGACGATCACGTAGCAGGTCTTACAGTC 262 
Construct       ATACCCGGTCACGGTCTCGCTCCCGCTCCCATAGACGATCACGTAGCAGGTCTTACAGTC 480 
                ************************************************************ 
 
3’ end of TRA2B insert showing the frame using pCDNArev 
 
TRA2B           TAGGCGTTCAAGAGGATTTGCCTTTGTATATTTTGAAAATGTAGATGATGCCAAGGAAGC 524 
Construct       TAGGCGTTCAAGAGGATTTGCCTTTGTATATTTTGAAAATGTAGATGATGCCAAGGAAGC 780 
                ************************************************************ 
 
TRA2B           TAAAGAACGTGCCAATGGAATGGAGCTTGATGGGCGTAGGATCAGAGTTGATTTCTCTAT 584 
Construct       TAAAGAACGTGCCAATGGAATGGAGCTTGATGGGCGTAGGATCAGAGTTGATTTCTCTAT 840 
                ************************************************************ 
 
TRA2B           AACAAAAAGACCACATACGCCAACACCAGGAATTTACATGGGGAGACCTACCTATGGCAG 644 
Construct       AACAAAAAGACCACATACGCCAACACCAGGAATTTACATGGGGAGACCTACCTATGGCAG 900 
                ************************************************************ 
 
TRA2B           CTCTCGCCGTCGGGATTACTATGACAGAGGATATGATCGGGGCTATGATGATCGGGACTA 704 
Construct       CTCTCGCCGTCGGGATTACTATGACAGAGGATATGATCGGGGCTATGATGATCGGGACTA 960 
                ************************************************************ 
 
TRA2B           CTATAGCAGATCATACAGAGGAGGAGGTGGAGGAGGAGGAGGATGGAGAGCTGCCCAAGA 764 
Construct       CTATAGCAGATCATACAGAGGAGGAGGTGGAGGAGGAGGAGGATGGAGAGCTGCCCAAGA 1020 
                ************************************************************ 
 
TRA2B           CAGGGATCAGATTTATAGAAGGCGGTCACCTTCTCCTTACTATAGTCGTGGAGGATACAG 824 
Construct       CAGGGATCAGATTTATAGAAGGCGGTCACCTTCTCCTTACTATAGTCGTGGAGGATACAG 1080 
                ************************************************************ 
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TRA2B           ATCACGTTCCAGATCTCGATCATACTCACCTCGTCGCTATTAA----------------- 867 
Construct       ATCACGTTCCAGATCTCGATCATACTCACCTCGTCGCTATTAAGTCGAGTCTAGAGGGCC 1140 
                ******************************************* 
                                                                                     Stop codon↑   
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Appendix B 
 
(The predicted binding sites of RNA binding proteins within the alternatively spliced 
exons of ACOT9 and MYOF) 
 
ACOT9: 
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MOYF:  
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(The predicted binding sites of RNA binding proteins within the alternatively spliced 
exons of ENAH) 
 
ENAH:  
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